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Primary afferent neurons are equipped with sensory transduction channels which allow the 
conversion of physical and chemical stimuli into electrical signals. TRP channels are a 
heterogeneous superfamily of largely non-selective cation channels, which have been 
implicated in a myriad of sensory transduction mechanisms from the detection of 
temperature to the sensation of touch. Many TRP channels are key targets for the study of 
pain physiology due to their polymodal activation and expression in small diameter, 
unmyelinated sensory fibres. The aim of my project was to examine the roles of TRP 
channels in sensory transduction mechanisms. Three results chapters focusing on three 
different TRP channels are presented.  
A novel role for the established cold thermosensor, TRPM8, as a cellular osmosensor was 
determined. The studies presented establish that TRPM8 is activated by increases in 
extracellular osmolality and is partially activated at normal physiological osmolalities. Cool 
temperatures increase the sensitivity of TRPM8 to osmotic stimuli and activation of 
phospholipase enzymes modulates activation of TRPM8 by hyperosmotic solutions. TRPM8 
is expressed within sensory neurons where it functions as the chief detector of increased 
osmolality in addition to a molecular sensor of cold sensations. 
The role of TRPM3 as a candidate heat transduction channel is examined. The findings 
presented demonstrate that recombinantly expressed TRPM3 channels are heat-sensitive 
and mice lacking functional TRPM3 channels lose a population of heat-activated neurons 
and have impaired behavioural responses to noxious heat. Moreover, modulation of 
TRPM3 by intracellular pathways downstream of G-protein coupled receptor activation has 
been determined. Activation of TRPM3 in sensory neurons is shown to be robustly inhibited 
by morphine in a predominantly mu-opioid receptor and Gi dependent mechanism. 
Additionally the role of TRPM3 in several pain states is examined.  
Finally, this thesis reports on the characterisation of a medium-throughput CGRP release 
assay for examining activation of TRPA1 natively expressed on the central terminals of 
dorsal root ganglion neurons. Activation of TRPA1 expressed on spinal cord synaptosomes 
by a selection of agonists evokes a concentration-dependent release of CGRP which is 
inhibited by TRPA1 antagonists. The VGCC subtypes important for TRPA1 and 
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1.1 Introduction to sensation 
The ability to sense and respond to stimuli present within the local environment is crucial 
for organism survival. Humans are thought to have five traditional exteroceptive senses 
which allow them to perceive their outside surroundings. These five senses were first 
defined by Aristotle in De Anima, book II, and include the senses of sight, hearing, smell, 
taste and touch (Damann et al., 2008). In addition to sensing the outside world using 
exteroceptive senses, humans are also able to perceive sensations which arise internally 
through interoceptive senses. 
1.2 The somatosensory nervous system  
Sensory nerves continuously survey the internal and external environments and convey a 
plethora of sensory information to the central nervous system (CNS) concerning multiple 
sensory modalities. Mechanical sensations such as touch, pressure and vibration, in 
addition to the sensations of temperature and pain are processed by the somatosensory 
nervous system. 
Anatomically, the somatosensory nervous system consists of a pathway of three neurons. 
The first order neuron or primary afferent neuron innervates target organs in the 
periphery. The second order neuron is located within the spinal cord or brainstem and 
relays information to a third order neuron within the brain. The dorsal column-medial 
lemniscal pathway and the spinothalamic tract are distinct neuronal pathways which carry 
information relating to innocuous mechanical sensation and temperature/pain, 
respectively. 
1.3 The primary afferent neuron  
Primary afferent neurons of the somatosensory system are pseudounipolar and are 
composed of two axonal branches (see Figure 1-1), a peripheral branch which provides 
innervation of target tissues and a central branch which terminates onto second order 
neurons located within the dorsal horn of the spinal cord or the sensory nucleus in the 
brain (Mosso and Kruger, 1973; Wall, 1967). The cell bodies of primary afferent neurons 
which carry information from the body are contained within the dorsal root ganglia (DRG). 
In contrast, the cell bodies of sensory neurons carrying information from the face, head and 




1.3.1 Sensory nerve modalities 
The nineteenth century Scottish physician, Charles Bell (1774-1842), was one of the first to 
convey the idea that sensory nerves were modality-specific. This concept was shared by the 
German physiologist Johannes Müller (1801-1858) who formulated the ‘law of specific 
nerve energies’ which stated that the perception of a sense was reliant upon the pathway 
which carried it and not the stimulus which evoked it (Norrsell et al., 1999). 
 
Figure 1-1 Primary afferent nerves of the somatosensory system 
Primary afferent nerves which have their cell bodies in the DRG terminate onto second order neurons in the 
dorsal horn of the spinal cord. These spinal neurons carry sensory information to third order neurons in the 
brain, Adapted from (Mantyh, 2006). 
Consistent with this concept, three researchers, Magnus Blix, Alfred Goldscheider and 
Henry Donaldson independently published papers in the early 1880’s which detailed the 
existence of distinct cutaneous spots which were selective for specific sensory modalities 
i.e. cool, warm, touch and pain (Norrsell et al., 1999). These findings were supported by the 
work of Austrian-German physiologist Max von Frey (1852-1932), who studied cutaneous 
sensation in detail and confirmed the existence of punctate cold, warm, tactile and pain 
spots on the skin (Kruger, 1996). It is now known that different primary afferent neurons 
possess sensitivity to one or more specific sensory modalities. Nerve fibres are often 
classified according to the sensory modalities that they transduce and can be broadly 
categorised as mechanoreceptors, thermoreceptors and nociceptors. 
1.3.2 Primary afferent nerve fibre types 
Sensory nerve fibres which contribute to different sensations can be categorised according 
to their diameter size and myelination characteristics (see Figure 1-2). Aα-fibres are very 
large diameter (15-20mm), thickly-myelinated neurons which are responsible for signalling 
proprioceptive information. Aβ-fibres are large-diameter (5-15µm), myelinated fibres 
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which largely signal information about innocuous (harmless/non-painful) mechanical 
stimuli and have fast conduction velocities of ~50 m/s (Squire et al., 2002). 
 
Figure 1-2 Primary afferent nerve fibre types 
Diagram illustrating the properties of different classes of primary afferent nerve fibres. Approximate 
temperature thresholds are listed for heat-sensitive nerve fibres. Adapted from (Julius and Basbaum, 2001). 
In contrast to Aβ-fibres, Aδ-fibres are thinly myelinated, medium-diameter (1-5µm) 
neurons. They have slower conduction velocities than Aβ-fibres and are involved in 
thermosensing and nociception. This class of fibres can be further divided into two sub-
populations, Type I and Type II, based on their heat sensitivity. Type I fibres have high heat 
thresholds whilst Type II Aδ-fibres have comparatively lower thresholds for heat activation 
(Basbaum et al., 2009; Dubin and Patapoutian, 2010; Squire et al., 2002). 
C-fibres are very small diameter (<1µm) fibres and in contrast to A-fibres, are completely 
unmyelinated. C-fibres have very slow conduction velocities and similar to Aδ-fibres these 
neurons are principally involved in the detection of temperature and pain (Basbaum et al., 
2009; Squire et al., 2002). The majority of C-fibres are sensitive to mechanical and heat 
stimuli (CMH), or mechanical and cold stimuli (CMC) or mechanical, cold and heat stimuli 
(CMHC). Interestingly, a population of C-fibres are insensitive to both heat and mechanical 
stimuli under physiological conditions but gain sensitivity to these stimuli following 
inflammatory sensitisation (Dubin and Patapoutian, 2010). A population of C-fibres has also 




1.3.3 Nociceptive nerve fibres 
Primary afferent neurons which are selectively gated by noxious (painful) stimuli are 
referred to as ‘nociceptors’. This term was coined by the English neurophysiologist, Charles 
Sherrington (1857-1952) in 1906 (Woolf and Ma, 2007). Evidence of peripheral nerve fibres 
which are selectively activated by high threshold or ‘noxious’ stimuli was presented in 
papers by Edward Perl and colleagues in the late 1960s and early 1970s. Perl et al recorded 
the activities of cutaneous nerve fibres in cats and primates and identified nerves which 
were activated by noxious stimuli but showed little or no activity to innocuous stimuli 
(Bessou and Perl, 1969; Burgess and Perl, 1967; Perl, 1968).  
Previous to Perl’s research, the Austrian-German physiologist Max Von Frey (1852-1932) 
had sought to associate sensory modalities with different classes of nerve endings by 
comparing the numbers of specific modality spots present within a cutaneous area with the 
numbers of different categories of nerve endings (Kruger, 1996). On the basis of these 
observations von Frey suggested that the sensation of pain was associated with 
unencapsulated free nerve endings (Norrsell et al., 1999). Charles Sherrington (1857-1952), 
concurred with von Frey’s observation. Sherrington reported from his own research that 
areas where stimulation lead only to sensations of pain were innervated by free nerve 
endings which were either unmyelinated or thinly myelinated (Kruger, 1996). The 
characteristics of nociceptors are now well documented (Basbaum et al., 2009; Woolf and 
Ma, 2007). Nociceptors are composed of C and Aδ primary afferent nerve fibres which 
innervate peripheral tissues as free nerve endings.  
Noxious stimulation in humans elicits two sensations of pain, the first a sharp, rapid pain 
and the second a delayed, longer lasting, dull pain (Julius and Basbaum, 2001). It is widely 
assumed that the difference in conduction velocities between Aδ (~6-25 m s-1) and C fibres 
(~ 1 m s-1) accounts for these two distinct pain sensations (see Figure 1-3).  
1.3.3.1 Neurochemical characterisation of nociceptors 
Unmyelinated, nociceptive, C-fibres can be divided into two neurochemical classes based 
on their neuropeptide content: peptidergic and non-peptidergic nociceptors (Basbaum et 
al., 2009; Woolf and Ma, 2007). Peptidergic nociceptors can be distinguished from the non-
peptidergic population by their expression of the peptide neurotransmitters substance P 
(SP) and calcitonin-gene related peptide (CGRP). The non-peptidergic nociceptors are 
characterised by an ability to bind isolectin B4 (IB4) and have been found to express 
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receptors belonging to the Mrg family of G protein coupled receptors (Dong et al., 2001; 
Snider and McMahon, 1998).  
 
Figure 1-3 Pain sensations associated with different nociceptor fibre types  
The sharp, first pain elicited by noxious stimuli can be attributed to activation of medium-diameter, lightly 
myelinated Aδ-fibres and the activation of the more slowly-conducting, small-diameter, unmyelinated C-fibres 
is responsible for the second, dull, aching pain. Activation of large-diameter, myelinated, fast-conducting Aα 
and Aβ fibres does not evoke painful sensations. Adapted from (Julius and Basbaum, 2001). 
All embryonic nociceptive neurons express the TrkA receptor for nerve growth factor 
(NGF), however, studies have shown that in early postnatal life a population of nociceptive 
nerve fibres stops expressing TrkA and starts to express a component of the glial cell line-
derived neurotrophic factor (GDNF) receptor, RET. It is these RET-expressing fibres which 
become the non-peptidergic population of nociceptors (Bennett et al., 1996; Molliver et al., 
1997; Snider and McMahon, 1998). The peptidergic nociceptor sub-population is formed 
from the remaining nerve fibres which continue to express the TrkA NGF receptor (Snider 
and McMahon, 1998).  
1.3.4 Central projections of primary afferent neurons 
The central terminals of primary afferent nerve fibres (from the body) innervate the dorsal 
horn of the spinal cord (Basbaum et al., 2009). The different categories of nerve fibre types 
discussed earlier, project to different locations within the dorsal horn (see Figure 1-4). The 
large, myelinated Aβ fibres terminate deep within the dorsal horn (laminae III-V) whereas, 
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the small-diameter, nociceptive C -fibres, terminate within the superficial layers of the 
dorsal horn (laminae I and II). The medium diameter, nociceptive, Aδ-fibres terminate 
within superficial laminae I and deep laminae V (Basbaum et al., 2009). 
 
Figure 1-4 Central projection patterns of primary afferent fibres  
Different classes of primary afferent neurons project to distinct areas of the dorsal horn. Nociceptive nerve-
fibres (Aδ- and C-fibres) terminate within the superficial layers (lamina I-II) of the dorsal horn of the spinal cord. 
In contrast nerve-fibres carrying information about innocuous touch (Aβ-fibres) terminate deeper within the 
dorsal horn (lamina III-IV).  
Projection patterns of C-fibre nociceptor subpopulations have been even further dissected; 
peptidergic, TrkA-expressing nerve fibres appear to mostly terminate in lamina I and the 
outer layer of lamina II, in contrast, the IB4-binding nociceptor population project to the 
inner layer of lamina II (Snider and McMahon, 1998).  
1.4 TRP Channels 
Primary afferent neurons are equipped with sensory transduction channels which allow the 
conversion of physical and chemical stimuli into electrical signals. Over the past two 
decades, extensive research into the transient receptor potential (TRP) family of ion 
channels has revealed a role for TRP channels in the transduction of a diverse range of 
stimuli (Damann et al., 2008; Eijkelkamp et al., 2013; Sexton et al., 2014; Vriens et al., 
2014a).  
TRP channels are a heterogeneous superfamily of largely non-selective cation channels, 
members have been found in both invertebrate and vertebrate animal species, and have 
even been found in yeast (Nilius and Owsianik, 2011). 
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1.4.1 Discovery  
The first TRP channel was discovered through the finding of a mutation in the visual system 
of the fruit fly, Drosophila melanogaster (Cosens and Manning, 1969). In this system, 
rhodopsin is coupled to phospholipase C (PLC) activation which, in turn, opens cationic 
channels to evoke a depolarising membrane current (Pedersen et al., 2005). In contrast to 
the wildtype, sustained receptor potential, the Drosophila TRP mutant exhibited a transient 
response to a continuous light stimulus (Cosens and Manning, 1969). The gene responsible 
for this transient receptor potential was accordingly named the trp gene and was cloned in 
1989 (Montell and Rubin, 1989). 
1.4.2 Sub-families  
Members of the TRP channel family can be separated into seven sub-families (TRPC, TRPV, 
TRPM, TRPA, TRPML, TRPP and TRPN) based on protein homology (Nilius and Owsianik, 
2011). Members of the TRPN sub-family are not present in mammals and have only been 
identified in lower vertebrates and invertebrates. At present, the mammalian TRP channel 
family consists of 28 members belonging to six TRP sub-families, 27 of which are expressed 
in humans (as human TRPC2 has been identified as a pseudogene). 
1.4.3 Structure 
TRP channels assemble into tetramers to form an ion permeable pore. Some studies have 
reported the formation of functional heteromultimeric TRP channels however most TRP 
channels are thought to function as homotetramers (Nilius and Owsianik, 2011). Each TRP 
channel subunit or monomer is characterised by six transmembrane (TM) domains, 
intracellular amino (N) and carboxy (C) termini, and a pore region which is located between 
TM5 and TM6 (see Figure 1-5).  
The intracellular termini of TRP channels contain a wide range of domains and can vary in 
length (Hellmich and Gaudet, 2014; Nilius and Owsianik, 2011). Notably, some members of 
the TRPM sub-family, namely TRPM2, TRPM6 and TRPM7, feature enzyme domains within 
their intracellular C-termini (Perraud et al., 2001; Runnels et al., 2001; Schlingmann et al., 
2002). Another structural characteristic of many TRP channels is the presence of ankyrin 
repeat domains (ARDs). Ankyrin repeats are motifs of ~33-34 amino acids which form two 
α-helices connected to a β-hairpin loop (Hellmich and Gaudet, 2014). ARDs have been 
identified in the intracellular N-termini of channels belonging to the TRPA, TRPV, TRPC and 
TRPN sub-families. The number of repeats present within a domain vary, ranging from 29 
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predicted repeats in TRPNs, to 17 in TRPAs,  6 in TRPVs and  4 in TRPCs (Hellmich and 
Gaudet, 2014). In the context of TRPV channels, ARDs have been suggested to be important 
for channel assembly and appear to exert an inhibitory role on channel sensitivity (Hellmich 
and Gaudet, 2014). 
 
Figure 1-5 TRP channel structure  
TRP channel subunits feature six membrane-spanning domains (TM1-6) with a pore region located between the 
fifth and sixth transmembrane domains. The majority of TRP channels are non-selective cation channels and are 
permeable to both monovalent and divalent cations.  
Many TRP channels also contain motifs which are important for regulation of channel 
function; these include, binding domains for the calmodulin (CaM) protein and sites for 
phosphorylation and lipid interaction (Nilius and Owsianik, 2011). Members of some TRP 
subfamilies also contain coiled-coil domains which have been demonstrated to be 
important for channel assembly (Hellmich and Gaudet, 2014; Tsuruda et al., 2006). 
1.4.4 Mammalian TRP channels  
1.4.4.1 TRPC 
Members of the TRPC or ‘canonical’ subfamily of TRP channels are the closest mammalian 
relatives to the D.melanogaster TRP channel. TRPC1 was the first identified mammalian 
TRP channel and was cloned in 1995 (Petersen et al., 1995; Wes et al., 1995). There are 
seven mammalian TRPC channels in total and these can be organised into four subsets 
based on function and sequence homology (see Figure 1-6): TRPC1, TRPC2, TRPC3/6/7 and 
TRPC4/5 (Pedersen et al., 2005). Notably, TRPC channels can form heteromultimeric 
channels both within and between subsets which possess distinct properties that differ 
from those of homotetramers (Pedersen et al., 2005). In general, TRPC channel activity is 
stimulated by receptors which are coupled to PLC activation. TRPC1 is widely expressed and 
is reported to have important functions within the brain (Clapham, 2003). Additionally, it 
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has also been identified as a mechanosensitive component of the stretch-activated cation 
channel in vertebrate cells and has been implicated in the transduction of innocuous 
mechanical stimuli (Garrison et al., 2012; Maroto et al., 2005). As mentioned previously 
TRPC2 is a pseudogene in humans, however in rats it is important for pheromone detection 
as well as sexual and social behaviours (Pedersen et al., 2005). TRPC3, 6 and 7 are highly 
expressed in cardiac and smooth muscle cells and their activity can be increased by DAG 
(Clapham, 2003). Moreover, TRPC3 and TRPC6 are expressed in a subset of small-diameter 
sensory neurons where they are thought to function as components of a mechanically-
activated complex (Eijkelkamp et al., 2013; Quick et al., 2012). TRPC4 and 5 are both widely 
expressed. TRPC4 appears to play roles in a wide range of biological processes including 
axon regeneration and myotube formation (Freichel et al., 2014). TRPC5 is also implicated 
in a diverse array of biological functions. Interestingly, TRPC5 has been implicated in the 
transduction of innocuous cold and mechanical/osmotic stimuli (Gomis et al., 2008; 
Zimmermann et al., 2011).  
 
Figure 1-6 Phylogenetic tree of mammalian TRP channels  






The TRPV or ‘vanilloid’ subfamily of TRP channels is named after its founding member, 
TRPV1, a vanilloid and heat-sensitive channel (Caterina et al., 1997). TRPV1 was cloned in 
1997 and has since been found to be important for regulation of body temperature, 
behavioural responses to acute noxious heat and hyperalgesia following tissue injury 
(Caterina et al., 2000; Davis et al., 2000; Romanovsky et al., 2009). TRPV1 is expressed in 
sensory neurons as well as non-neuronal cells and in addition to being activated by 
vanilloid compounds, TRPV1 is also activated by protons, anandamide and the lipid 
products, 12- and 15-(S)-HPETE, 5-(S)-HETE, and leukotriene B4 (for review see Bevan et al., 
2014). Many members of the TRPV subfamily have been identified as molecular 
transducers of thermal stimuli. For example, TRPV2, which is 50% identical to TRPV1, is also 
expressed in sensory neurons and is activated by painfully hot temperatures with a higher 
temperature threshold than TRPV1 (Caterina et al., 1999). TRPV2 is also sensitive to 
hypotonic stimulation and cell stretch, and has been implicated in the hypotonicity-induced 
responses of mouse vascular myocytes (Muraki et al., 2003). TRPV3 and TRPV4 have been 
identified as heat-sensitive ion channels which are activated by ‘warm’ temperatures (Peier 
et al., 2002a; Smith et al., 2002; Xu et al., 2002). In addition, to being heat-sensitive TRPV4 
is also sensitive to decreases in osmolarity and has been implicated in mechanisms 
controlling water intake (Liedtke and Friedman, 2003; Liedtke et al., 2000, 2003). TRPV5 
and TRPV6 are the most Ca2+ selective TRP channels and are highly expressed in the kidney 
and intestine where they play important roles in Ca2+ reabsorption (den Dekker et al., 
2003). TRPV5 and TRPV6 can form either homotetramers or heteromultimeric channels 
with each other (Pedersen et al., 2005).  
1.4.4.3 TRPM 
The TRPM or melastatin subfamily of TRP channels consists of eight identified channels, 
TRPM1-8, which can be separated into four pairs due to their amino acid identity; TRPM1 
and TRPM3, TRPM2 and TRPM8, TRPM4 and TRPM5, and TRPM6 and TRPM7 (Grimm et al., 
2003). The first identified member of this subfamily, TRPM1 (or melastatin), is thought to 
be a tumour suppressor protein, it was found to be poorly expressed in a highly metastatic 
cell line and highly expressed in weakly metastatic cell line (Duncan et al., 1998). In addition 
to this role, TRPM1 has also been implicated in the responses of mouse retinal ON-bipolar 
cells to light (Irie and Furukawa, 2014). The TRPM3 channel shares 57% sequence identity 
with TRPM1 and is widely expressed, but has not been extensively characterised. Multiple 
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splice variants for TRPM3 exist, one variant has been shown to be activated by hypotonicity 
and another has been implicated in noxious heat-sensing (Grimm et al., 2003; Vriens et al., 
2011). In addition, TRPM3 is activated by the neurosteroid pregnenolone sulphate, ᴅ-
erytho-sphingosine and nifedipine (Grimm et al., 2005; Wagner et al., 2008).  
Interestingly, the TRPM2 channel contains a Nudix hydrolase domain in its intracellular C-
terminal which is able to function as an ADP-ribose pyrophosphatase (Perraud et al., 2001). 
TRPM2 is activated ADP-ribose and Ca2+, in addition to reactive oxygen and nitrogen 
species (Faouzi and Penner, 2014). TRPM8 has ~42% sequence identity with TRPM2 and 
was originally identified in prostate tissue (Pedersen et al., 2005; Tsavaler et al., 2001). 
Expression of TRPM8 has been shown to be upregulated in tumours (Almaraz et al., 2014). 
Notably, TRPM8 is expressed in a subpopulation of small diameter sensory neurons which 
are sensitive to cold and is implicated in mammalian cold-sensing mechanisms (Bautista et 
al., 2007; Colburn et al., 2007; Dhaka et al., 2007; McKemy et al., 2002; Peier et al., 2002b). 
Activators of TRPM8 include: cool temperatures, the naturally-occurring cooling compound 
from the mint plant, menthol, and the synthetic cooling agent, icilin (McKemy et al., 2002; 
Peier et al., 2002b).  
In contrast to other members of the TRP family, TRPM4 and TRPM5 are selective for 
monovalent ions and are directly gated by Ca2+ (Guinamard et al., 2011; Pedersen et al., 
2005). TRPM4 is widely expressed and has been implicated in pressure-induced vascular 
smooth muscle depolarisation, insulin secretion from pancreatic β-cells and mechanisms of 
cardiac hypertrophy (Mathar et al., 2014). In contrast, TRPM5 functions within taste cells to 
mediate bitter, sweet and umami taste sensations (Liman, 2014; Zhang et al., 2003). 
Activation of TRPM5 in taste cells occurs downstream of GPCR-mediated activation of 
PLCβ2. The final pair of TRPM members, TRPM6 and TRPM7, share 50% sequence identity 
and both contain an atypical α-kinase domain in their intracellular C-termini (Runnels et al., 
2001; Schlingmann et al., 2002). TRPM6 is highly expressed in epithelial cells of the kidney 
and intestine, whilst TRPM7 appears to be ubiquitously expressed. Both channels are 
important for Mg+ homeostasis (Chubanov and Gudermann, 2014; Fleig and Chubanov, 
2014). 
1.4.4.4 TRPA 
The TRPA1 channel is the sole member of the mammalian TRPA family, it is expressed in a 
subpopulation of small to medium diameter sensory neurons and can also been found in 
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non-neuronal cells such as epithelial cells, enterochromaffin cells and pancreatic β cells 
(Story et al., 2003a; Zygmunt and Högestätt, 2014). TRPA1 is activated by pungent food 
compounds such as cinnamaldehyde (cinnamon), allyl isothiocyanate (mustard oil), and 
allicin (garlic). It can also be activated by environmental irritants such as acrolein and 
products of oxidative stress (Andersson et al., 2008; Bautista et al., 2006). TRPA1 has also 
been reported to be activated by cold temperatures and has been implicated in the 
transduction of noxious cold (Fajardo et al., 2008a; Karashima et al., 2009; Kwan et al., 
2006) however activation of TRPA1 by cold is controversial (Bautista et al., 2006; Jordt et 
al., 2004). Moreover, various reports have suggested a role for TRPA1 in 
mechanotransduction (Brierley et al., 2011; Corey et al., 2004; Kwan et al., 2006, 2009). 
1.4.4.5 TRPP + TRPML 
The TRPP or ‘polycystin’ subfamily of TRP channels consists of three members: TRPP2, 
TRPP3 and TRPP5. TRPP channels are thought to form functional complexes with members 
of the polycystin-1 family, which are larger 11 transmembrane domain (TMD) proteins 
(Semmo et al., 2014). Mutations in the TRPP2 channel gene result in polycystic kidney 
disease a form of inherited kidney failure (Nilius and Owsianik, 2011). TRPP2 is also 
required for vertebrate left-right asymmetry (Semmo et al., 2014). Heteromeric complexes 
of TRPP3 and a PKD1L3 (a member of the polycystin-1 family) have been implicated in sour 
taste transduction (Semmo et al., 2014). 
The TRPML or ‘mucolipin’ subfamily of TRP channels also has three members: TRPML1-3 
(Nilius and Owsianik, 2011). A mutation in the founding member of this family, TRPML1, 
causes the lysosomal storage disease, mucolipidosis type IV (MLIV). TRPML1 is 
predominantly expressed on late endosomes/lysosomes where it is thought to mediate 
divalent cation release into the cytosol of cells (Wang et al., 2014). Similar to TRPML1, 
TRPML2 and TRPML3 are also localised to the membranes of endosomes and lysosomes 
(García-Añoveros and Wiwatpanit, 2014; Grimm et al., 2014).  
1.5 The molecular basis of sensation  
Primary afferent neurons are sensitive to changes in temperature, mechanical 
perturbations, fluctuations in extracellular osmolarity and exposure to certain chemicals. 
The sensitivity of individual nerve fibres to these stimuli is dependent on the selection of 





Sensory neurons respond to both innocuous warmth and noxious heat, with a distinct 
threshold for the latter which lies around 43°C (Basbaum et al., 2009). The search for the 
molecular receptor for capsaicin, the pungent ingredient found in chilli peppers which was 
known to cause activation of nociceptive sensory neurons and a sensation of ‘burning pain’, 
lead to the discovery of TRPV1 (Caterina et al., 1997; Szolcsányi, 1977). TRPV1, in addition 
to being the receptor for capsaicin, was also shown to be a thermosensitive channel 
activated by ‘hot’ temperatures (Caterina et al., 1997, 2000). Interestingly, the temperature 
activation threshold for TRPV1 (~43°C) mirrored the temperature at which heat becomes 
painful in humans (Basbaum et al., 2009; Caterina et al., 2000). This finding combined with 
the expression of TRPV1 in the majority of heat-sensitive sensory neurons, strongly 
suggested a role for TRPV1 as the molecular sensor for noxious heat (Basbaum et al., 2009; 
Caterina et al., 1997, 2000). However, studies examining mice lacking functional TRPV1 
channels (Trpv1-/-) reported limited effects on acute noxious heat sensitivity in vivo. In one 
study Trpv1-/- mice displayed longer latencies to paw and tail withdrawal from a plate or 
water bath set at noxious high temperatures (>50°C) respectively, but showed little to no 
difference in latency to paw withdrawal from radiant hot temperatures, suggesting that 
mice without TRPV1 channels are still sensitive to noxious heat (Caterina et al., 2000). 
Another study reported that there were no significant differences in the paw withdrawal 
responses of Trpv1+/+, Trpv1-/+ and Trpv1-/- mice to a plate heated to noxious temperatures 
or radiant noxious heat (Davis et al., 2000). Interestingly, a study which examined mice 
which had been given a high dose of intrathecal capsaicin to ablate TRPV1-expressing 
central nerve terminals, did report profound deficits in noxious heat sensing to both hot-
plate and radiant heat tests, suggesting a requirement of TRPV1-expressing nociceptors for 
noxious heat sensitivity (Cavanaugh et al., 2009). These studies indicate that whilst TRPV1 
is likely to play a role in sensing noxious heat, other sensors of acute noxious heat are still 
to be identified.  
Other ion channels belonging to the TRPV subfamily have since been implicated as 
potential heat transducers which function alongside TRPV1 (see Figure 1-7). TRPV2, a 
capsaicin-insensitive TRPV1 homologue expressed in medium to large diameter sensory 
neurons, is activated by hot temperatures with a temperature activation threshold of ~52°C  
(Caterina et al., 1999). However, studies examining the acute nociceptive responses of 
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Trpv2-/- mice revealed that mice lacking functional TRPV2 channels display normal 
responses to acute noxious heat even above temperatures required to activate the 
channel, suggesting that TRPV2 is not essential for sensing noxious hot temperatures (Park 
et al., 2011). Further experiments demonstrated that the lack of effect from TRPV2 deletion 
was not due to compensation by TRPV1, as double TRPV1/TRPV2 knockouts did not differ 
in their responses to acute noxious heat from TRPV1 null mice (Park et al., 2011). These 
findings were consistent with an earlier study, which reported that 11 out of 12 heat-
sensitive Trpv1-/- C-fibres sampled did not express TRPV2 (Woodbury et al., 2004). 
TRPV3 and TRPV4 have been identified as sensors of ‘warm’ innocuous temperatures. 
Temperature thresholds between 31-39°C have been reported for TRPV3 (Peier et al., 
2002a; Smith et al., 2002; Xu et al., 2002). TRPV3 is predominantly expressed by 
keratinocytes, however some studies have reported expression by sensory nerve ganglia 
with an overlap with TRPV1 expression (Chung et al., 2004; Peier et al., 2002a; Smith et al., 
2002; Xu et al., 2002). Reports have shown that mice lacking functional TRPV3 channels 
display a reduced preference for innocuous warm temperatures on the two plate 
preference test compared to their wildtype counterparts (Moqrich et al., 2005). Although 
heat-evoked TRPV3 currents occur at innocuous temperatures, currents continue to 
increase when temperatures are raised to within the noxious range (Peier et al., 2002a). 
Consistent with this finding, Trpv3-/- mice were shown in one study, to display impaired 
behavioural responses to acute nociceptive thermal stimuli. Trpv3-/- mice displayed 
increased latencies to tail flick-evoked by a 50°C and 52°C water bath, and to paw 
withdrawal from a 55°C hot plate (Moqrich et al., 2005). However, a study examining Trpv3-
/- mice on C57Bl/6 and 129S6 backgrounds (in contrast to the 129S6/C57BL6 mixed 
background of mice studied in the report by Moqrich and colleagues) has disputed the 
importance of TRPV3 for heat sensation, reporting no significant changes in behaviour in 
thermal preference or nociceptive heat tests between Trpv3-/- and wildtype mice (Huang et 
al., 2011).  
TRPV4 is also activated by ambient temperatures with a temperature activation threshold 
of 25-34°C (Güler et al., 2002; Watanabe et al., 2002). The TRPV4 channel is sensitive to 
hypotonic stimuli and, consistent with this finding, hypoosmotic solutions potentiate heat-
evoked responses whilst hyperosmotic solutions inhibit them (Güler et al., 2002). Similar to 
TRPV3, TRPV4 channels are expressed by skin keratinocytes, where they are postulated to 
be responsible for the majority of heat-evoked currents (Chung et al., 2004). Primary 
30 
 
mouse keratinocytes exhibit two currents in response to innocuous warming, one which is 
weakly rectifying and desensitises, and another which is outwardly rectifying and sensitises 
(Chung et al., 2004). The former is attributed to TRPV4 and is the current most commonly 
observed in keratinocytes: it is diminished in Trpv4-/- keratinocytes and is re-established by 
transfection of wildtype TRPV4 (Chung et al., 2004). These results suggest that TRPV4 is 
required for a large element of heat sensing in keratinocytes, however examination of 
Trpv4-/- mice determined no differences in their responses to acute nociceptive thermal 
stimuli compared to the responses of wildtype mice, suggesting that TRPV4 is not required 
for noxious heat sensing (Liedtke et al., 2003). Furthermore, a study examining 
TRPV3/TRPV4 double knockouts reported no impairments to noxious or innocuous heat 
sensing and demonstrated that this was not due to compensatory heat-sensing by TRPV1 
channels masking a deficit in the double knockout mice, suggesting that neither TRPV3 
channels nor TRPV4 channels are required for heat sensing (Huang et al., 2011).   
Recently a steroid-sensitive member of the TRP melastatin sub-family, TRPM3, has been 
implicated in the mechanisms of noxious heat detection (Vriens et al., 2011), see Chapter 4 
for a full discussion.  
Ion channels which do not belong to the TRP channel family have also been implicated in 
heat-sensing mechanisms. A Ca2+ activated chloride channel (CaCC), named anoctamin 1 
(ANO1), has been reported to be activated by heat with a threshold temperature of ~44°C 
(Cho et al., 2012). ANO1 is expressed within the nociceptive subpopulation of sensory 
neurons with a high level of co-expression with TRPV1 (~80%). Co-treatment of WT DRG 
neurons with a TRPV1 antagonist and the CaCC blocker, mefloquine, was reported to 
abolish heat-evoked currents and mefloquine was reported to block heat responses in 
Trpv1-/- neurons (Cho et al., 2012). Consistent with these findings, wildtype and Trpv1-/- 
mice intrathecally injected with small interfering RNA (siRNA) specific for Ano1 displayed 
significantly increased tail withdrawal latencies from water heated to noxious 
temperatures (50-54°C) and paw withdrawal latencies from radiant noxious heat in 
comparison to mice injected with scrambled siRNA. Similar impairments in noxious heat 
sensing were reported for ANO1 conditional knockout mice (CKO) where ANO1 expression 
was knocked down in sensory neurons of the DRG (Cho et al., 2012). These findings 




1.5.1.2 Cold  
In humans a sensation of innocuous cooling, which is distinct from cold pain, can be evoked 
by cool temperatures which are just 1°C lower than basal skin temperature (Erpelding et 
al., 2012). Cold temperatures are purported to feel painful when they fall below 15°C, 
however, a wide-range of cold temperatures (0-28°C) can be perceived as painful 
sensations (Erpelding et al., 2012; McKemy, 2013). 
Primary afferent nerve fibres which have their cell bodies in the DRG and TG, respond to 
cooling within both the innocuous and noxious range. They are typically Aδ or C-fibres and 
two populations with differing thresholds exist. One population of cold-sensitive nerve 
fibres is activated by temperatures within the innocuous range (30-15°C). This sub-group of 
cool-sensitive neurons tends to display spontaneous activity at physiological skin 
temperature which is increased upon cooling and decreased upon warming. The other 
population of cold-sensitive nerve fibres begins to fire at noxious cold temperatures 
(<15°C) and is composed of ‘cold nociceptors’ which are typically quiescent at normal skin 
temperature and are only activated when stimulated by noxiously cold temperatures 
(McKemy, 2013). 
Initially, it was theorised that cold sensation was signalled by cold-mediated inhibition of 
the Na+/K+ pump and a resulting depolarisation of the plasma membrane (Pierau et al., 
1974). An inhibitor of the sodium-potassium adenosine triphosphatase, oubain, was shown 
to alter the activity of cold-sensitive nerve fibres (Pierau et al., 1974) however a later study 
demonstrated that oubain did not evoke depolarisation in the majority of  cold-sensitive 
DRG neurons and, in the small number of neurons where oubain did evoke depolarisation, 
it was insufficient to trigger action potential firing (Reid and Flonta, 2001a). This later 
finding demonstrated that inhibition of the Na+/K+ pump was not the chief mechanism for 
cold transduction. 
Other background ion channels have also been implicated in cold transduction mechanisms 
(McKemy, 2013). One study suggested that cold-induced activation of cold-insensitive 
neurons is prevented by a K+ current (IKD) and demonstrated that inhibition of this current 
by 4-aminopyridine was able to induce cold-sensitivity (Viana et al., 2002). Background K+ 
channels belonging to the K2P family, TREK-1 and TRAAK, have also been implicated in the 
mechanisms of cold sensation (Noël et al., 2009). Deletion of TREK-1 and TRAAK increases 
the number of cold-sensitive neurons and shifts the temperature threshold of neurons 
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which normally respond to noxious cold temperatures to higher temperatures, therefore 
resulting in the activation of cold nociceptors at warmer temperatures (Noël et al., 2009). 
Consistent with these findings TREK-1 and TRAAK double knockout mice experience cold 
hypersensitivity (Noël et al., 2009).  It is postulated that the opening of both TREK-1 and 
TRAAK reduces the excitability of the neurons on which they are expressed and when these 
channels are absent or closed, cold-sensitive neurons become more easily excitable (Noël 
et al., 2009). 
A study by Suto and Gutoh (1999) examining activation of rat DRG neurons by a cool 
stimulus (20°C) demonstrated that cooling could evoke the influx of calcium ions. The 
authors of this study demonstrated this process was not secondary to Na+ mediated 
depolarisation as removal of external Na+ had no effect on the response (Suto and Gotoh, 
1999). This finding demonstrated the existence of a cold-sensitive channel which allowed 
the influx of calcium in response to cooling. An overlap between the cold sensitivity of 
neurons and activation by the naturally-occurring cooling compound from the mint plant, 
menthol (Reid and Flonta, 2001b), suggested a common transduction process for these 
stimuli and lead to the discovery of TRPM8, a receptor for menthol and cold and a relative 
of the noxious heat sensor, TRPV1 (McKemy et al., 2002; Peier et al., 2002b). TRPM8 is 
expressed in 5-10% of primary afferent neurons of the DRG and at slightly higher levels in 
the TG and is activated by cooling with a threshold temperature of ~25°C (McKemy et al., 
2002; Peier et al., 2002b). Studies examining cold sensation in mice lacking functional 
TRPM8 channels have shown that dissociated sensory neurons and nerve fibres from 
Trpm8-/- mice lose sensitivity to menthol and cold (Bautista et al., 2007; Colburn et al., 
2007). Moreover, Trpm8-/- mice have impaired thermal discrimination behaviour in 
comparison to their wildtype counterparts and display decreased behavioural responses to 
application of acetone to the paw, which evokes evaporative cooling (Bautista et al., 2007; 
Colburn et al., 2007; Dhaka et al., 2007). 
Although TRPM8 was shown to contribute to the sensation of innocuous cold 
temperatures, it was difficult to ascertain whether TRPM8 played a role in noxious cold 
sensing (Sexton et al., 2014). One temperature discrimination study reported that Trpm8-/- 
mice (unlike Trpm8+/+ mice) did not avoid the cool plates in preference to a plate at an 
innocuous warm temperature until temperatures of the cold plate dropped below 15°C: at 
these lower temperatures the mice began to show avoidance behaviour, suggesting that 
Trpm8-/- mice can sense noxious cold temperatures (Bautista et al., 2007). Indeed, the same 
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study reported that the number of cold-sensitive TG neurons with a temperature activation 
threshold of 12°C was unchanged in Trpm8-/- mice. In addition, early studies reported 
contradictory data on noxious cold-plate evoked behaviour. One study found that Trpm8-/- 
mice placed on a 0°C cold plate displayed longer latencies to a hind paw response in 
comparison to wildtype animals (Colburn et al., 2007). In contrast, two other studies 
showed that hind paw withdrawal latency responses to a 10, 0, -1 and -5°C cold plate did 
not differ between Trpm8-/- and Trpm8+/+ mice (Bautista et al., 2007; Dhaka et al., 2007).  
However, a later study by Knowlton and colleagues (2013) examining mice with ablated 
TRPM8 neurons (DTx-injected Trpm8DTR mice/ ablated) and Trpm8-/- mice, attributed this 
discrepancy to the huge variability of hind-paw responses in this assay. Knowlton et al 
reported significant increases in the latencies to forepaw responses by ablated and Trpm8-/- 
mice, to a 0°C cold plate, in comparison to control mice. The study measured two different 
forepaw behaviours, forepaw flinching and forepaw licking, which were described by the 
authors as robust and repeatable (Knowlton et al., 2013). These findings suggest that 
TRPM8 is also a transducer of noxious cold temperatures although a residual capability for 
sensing noxious cold is present in Trpm8-/- mice. 
The sensation of noxious cold has been attributed to activation of TRPA1, a TRP channel 
expressed in a subpopulation of nociceptive sensory neurons which usually co-express the 
noxious heat sensor TRPV1 (Story et al., 2003a). Activation of TRPA1 was reported to occur 
at noxious cold temperatures which were much lower than required for activation of 
TRPM8, with a threshold temperature of ~17°C (Story et al., 2003a). However, the 
contribution of TRPA1 to cold sensation is a subject of much debate (Basbaum et al., 2009; 
McKemy, 2005, 2013; Sexton et al., 2014). TRPA1 has been identified as the receptor for a 
selection pungent food irritants including cinnamaldehyde, allyl isothiocyanate (AITC) and 
allicin (Bandell et al., 2004; Bautista et al., 2006; Jordt et al., 2004). One study using AITC as 
a probe for TRPA1 expressing TG neurons, demonstrated that 96% of AITC-sensitive 
neurons were insensitive to a noxious cold stimulus (Jordt et al., 2004). Interestingly, the 
same study demonstrated that cooling (22-6°C) lead to a reduction in the AITC-evoked 
responses of TRPA1-expressing oocytes. Furthermore, one study examining TRPA1 
knockout mice found that the number of neurons responding to a cold stimulus and the 
amplitudes of cold-evoked responses were unchanged in TG neurons from Trpa1-/- mice 
(Bautista et al., 2006). These findings suggested that TRPA1 is not involved in the 
mechanisms of noxious cold sensation and is not inherently sensitive to cooling. However, 
a separate study disputed these findings, demonstrating that there was a significant 
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reduction in the number of cold-sensitive TG neurons from Trpa1-/- mice compared to 
wildtype mice and a shift in the thresholds of the remaining neurons to higher 
temperatures (Karashima et al., 2009). Moreover, TRPA1 activity has been demonstrated to 
be required for the cold-evoked responses of vagal sensory neurons (Fajardo et al., 2008a). 
The findings of Karashima et al (2009) and Fajardo et al (2008) implicate TRPA1 channels in 
cellular cold transduction mechanisms. In contrast to the findings by Jordt and colleagues 
(2004), one study reported that cold (25-10°C) potentiated AITC-induced currents in TRPA1-
expressing HEK293 cells and isolated DRG neurons suggesting that cold could potentiate 
tonic activation of TRPA1 (del Camino et al., 2010). 
The role played by TRPA1 in cold sensation at the behavioural level has also proved difficult 
to determine. Bautista and colleagues (2006) reported that Trpa1-/- animals display normal 
behavioural responses to noxious cold stimuli (cold-plate tests: latency to hindpaw 
lift/shivering and acetone-evoked cooling: number of flinches/licks per min) suggesting that 
mice lacking functional TRPA1 channels retain their ability to sense noxious cold 
temperatures. However, the findings of a separate study reported that female Trpa1-/- mice 
exhibit reduced responses to a 0°C noxious cold plate (number of paw lifts) and acetone-
evoked cooling (number of paw shakes) suggesting that TRPA1 is required in part for 
sensing intensely cold temperatures (Kwan et al., 2006). Interestingly, male Trpa1-/- mice 
did not display significantly impaired responses compared to their wildtype counterparts ; 
suggesting that for male mice TRPA1 does not play an important role in noxious cold 
detection (Kwan et al., 2006). Another study found no difference in the latency to shivering 
or paw rubbing in response to a 0°C cold plate but did report a difference in nocifensive 
jumping between Trpa1-/- and Trpa1+/+ mice (Karashima et al., 2009). The authors of this 
study reported that both male and female Trpa1-/- mice jump significantly less when placed 
on a the noxious cold plate. Moreover, Trpa1-/- mice displayed significantly longer latencies 
to tail withdrawal from a -10°C solution in comparison to wildtype mice (Karashima et al., 
2009). A study examining mice with ablated TRPV1-expressing central nerve terminals 
established that cold-sensitivity was normal in these mice. Ablated mice avoided innocuous 
cold for a warmer environment and displayed normal responses to a noxious cold plate 
(Cavanaugh et al., 2009). Due to the fact that TRPA1 expression is restricted to the TRPV1-
expressing nerve population (Kobayashi et al., 2005), this data supports the proposition 




Figure 1-7 Thermosensitive TRP channels  
Temperature activation ranges for TRPM8, TRPA1, TRPV1, TRPV2, TRPV3 and TRPV4. Adapted from (Tominaga, 
2007). 
Interestingly, a member of the TRPC family has also been implicated in cold transduction. 
TRPC5 was found in one study to be cold-sensitive when expressed in a recombinant cell 
line, TRPC5 currents increased as temperatures were decreased below 37°C achieving 
maximum responses at 25°C (Zimmermann et al., 2011).  TRPC5-cold activated currents 
were potentiated by Gq-coupled receptor activation. Despite the ability of TRPC5 channels 
to confer cold sensitivity to a cell line, animals lacking functional TRPC5 channels did not 
display deficits in behavioural responses to cool temperatures (Zimmermann et al., 2011). 
However, TRPC5 may contribute to innocuous cold sensation alongside TRPM8. 
1.5.2 Mechanosensation  
A diverse array of mechanical sensations are signalled by mechanosensitive nerve fibres 
which innervate the skin, viscera, tendons, muscles and joints (Delmas et al., 2011). 
Mechanosensitive neurons which innervate the skin terminate as encapsulated or free 
nerve endings (Lewin and Moshourab, 2004). Innocuous mechanical stimuli such as 
vibration and stretch are detected by encapsulated Aβ nerve-endings (Meissner, Pacinian 
and Ruffini corpuscles) which are present in dermis of the skin. Additionally, innocuous 
mechanical stimuli are detected by Merkel cell-neurite complexes coupled to Aβ fibres and 
low-threshold C-fibre free nerve-endings. Moreover, light brush mechanical sensations are 
transduced by Aβ and Aδ fibres which are connected to guard hairs (G-hair follicle) and 
down hairs (D-hair follicle), respectively (Delmas et al., 2011). Noxious mechanical stimuli 
are transduced by free nerve endings belonging to the C and Aδ neuronal subtypes 
(Basbaum et al., 2009).  
Little is known about mammalian mechanotransducer channels, on which the entire 
process of mechanotransduction is dependent. It is thought that mechanical force causes 
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the opening of excitatory, cation permeable channels which leads to the depolarisation of 
the nerve terminal and generation of an action potential (Delmas et al., 2011). 
Candidate mechanotransduction channels include members of the acid sensing ion channel 
(ASIC) sub-family of degenerin–epithelial Na+ channels (DEG/ENaCs). ASICs were first 
implicated in the transduction of mechanical stimuli after invertebrate homologues of 
these channels (MEC subunits) were found to be required for the transduction of touch in 
Caenorhabditis elegans (C.elegans). ASIC1, 2 and 3 are expressed by sensory neurons of the 
DRG and nodose ganglia (Page et al., 2005). Interestingly, studies have shown that deletion 
of ASIC1 results in increased mechanosensitivity of gastrointestinal nerve fibres but has no 
effect on cutaneous mechanoreceptor sensitivity (Page et al., 2004, 2005). Similar to the 
findings with ASIC1, studies have shown that the mechanosensitivity of cutaneous afferents 
is unchanged in ASIC2 knockout mice (Roza et al., 2004). Other studies have found that 
ASIC2 deletion has mixed effects on the mechanosensitivity of gastrointestinal fibres  (Page 
et al., 2005). In ASIC3 null-mice, mechanosensitivity of the majority of afferent fibres 
innervating the gut is decreased (Page et al., 2005). Furthermore, in the absence of ASIC3 
the mechanosensitivity of A-fibre mechanonociceptors is decreased (Price et al., 2001). 
However, a study examining DRG neuron mechanosensitivity demonstrated that neither 
ASIC2 nor ASIC3 play roles in mechanically activated currents in sensory neuron ganglia 
(Drew et al., 2004). The precise functions of ASICs in mechanotransduction are still unclear. 
Other promising candidates for the mammalian mechanotransduction channel belong to 
the TRP channel family. Invertebrate TRPN channels have been reported to play important 
roles in mechanotransduction. In Drosophila mechanosensory organs, NOMPC appears to 
act as a primary mechanotransducer channel (Lee et al., 2010a; Walker et al., 2000). In the 
nematode, C.elegans, a TRPN homologue has a role in mediating proprioceptive behaviour 
(Li et al., 2006) and interestingly zebrafish require a TRPN orthologue to sense vibration 
and after knockdown of the channel with a morpholino antisense oligonucleotide the 
zebrafish do not respond to acoustic stimuli (Sidi et al., 2003). 
TRPA1 has also been suggested to play a mechanosensory role. Ion channels located at the 
tips of sensory hair bundles in the inner ear open in response to mechanical deflection 
allowing the perception of sound. TRPA1 expression is localised to the tips of hair cell 
stereocilia and TRPA1 was initially thought to function here as a hair cell mechanosensitive 
transduction channel (Corey et al., 2004). However, a subsequent study demonstrated that 
TRPA1 KO mice did not display hearing deficits, suggesting that TRPA1 is not required for 
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hair cell transduction (Kwan et al., 2006). Interestingly, findings from this study implicated 
TRPA1 in cutaneous mechanotransduction, mice lacking functional TRPA1 channels were 
shown to display deficits in their response to punctate mechanical stimuli (Kwan et al., 
2006). However, a separate study reported that mechanical paw withdrawal thresholds of 
wildtype and Trpa1-/- mice are not significantly different; suggesting that TRPA1 does not 
play a role in acute mechanosensation (Bautista et al., 2006). 
Notably, a study examining the properties of cutaneous mechanosensitive nerve fibres in a 
skin-nerve preparation, found that C and Aδ mechanonociceptors from Trpa1-/- mice 
exhibited decreased mechanically evoked action potential firing in comparison to wildtype 
fibres suggesting an involvement of TRPA1 in the transduction of noxious mechanical 
stimuli (Kwan et al., 2009). Interestingly, mixed effects (increases and decreases) were 
reported on the firing rates of different sub-types of mechanosensitive Aβ fibres (Kwan et 
al., 2009). The findings of a separate study demonstrated that within a subset of small 
diameter sensory neurons TRPA1 contributes to intermediately adapting mechanically-
activated currents (Brierley et al., 2011). These findings suggest that whilst TRPA1 might be 
important for some mechanosensing activity it is not the principal transducer of mechanical 
stimuli. 
Members of the TRPC family have also been implicated in mechanotransduction. TRPC3 
and TRPC6 are expressed in a subpopulation of small-diameter sensory neurons and 
deletion of these channels leads to deficits in mechanosensitivity (Quick et al., 2012). A 
study reported that TRPC3/C6 double, but not single, knockout mice displayed a reduced 
sensitivity to innocuous mechanical stimuli (von Frey hairs and a cotton bud) but did not 
exhibit impaired behavioural responses in a test of noxious mechanosensitivity. Notably, in 
small-diameter neurons from TRPC3/C6 double KO mice, the number of neurons displaying 
a rapidly adapting current was halved and this was accompanied by an increase in the 
number of neurons which were not mechanically-sensitive (Quick et al., 2012). Expression 
of TRPC3 and TRPC6 has also been identified in cochlear hair cells and deletion of both of 
these channels leads to a deficit in hearing in addition to vestibular impairments (Quick et 
al., 2012). Surprisingly, expression of TRPC3 and TRPC6 in CHO or HEK-293 cell lines was not 
able to confer mechanosensitivity, however expression of either TRPC3 alone or TRPC3 and 
TRPC6 together conferred sensitivity to a sensory neuron cell line (ND-C cells). These 




Another member of the TRPC family, TRPC1, is also expressed in sensory neurons and has 
been implicated in mechanotransduction. One study demonstrated that TRPC1 was able to 
confer mechanosensitivity to a CHO cell line and found that injection of Xenopus oocytes 
with a human TRPC1 cRNA attenuated endogenous mechanosensitive ion channel activity 
(Maroto et al., 2005). Another study has demonstrated that TRPC1 KO mice display reduced 
behavioural responses to ‘light’ mechanical stimuli (‘puffed out’ cotton bud and 0.68mN 
von Frey hair) in comparison to their wildtype counterparts (Garrison et al., 2012). The 
same study reported that rapidly adapting (RA) Aδ down-hair and slowly adapting (SA) Aβ 
mechanosensitive fibres from TRPC1 KO mice display reduced firing in response to 
mechanical stimuli in comparison to fibres from wildtype animals. These findings suggest 
that TRPC1 plays a role in the transduction of light touch. TRPC5 has also been suggested to 
function as a mechanosensitive channel. The findings of one study demonstrated that 
TRPC5 is activated by hypo-osmotic stimuli and cell stretch in a PIP2 dependent-manner, 
suggesting that TRPC5 channels expressed in sensory neurons may contribute to 
mechanosensation (Gomis et al., 2008). 
The large transmembrane proteins Piezo1 and Piezo2 have been identified as 
mechanosensing proteins which can assemble into homo-multimers and function as non-
selective cation channels (Coste et al., 2010, 2012; Volkers et al., 2014; Woo et al., 2014). 
Both Piezo1 and Piezo2 have been found to confer mechanosensitivity when expressed in 
heterologous systems (Coste et al., 2010). Piezo2 is expressed in 20% of DRG neurons and 
has been shown to be required for a sub-group of mechanically-activated currents (Coste et 
al., 2010). Notably, a recent study has shown that Piezo2 proteins are required for Merkel 
cell mechanotransduction; specific deletion of Piezo2 proteins expressed in Merkel cells 
resulted in significantly longer paw withdrawal latencies at low forces in the von Frey 
filament test (Woo et al., 2014). These findings suggest that Piezo proteins contribute to 
the transduction of innocuous mechanical stimuli. 
1.5.3 Osmosensation 
Subpopulations of sensory neurons which innervate peripheral tissues such as the airways, 
gastrointestinal tract, liver and cornea are sensitive to increases and decreases in 
extracellular fluid osmolality (Fox et al., 1995; Hirata and Meng, 2010; Lechner et al., 2011; 
Pedersen et al., 1998; Zhu et al., 2001). Members of the TRP family of ion channels have 
been suggested as molecular transducers of hypotonicity. The thermosensitive TRPV4 
channel has been reported to confer hypo-osmosensitivity to a HEK293 cell line (Liedtke et 
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al., 2000). Moreover, hypotonic solutions have been found to activate neurons expressing 
TRPV4 and deletion of TRPV4 results in the loss of hypotonicity-activated hepatic sensory 
neurons  (Alessandri-Haber et al., 2003; Lechner et al., 2011). The TRPV2 channel is also 
sensitive to decreases in osmolality and can be activated by cell stretch (Muraki et al., 
2003; Shibasaki et al., 2010). In addition to members of the vanilloid subfamily, TRPC1 and 
TRPC5 are also gated by cell-stretch and a human splice variant of TRPM3 has also been 
reported to be activated by hypotonic stimuli (Gomis et al., 2008; Grimm et al., 2003; 
Maroto et al., 2005). 
A molecular transducer of hyperosmotic stimuli in peripheral sensory neurons has not yet 
been identified. An N-terminal splice variant of TRPV1 has been purported to act as an 
osmosensory channel within osmosensitive areas of the mammalian central nervous 
system (Ciura and Bourque, 2006; Naeini et al., 2006; Sharif-Naeini et al., 2008). However, 
one study reported that the TRPV1 variant is not directly osmosensitive when expressed in 
Xenopus oocytes suggesting that it does not act as a transducer of hypertonic stimuli (Eilers 
et al., 2007). The findings of one further study suggest that TRPA1 can be activated by 
hyper-osmotic stimuli (Zhang et al., 2008). Please see section 3.1 for a more detailed 
discussion on TRP channels and osmosensation. 
1.1.1 Chemosensation  
In addition to being sensitive to thermal, mechanical and osmotic stimulation, primary 
afferent nerve fibres are also chemosensitive and can be activated by an array of chemical 
mediators such as purines, amino acids and pungent food compounds (Wood and 
Docherty, 1997).  
Between 40 and 96% of cultured DRG neurons have been shown to respond to the purine, 
ATP, by an increase in [Ca2+]i or depolarisation (Burnstock, 2000). ATP is able to activate 
sensory neurons by binding to ionotropic P2X receptors which exist as homo- or 
heteromultimeric channel complexes. Currently, seven P2X receptor subtypes have been 
identified, P2X1-7 (Burnstock, 2009). P2X1-6 have been reported to be expressed in sensory 
neurons of the DRG, TG and nodose ganglia (North, 1996). However, only P2X3 is selectively 
expressed by nociceptive sensory neurons (Burnstock, 2001; Chen et al., 1995; Wood and 
Docherty, 1997). The major purinergic ionotropic responses in sensory neurons are 




Sensory neurons are also activated by the neurotransmitter 5-HT, ~40% of cultured DRG 
neurons have been reported to be activated by 5-HT (Robertson and Bevan, 1991). The 
direct activation of the primary afferent nerve terminal by 5-HT occurs primarily through 
activation of the ionotropic 5-HT3 receptor, although, it is worth noting that activation of 
other 5-HT receptor subtypes, which are GPCRs, can lead to an increase in neuronal 
sensitivity via modulation of intracellular pathways (Wood and Docherty, 1997). Nicotinic 
and muscarinic receptors for the neurotransmitter acetylcholine are also expressed on 
sensory nerves and cholinergic agonists have been reported to excite peripheral nerve 
terminals and dorsal root ganglion neurons (Genzen et al., 2001; Nandigama et al., 2010; 
Smith et al., 2013; Steen and Reeh, 1993; Wood and Docherty, 1997). 
Primary afferent sensory neurons also express receptors for excitatory amino acids and 
metabotropic and ionotropic receptors for the excitatory neurotransmitter glutamate have 
been reported (Carlton and Hargett, 2007; Sato et al., 1993; Willcockson and Valtschanoff, 
2008). 
In addition, sensory neurons express Mrgprs, a family of GPCRs which was discovered in 
2001 (Dong et al., 2001). Members of the human (MrgprX1) and mouse (MrgprA3) Mrgpr 
families are activated by the pruritic, antimalarial drug, chloroquine (Liu et al., 2009; 
McNeil and Dong, 2014). Chloroquine excites DRG neurons resulting in increases in [Ca2+]i 
and action potential generation and this process is reliant upon expression of functional 
Mrgprs but has also been shown to be blocked by the non-selective TRP channel inhibitor, 
ruthenium red, suggesting an involvement of TRP channels in this pathway (Liu et al., 
2009). DRG neurons are activated by the endogenous pruritogen/pruritic peptide, BAM8-
22, which is a cleaved product of proenkephalin A, in a Mrgpr dependent manner (Liu et al., 
2009). Interestingly, a member of the Mrgpr family (MrgprC11) is activated by the synthetic 
activating peptide for proteinase-activated receptor 2 (PAR2), SLIGRL. Surprisingly, 
MrgprC11 and not PAR2, is responsible for SLIGRL-induced activation of DRG neurons and 
behavioural itch responses (Liu et al., 2011).  
As mentioned previously, sensory neurons can be activated by pungent compounds found 
in food and some of these molecules have been of central importance for studies of 
sensory neuron transduction mechanisms. Capsaicin from chilli peppers and piperine from 
black pepper activates TRPV1 expressed on sensory neurons (Caterina et al., 1997; 
McNamara et al., 2005). Compounds found in cinnamon, mustard oil and garlic activate 
sensory neurons in a TRPA1-dependent manner and the cooling compound from the mint 
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plant, menthol, activates sensory neurons predominantly through activation of TRPM8 
(Bautista et al., 2006; Jordt et al., 2004; McKemy et al., 2002; Peier et al., 2002b). 
Sensory neurons expressing TRPA1 can also be activated by environmental irritants such as 
acrolein and by oxidants and products of oxidative stress, such as H2O2, 4-HNE and 4-ONE 
(Andersson et al., 2008; Bautista et al., 2006). Additionally, hydrogen sulphide (H2S), 15d-
PGJ2 and methylglyoxal activate sensory neurons in a TRPA1-dependent manner 
(Andersson et al., 2008, 2012; Eberhardt et al., 2014, 2012; Taylor-Clark et al., 
2008a).Moreover, TRPV1 channels can be activated by the endogenous cannabinoid lipid, 
anandamide (Zygmunt et al., 1999) as well as the related lipid, 2-acylglycerol (Zygmunt et 
al., 2013). TRPA1 is activated by THC, the active principle in cannabis, and several other 
cannabinoids (Jordt et al., 2004; De Petrocellis et al., 2008; Zygmunt et al., 2002). 
1.6 Pain and inflammatory sensitisation  
High threshold ‘painful’ stimuli activate sensory transduction channels expressed on 
nociceptive nerve fibres resulting in the sensation of pain. Acute pain serves as a useful 
warning signal to the alert the body to environmental stimuli which could cause tissue 
damage (Basbaum et al., 2009). However, in some circumstances the pain pathway 
becomes sensitised leading to pain hypersensitivity (Basbaum et al., 2009). In this 
hypersensitive state pain is no longer serving as a useful warning signal. Stimuli which do 
not usually evoke sensations of pain become painful (allodynia) and the pain evoked by 
noxious stimuli is exaggerated (hyperalgesia). Pain hypersensitivity develops secondary to 
tissue injury and inflammation (inflammatory pain) or following sensory nerve damage 
(neuropathic pain).  
Tissue injury, and the resulting inflammatory response, leads to sensitisation of peripheral 
sensory nerve afferents. At the site of tissue injury, the area surrounding the terminals of 
sensory nerves is flooded with pro-inflammatory agents (Basbaum et al., 2009). These 
chemicals are released from cells which have been disrupted by injury, or are secreted 
from immune cells which have infiltrated the injury site or produced by the activity of 
inflammatory enzymes (Woolf and Ma, 2007). The resulting mixture of inflammatory 
compounds is commonly referred to as the ‘inflammatory soup’ and includes peptides 
(CGRP, SP, bradykinin), lipid mediators (prostaglandins, thromboxanes, leukotrienes, 
endocannabinoids), cytokines, chemokines, growth factors, protons and ATP (Basbaum et 
al., 2009; Woolf and Ma, 2007). These inflammatory agents act on peripheral sensory nerve 
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terminals to increase their sensitivity and in some cases may depolarise sensory afferents 
directly.  
Inflammatory mediators are able to increase the sensitivity of sensory nerve terminals by 
interacting with specific receptors. Some constituents of the inflammatory soup, for 
example protons and ATP, directly activate ion channels expressed at the peripheral nerve 
terminal (Dawes et al., 2013). The resulting influx of cations caused by opening of the ion 
channel evokes a depolarisation of the membrane and an increase in action potential firing. 
Other inflammatory agents such as prostaglandins, bradykinin, histamine and chemokines, 
bind to G-protein coupled receptors (GPCRs) to exert their effects (Ji et al., 2014). 
Activation of a GPCR by an inflammatory mediator results in activation of a heterotrimeric 
G protein and induction of a biochemical signalling cascade which is dependent on the class 
of G-protein activated. Activation of Gq stimulates phospholipase C (PLC) which cleaves the 
membrane phospholipid, phosphatidylinositol 4,5-bisphosphate (PIP2), into diacyl glycerol 
(DAG) and inositol 1,4,5-trisphosphate (IP3). Activation of Gs stimulates the activity of the 
membrane associated enzyme, adenylyl cyclase which synthesises the intracellular 
messenger, cAMP, from molecules of ATP (Dawes et al., 2013; Gilman, 1987). Induction of 
these signalling pathways typically culminates in activation of protein kinases (PKC, PKA) 
which are able to modulate the activity of transduction channels, including TRPA1 and 
TRPV1, and ion channels which are important for excitability and conduction (Nav1.7-1.9, 
HCN2) via phosphorylation thereby lowering their threshold for action potential generation 
and promoting increased neuronal firing (Emery et al., 2011; Ji et al., 2014; Schnorr et al., 
2014).  
Neurotrophic factors such as NGF, GDNF, brain-derived neurotrophic factor (BDNF) and 
artemin, elicit effects by binding to receptor tyrosine kinases (Chao, 2003). Upon activation 
the receptor monomers dimerise and activate downstream signalling pathways which can 
affect the transcription of pain and inflammation-related proteins and can also acutely 
modulate the activity of ion channels expressed at the nerve terminal (Basbaum et al., 
2009). Pro-inflammatory cytokines such as TNFα and IL-1 bind to cytokine receptors which 
also induce signalling cascades which are capable of modulating neuronal function (Dawes 
et al., 2013).  
In summary, inflammatory mediators sensitise nociceptive afferents to incoming stimuli by 
post-translational modification of receptors and ion channels and by altering gene 
expression; increasing the likelihood of neuronal excitation.  
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Chapter 2. General material and methods  
The methods listed here are the general materials and methods used, specific methods and 




2.1 Cell Culture 
2.1.1 Chinese hamster ovary cells  
Untransfected Chinese hamster ovary (CHO) cells were grown in MEM AQ supplemented 
with penicillin (100 U/ml), streptomycin (100 µg/ml) and foetal bovine serum (10%). CHO 
cells expressing mouse or human TRPM8, mouse TRPV3 or mouse TRPA1 were grown in the 
additional presence of hygromycin (200 µg/ml). TRPA1 expression was under the control of 
a tetracycline inducible promoter to avoid cell death due to constitutive TRPA1 activity and 
expression was induced by addition of tetracycline 12-18 hours before experimentation. 
CHO cells expressing mouse TRPM3 or rat TRPV1 were grown in MEM AQ supplemented 
with penicillin (100 U/ml), streptomycin (100 µg/ml), foetal bovine serum (10%) and G418 
(0.5mg/ml). 12-24 hours before experimentation cells were plated onto either 96 well 
black-walled plates (Costar) or poly-D-lysine coated (10µg.ml-1) glass 13mm cover slips at a 
high density (~80%). Cultures were maintained at 37°C in a humidified incubator gassed 
with 5% CO2 and cells were studied 12-24 hours after plating.  
2.1.2 Dorsal root and trigeminal ganglion neurons  
Dorsal root and trigeminal ganglion neurons were prepared from adult Wistar rats or 
C57Bl6 mice. Animals were killed by cervical dislocation, as approved by the United 
Kingdom Home Office, and spinal ganglia were removed from all levels of the spinal cord 
using aseptic methods. Ganglia were incubated in 0.25% collagenase in serum-free MEM 
(Invitrogen, Paisley, UK) containing 1% penicillin and streptomycin for 3 hours at 37°C in a 
humidified incubator gassed with 5% CO2 in air. This was followed by 20 minute incubation 
with 0.25% trypsin in MEM. The ganglia were then dissociated mechanically via trituration 
with flame polished Pasteur pipettes to obtain a suspension of single cells. Trypsin was 
removed by addition of 10ml MEM (containing 10% FBS) followed by centrifugation at ~168 
x g (1000 revolutions min-1) for 10 minutes. The pellet, containing the ganglia, was re-
suspended in MEM containing 1% penicillin and streptomycin, 10% FBS and 0.05% DNase. 
The cell suspension was then centrifuged through a 2ml cushion of sterile 15% bovine 
albumin in MEM at ~168 x g (1000 revolutions min-1) for 10 minutes. The pellet, containing 
the neurons, was then re-suspended in an appropriate volume of MEM containing 10% 
FBS, 50ng.ml-1 NGF and 10µM cytosine arabinoside to prevent/reduce the growth of non-
neuronal cells. The neurons were then plated at a high density (~80%) onto the centre of 
sterile 13mm glass coverslips previously coated with 10µg.ml-1 poly-D-lysine. Cultures were 
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maintained at 37°C in a humidified incubator gassed with 5% CO2 and cells were studied 
12- 24 hours after dissociation.  
2.2 Imaging of intracellular calcium levels  
2.2.1 Fura-2 
Fura-2 (Invitrogen), a UV excitable ratiometric calcium indicator dye was used to measure 
changes in [Ca2+]i. The excitation spectrum for Fura-2 changes upon binding calcium, 
emission measured at >510nm increases when the dye is excited at 340nm and decreases 
at 380nm excitation. 
Cells were loaded with the acetoxymethyl (AM) ester version of the dye which allows Fura-
2 to pass across cell membranes by passive diffusion. Intracellular esterases then cleave the 
ester bonds once the dye is inside the cell, yielding a relatively membrane-impermeant 
acidic form of the dye. For all calcium imaging experiments the cells or neurons were 
loaded with Fura-2 for 1-2 hour/s prior to experimentation. Fura-2 was loaded in 
physiological extracellular solution supplemented with 0.01% pluronic acid and 1mM 
probenecid. Pluronic acid promotes permeation of Fura-2 through the cell membrane, and 
probenecid helps to prevent Fura-2 from being exported from the cell by inhibiting organic-
anion transporters in the plasma membrane. 
2.2.2 Microscope-based imaging of intracellular calcium levels 
Cells or neurons were plated onto 13mm glass cover slips which formed the base of the 
perfusion chamber (volume~1ml). The chamber was mounted on to the stage of an 
inverted microscope (Nikon Diaphot) and cells were viewed using a 10x Fluor objective with 
a numerical aperture of 0.5. 
Test solutions were applied to cells by local microperfusion of solution through a fine tube 
placed very close to the cells being studied. The temperature of the superfusate was 
controlled using a Peltier device connected to a power supply (Marlow Industries, model 
SE5010) with the temperature measured at the orifice of the inflow tube. Cells and neurons 
were perfused with solutions supplied from one of 8 reservoirs. In experiments using 
neuronal preparations, neurons were distinguished from non-neuronal cells by a final 
depolarising challenge with a solution containing 50mM KCl, which evoked a calcium influx 
through voltage gated calcium channels.  
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Fura-2 signals were measured using RatioMaster Fluorescence Microscopy System (PTI). 
Cells were excited by light generated by a xenon-arc lamp which was passed alternately 
through one of two monochromonators (DeltaRam high speed monochromator, PTI) to 
transmit light of the pre-selected wavelengths (340nm and 380nm, ± 2nm). The emitted 
light was filtered by a long pass optical filter (>510nm) and captured by a cooled CCD 
camera (PTI CoolOne). Exposure length was equal for each excitation wavelength and 
determined by the user to ensure adequate signal without saturation of the camera 
(typically 100-400msec).  
PTI ImageMaster software served as the user interface during the experiments to monitor 
the fluorescence emission intensity ratios at 340nm/380nm excitation and was also used to 
select individual cells/neurons of interest for analysis. The intensity time-base data was 
exported into Microsoft Excel (Microsoft) for further analysis and then into Origin (Origin 
Pro, version 9.1) for graphical representation of the results.  
In experimental chapters, n is presented as n= X, Y, Z; where X refers to the total number of 
cells studied, Y refers to the number of coverslips studied and Z refers to the number of 
individual passages (recombinant cell line) or animals (neuronal preparations) studied.  
2.2.3 Fluorimeter measurement of intracellular calcium levels 
A FlexStation 3 (Molecular Devices, Sunnyvale, CA) a bench-top scanning fluorimeter and 
integrated fluid-transfer workstation was used to measure Fura-2 responses for 96-well 
plate experiments. Experiments were performed using triplicate columns so that 4 
experiments were carried out per 96-well plate. FlexStation experiments were performed 
using a cell line which was plated directly into the 96-well plate 12 to 24 hours before 
experimentation; cell confluency was typically greater than 80% at the time of 
experimentation. 
SoftMax Pro (Molecular Devices, version 5.1) software served as the user interface during 
the experiments and was also used to produce the fluorescence intensity time-base data. 
The intensity time-base data was exported into Microsoft Excel (Microsoft) for further 
analysis and then into Origin (Origin Pro, version 9.1) for graphical representation of the 
results. The 96-well plate experiments had duration of 180s, baseline signals were collected 
for the first 20s of the experiment, and at the 20s time-point of the experiment cells were 




In experimental chapters, n refers to the number of independent experiments performed 
(each from different cell passages). In each individual experiment a minimum of 3 replicate 
samples per treatment were used.  
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Chapter 3. TRPM8 is an osmosensor modulated by temperature   
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3.1 Introduction  
Primary afferent neurons innervate the skin and organs and provide feedback about 
internal and external sensory environments. Individual sensory neurons possess sensitivity 
to one or more modalities, and together they are able to detect a myriad of stimuli 
including mechanical perturbations, temperature fluctuations and exposure to chemicals.  
Sensory neurons innervating the airways, gastrointestinal tract, liver and cornea are 
activated by changes in extracellular osmolality; however the identity of neurons excited by 
increases in osmolality are unknown (Fox et al., 1995; Hirata and Meng, 2010; Lechner et 
al., 2011; Pedersen et al., 1998; Zhu et al., 2001).  
The molecular mechanism by which an osmotic stimulus evokes neuronal excitation is not 
clear, but it is thought to be either a mechanical process whereby membrane deformation 
physically gates ion channel activity or a process which is reliant upon osmotic activation of 
an intracellular pathway (Bourque, 2008; Zhang et al., 2007).   
3.1.1 TRP Channels and osmosensation  
Members of the transient receptor potential (TRP) family of ion channels act as cellular 
sensors for a diverse range of stimuli including temperature, pH, pungent chemicals and 
osmotic pressure (see section 1.4 for a full discussion).  
3.1.2 OSM-9 
The first study to provide evidence of TRP channel involvement in osmosensing processes 
was examining a TRPV orthologue, OSM-9, expressed in Caenorhabditis elegans (C.elegans) 
(Colbert et al., 1997). The OSM-9 gene encodes a 6 transmembrane domain channel which 
is expressed on sensory nerve endings and has a high resemblance to other TRP channels 
around the sixth transmembrane domain; a highly conserved area in the TRP family 
(Colbert et al., 1997).  
ASH sensory neurons are responsible for initiating backward movement of the nematode in 
response to high osmotic strength and gentle touch of the nose. OSM-9 expression was 
identified in a subset of sensory neurons and mutations in the OSM-9 channel gene lead to 
deficits in nematode avoidance behaviours (Colbert et al., 1997). In addition to these 





TRPV4 is a mammalian orthologue of OSM-9 and shares a 26% amino acid identity (44% 
identity or conservative change) with the channel (Liedtke et al., 2003). When TRPV4 was 
expressed in the OSM-9 mutant nematodes it was able to rescue osmotic and nose touch 
avoidance behaviours but not olfactory deficits; this suggests a divergence of roles 
between vertebrate and invertebrate TRP channels (Liedtke et al., 2003). Odorant 
sensation in C. elegans requires GPCR signalling and it has been suggested that TRPV4 
might fail to interact with the required component of the GPCR pathway (Liedtke et al., 
2003). 
TRPV4, when expressed in a recombinant system is sensitive to decreases in osmolarity. 
Chinese hamster ovary (CHO) cells transfected with rat and chicken TRPV4 but not 
untransfected cells, displayed [Ca2+]i responses when isotonic extracellular solution (295 
mmol kg−1) was replaced with a hypotonic solution (245 mmol kg−1) (Liedtke et al., 2000). 
TRPV4 has been identified in areas known to be sensitive to fluctuations in osmolality such 
as the neurons of two sensory circumventricular organs the subfornical organ (SFO) and the 
organum vasculosum lamina terminalis (OVLT) (Liedtke et al., 2000). TRPV4 was also 
expressed in other sensory areas of the body such as the inner ear and the trigeminal 
ganglia; this suggests that TRPV4 might also be associated with other sensory processes 
which are independent of osmosensation  (Liedtke et al., 2000). 
Trpv4-/- mice were found to have deficits in fluid homeostasis. Trpv4-/- mice drank less 
water than their wildtype counterparts, both spontaneously and when deprived of water 
for 48hrs (Liedtke and Friedman, 2003). In addition this study found that TRPV4 null 
animals have higher blood osmolality levels and lower levels of the antidiuretic hormone, 
ADH (Liedtke and Friedman, 2003). These results directly contrast with the results of 
another study which reported that disruption of the mouse TRPV4 gene did not affect 
plasma osmolality and found that water deprivation lead to an increased ADH level 
(Mizuno et al., 2003).  
Exposure to hypotonic solutions (219 mOsm) has been shown to depolarise DRG neurons 
expressing TRPV4 and to evoke an increase in intracellular calcium concentration in 
nociceptive neurons (Alessandri-Haber et al., 2003). Exposure to a hypotonic solution 
activated 54% of C fibres from the saphenous nerve and the number of action potentials 
evoked was increased when the nerve fibres were pre-sensitised by PGE2. Application of a 
51 
 
hypotonic stimulus to skin sensitised by PGE2 caused pain-related behaviour (flinching) in 
rats, and this behaviour was reduced when rats were treated with a TRPV4 antisense 
solution (Alessandri-Haber et al., 2003). 
Xu and colleagues discovered that a pronounced tyrosine phosphorylation of 
heterologously expressed TRPV4 occurred when cells were exposed to hypotonic stress 
(150 mosm/kg H2O) but not hypertonic stress (Xu et al., 2003). This was also evident in a 
native system; TRPV4 expressed in a mouse distal convoluted tubule cell line underwent a 
time-dependent tyrosine phosphorylation when exposed to hypotonic stress. This evoked 
phosphorylation was partially attenuated by the tyrosine kinase inhibitor genistein and 
completely inhibited by a selective Src family tyrosine kinase inhibitor PP1. In contrast a 
selective Syk inhibitor had no effect. In the same study, co-immunoprecipitation 
experiments revealed physical interactions between TRPV4 and Lyn, Src, Fyn, Hck, Lyk and 
Yes Src family kinases. Furthermore, confocal immunofluorescence studies identified 
complete co-localisation of TRPV4 with Lyn and a small degree of co-localisation with Src. 
Importantly, Xu and colleagues (2003) found that hypotonicity-induced phosphorylation of 
TRPV4 in a recombinant cell line was significantly impaired by a tyrosine-253 to 
phenylalanine (Y253F) mutation, and in contrast to cells transfected with wildtype (WT) 
TRPV4, the mutant Y253F TRPV4 failed to respond to hypotonic stimuli. However, these 
findings could not be replicated by Vriens and colleagues (2004). Vriens et al reported that 
cells expressing the Y253F TRPV4 mutant displayed hypotonicity-induced responses which 
were identical to the responses evoked in cells expressing WT TRPV4. The authors of the 
study reported that inhibition of phospholipase-A2 (PLA2) enzyme activity by four 
structurally dissimilar PLA2 inhibitors attenuated hypotonicity-induced [Ca
2+]i responses 
(Vriens et al., 2004). Hypotonic responses were also prevented by cytochrome P450 
epoxygenase inhibition. The authors of the study suggest that activation of TRPV4 by 
hypotonicity could be the result of PLA2-dependent production of arachidonic acid which is 
metabolised by cytochrome P450 epoxygenase to 5′,6′-EET which activates TRPV4 (Vriens 
et al., 2004; Watanabe et al., 2003).  
In addition to the role of TRPV4 as a sensor of hypotonic conditions, it has also been argued 
that TRPV4 serves as a transducer of hypertonic stimuli during inflammatory states 
(Alessandri-Haber et al., 2005). Alessandri-Haber and colleagues (2005) observed that 
injection of a 2% NaCl solution into the rat hind paw elicited nociceptive behaviours which 
could be amplified by pre-sensitisation of skin with PGE2. An intrathecal injection of 
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antisense oligodeoxynucleotides (ODN) for TRPV4 reduced the nociceptive response by 
46%.  
Parallel studies established that injection of hypertonic solutions into the hind paws of mice 
also evokes nociceptive behaviours (licking and shaking the affected paw). The nociceptive 
behaviour was amplified by sensitisation with PGE2 and was attenuated in Trpv4
-/- mice. 
Injection of the mouse paw with PP1 (a Src family tyrosine kinase inhibitor), was able to 
inhibit the nociceptive behaviours evoked by hypertonic solution to PGE2 sensitised skin in 
the Trpv4+/+ mice but not the Trpv4-/- mice (Alessandri-Haber et al., 2005). Interestingly, a 
hypertonic challenge (mannitol) of up to 646 mOsm induced similar [Ca2+]i responses in 
small diameter DRG neurons (both % of neurons responding and increase in fluorescence 
ratio), from both TRPV4 WT and null mice, even when DRG neurons were pre-sensitised 
with PGE2 (Alessandri-Haber et al., 2005).  
TRPV4 has also been shown to be expressed on sensory nerve endings innervating hepatic 
blood vessels where it is suggested to be a sensor and transducer of hypo-osmotic shifts in 
hepatic osmolality (Lechner et al., 2011). In WT mice, 91.3% of retrogradely labelled 
hepatic sensory neurons responded to a hypotonic stimulus (260 mOsm), and this 
percentage was reduced to 31.6% in mice lacking TRPV4 (Lechner et al., 2011).  
In summary, TRPV4 is sensitive to decreases in osmolality when expressed heterologously 
or natively in a kidney tubule cell line, and channel activation could be dependent on either 
phosphorylation of the channel by Src family kinases or a PLA2-dependent mechanism. 
Furthermore, sensory neurons expressing TRPV4 respond to hypotonic stimulation, and in 
vivo nociceptive responses to hypotonic and hypertonic stimuli can be sensitized by 
prostaglandin treatment and attenuated by TRPV4 silencing with antisense 
oligonucleotides.  
3.1.4 TRPV1 
TRPV1 has also been proposed to play a role in osmosensory transduction in the 
mammalian CNS. An N-terminal splice variant of TRPV1 is expressed by magnocellular 
neurosecretory cells (MNCs) in the supraoptic nucleus (SON). In these neurons, increases in 
membrane conductance associated with a hyperosmotically-induced decrease in cell 
volume were reduced by the promiscuous TRPV antagonist ruthenium red and absent in 
MNCs from Trpv1-/- mice. Trpv1-/- mice also had a higher basal serum osmolality compared 
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to wildtype mice and a reduced ADH response to increased osmolality compared to 
wildtype mice (Naeini et al., 2006). 
A further study examining the intrinsic osmosensitivity of the organum vasculosum lamina 
terminalis (OVLT) demonstrated that OVLT neurons responded to increases in osmolality by 
increases in membrane conductance and an increased frequency of action potential 
discharges (Ciura and Bourque, 2006). This response to a hyperosmotic challenge was 
ruthenium red sensitive and absent in Trpv1-/- mice. In addition Trpv1-/- mice consumed 
significantly less water than wildtype mice in response to a systemic hyperosmotic 
challenge (30 min water deprivation and intraperitoneal injection of 1M NaCl), suggesting 
that TRPV1 plays a role in the regulation of water intake (Ciura and Bourque, 2006). 
However, these findings were disputed by a study which reported that water intake in 
response to subcutaneous injection of 0.5M or 1.0M NaCl was not impaired in Trpv1-/- mice 
(Taylor et al., 2008). Furthermore, Taylor et al reported that water intake in response to 
chronic hyperosmolality (overnight water deprivation or access to only 2% NaCl solution for 
2 days) was not disrupted in Trpv1-/- mice. Interestingly, the study also showed that there 
were no differences in plasma osmolality level between wildtype and Trpv1-/- mice at 
baseline or in response to acute (subcutaneous injection of 1M NaCl) or chronic 
hyperosmolality (access to only 2% NaCl solution for 2 days). A recent study from the same 
research group reported that Trpv1-/-v4-/- double knockout (and Trpv4-/- single knockout) 
mice do not display water intake impairments in response to acute (intraperitoneal or 
subcutaneous injection of 0.5M or 1.0M NaCl) or chronic hyperosmolality (access to only 
2% NaCl solution for 2 days). In addition the plasma osmolality levels of Trpv1-/-v4-/- double 
knockout (and Trpv4-/- single knockout) mice were not significantly different from 
osmolality levels in WT mice (Kinsman et al., 2014). In contrast to the findings by Ciura and 
Bourque (2006) these findings suggest that TRPV1 is not essential for mechanisms which 
regulate water intake in response to increased osmolality.  
3.1.5 TRPV2 
TRPV2, a channel which has ~50% homology with TRPV1 and is expressed in sensory 
ganglia and other neural tissues, has also been implicated in osmosensory transduction 
mechanisms (Caterina et al., 1999; Muraki et al., 2003). Hypotonic (227 mosm) stimulation 
of mouse aortic myocytes evoked a non-selective cation current and elevated intracellular 
calcium, and this response was inhibited by ruthenium red (Muraki et al., 2003). Expression 
analysis established the presence of TRPV2 mRNA and protein in mouse vascular myocytes, 
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and treatment with TRPV2 anti-sense oligodeoxynucleotides impaired the myocyte 
responses to hypotonic stimulation (Muraki et al., 2003). Furthermore, hypotonic solutions 
and cell stretch (by application of negative pressure to the patch pipette) evoked 
membrane currents in CHO cells (cell-attached mode) transiently expressing TRPV2 but not 
in un-transfected control cells. A study by Shibasaki and colleagues (2011) reported that 
TRPV2 channels are activated by membrane stretch during development and promote axon 
outgrowth (Shibasaki et al., 2010). 
3.1.6 Nanchung and water witch 
A Drosophila protein, nanchung, which is a TRPV channel orthologue, together with a 
protein from the TRPA family, water witch, have been identified as  important sensors of 
environmental humidity. Nanchung expression is required for detection of dry air whilst 
water witch is needed in order to sense moisture. Hygrosensing behaviour was examined 
by placing flies between two tubes, one in which air flowing into the tube was at ~100% 
humidity and one where air was at ~0% humidity. Both proteins are required for 
behavioural responses to humidity. The number of flies locating to the humid tube was 
increased in experiments examining flies with a nanchung deletion or flies driving water 
witchRNAi expression (with a promoter expressed in neurons or a waterwitch promoter) 
compared to wildtype flies (Liu et al., 2007). The authors established two distinct 
populations of antennal hygrosensing neurons, one population which responded to dry air 
and another which responded to moist air (Liu et al., 2007).  Nanchung deletion abolished 
the dry air responses and water witch disruption reduced responses to moist air.  
3.1.7 TRPC1 
Outside of the TRPV family, members of other TRP subfamilies have been implicated in the 
transduction of membrane-stretch, TRPC1, a member of the canonical family, has been 
identified as a component of the stretch-activated cation channel in vertebrate cells 
(Maroto et al., 2005). Cell-attached membrane patches from CHO cells heterologously 
expressing human TRPC1 were reported to display greater mechanosensitive channel 
activity than patches from untransfected cells in response to pipette applied membrane 
pressure (increasing steps of suction).  
3.1.8 TRPA1 
A member of the ankyrin subfamily of TRP channels has also been identified as an 
osmotically-activated channel. In one study TRPA1 was found to respond to stimulation by 
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hypertonic solutions (Zhang et al., 2008). Rat TRPA1 expressed in human embryonic kidney 
293 (HEK293) cells responded to hyperosmotic solutions with an increase in [Ca2+]i. 
Ruthenium red (non-selective TRPA1 inhibitor) and camphor blocked the whole-cell 
currents induced by hypertonic solutions. In addition, hypertonically-evoked channel 
activity was only achieved in membrane patches that were also responsive to the TRPA1 
agonist AITC (Zhang et al., 2008). In contrast to the results presented in the study by Zhang 
and colleagues, previously unpublished data (S. Bevan) has shown that hyperosmotic 
activation (up to ~500 mosm kg-1) failed to evoke any significant increases in [Ca2+]i in a 
CHO cell line heterologously expressing mouse TRPA1. 
3.1.9 TRPM3 
In addition to members of the vanilloid, ankyrin and canonical sub-families of TRP channels, 
a member of the melastatin family has also been shown to be activated by changes in 
osmolality. Grimm and colleagues (2003) identified a splice variant of the human TRPM3 
channel, TRPM31325, which was expressed in the human kidney, brain, ovaria and pancreas. 
Exposure of HEK293 cells transfected with TRPM31325, but not un-transfected HEK293 cells, 
to a hypotonic solution (200 mosmol liter-1) resulted in a rise in [Ca2+]i (Grimm et al., 2003). 
Furthermore application of a hypertonic solution (400 mosmol liter-1) caused a 
decrease in [Ca2+]i  but not in cells transfected with YFP (Grimm et al., 2003).  
3.1.10 What is the mammalian osmosensor for increased osmolality?  
Whilst TRPV4 appears to play a role in the detection of osmotic variation below the 
homeostatic set-point, a mammalian sensory neuron equivalent for detection of raised 
osmolality has not been identified. The N-terminal splice variant of TRPV1 which has been 
purported to act as an osmosensory channel within the mammalian central nervous system 
was found not to be directly osmosensitive when expressed in Xenopus oocytes (Eilers et 
al., 2007). Therefore the existence of a transduction channel expressed in sensory neurons 





Table 3-1 Summary of the established roles of TRP channels in osmosensation 
Table detailing TRP channel family members which have been reported to play a role in the osmosensory 
mechanisms of different species.  
Channel TRP Family Species Osmosensitivity 
OSM-9 
 
Vanilloid  Caenorhabditis 
elegans 
Sensitive to hypertonic 
stimuli. Responsible for 
nematode responses to some 
olfactory and osmotic stimuli, 
and mechanosensory nose 
touch responses 
(Colbert et al., 1997). 
Nanchung  Vanilloid  Drosophila 
melanogaster 
Required for sensation of 
environmental humidity. 
Sensitive to dry air (Liu et al., 
2007). 
TRPV4  Vanilloid Mammalian  Sensitive to hypotonic stimuli 
when heterologously or 
natively expressed. Expressed 
on osmosensitive neurons. 
Rescues osmotic and nose-
touch responses in OSM-9 
deficient nematodes (Lechner 
et al., 2011; Liedtke et al., 
2000, 2003; Xu et al., 2003). 
TRPV1 Vanilloid Mammalian  N-terminal splice variant of 
TRPV1 expressed on MNC, 
SON and OVLT neurons. 
Sensitive to increases in 
osmolality and may play a 
role in regulation of water 
intake (Ciura and Bourque, 
2006; Naeini et al., 2006). 
TRPV2 Vanilloid Mammalian  Sensitive to hypotonic 
solutions and cell stretch 
when heterologously 
expressed. Important for 
cardiac myocyte responses to 
hypotonic stimulation and cell 
stretch (Muraki et al., 2003). 
TRPC1 Canonical Mammalian  Component of the stretch-
activated cation channel in 
vertebrate cells (Maroto et 
al., 2005). 
Water witch  Ankyrin Drosophila 
melanogaster 
Required for sensation of 
environmental humidity. 
Sensitive to moist air.  
(Liu et al., 2007) 
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TRPA1 Ankyrin  Mammalian  Sensitive to hypertonic 
stimulation when 
heterologously expressed 
(Zhang et al., 2008).  
TRPM3 Melastatin  Mammalian Human TRPM3 variant 
activated by hypotonic 
stimulation and inhibited by 
hypertonic solutions when 
expressed in a recombinant 




3.2 Aim of the present study  
The aim of the research presented in this chapter was to examine whether TRPM8 is a 
cellular osmosensor. A further aim was to investigate how activation or inhibition of 
intracellular pathways, which have been previously shown to modify TRPM8 activity and 
which have been linked with hypertonic conditions, modulate the osmosensitivity of 
TRPM8. Finally as TRPM8 is an established thermosensitive channel, the present study also 
investigated the interaction between osmotic responses and temperature. These 
experimental aims were investigated using single cell and cell population Ca2+ 
measurements of CHO cells heterologously expressing the TRPM8 channel and rat DRG 




3.3 Materials and Methods  
3.3.1 Solutions 
The compositions of the physiological and slightly hypotonic (267 mosm kg-1) extracellular 
solutions used in these experiments are shown in Table 3-2 and Table 3-3. The osmolality of 
the slightly hypotonic solution (267 mosm kg-1) was varied by addition of either sucrose or 
NaCl. Osmolality was measured by freezing point depression using an osmometer (Roebling 
13). For Ca2+-free experiments CaCl2 was omitted from the buffer and 1mM EGTA was 
added. All solutions were buffered to pH 7.4 (NaOH).  
Table 3-2 Composition of physiological extracellular solution 
 Concentration (mM) 







Table 3-3 Composition of slightly hypotonic extracellular solution 
 Concentration (mM) 









3.3.2 Reagents  
Master stock solutions of icilin (Biomol; Exeter, UK) capsaicin (Sigma-Aldrich; St Louis, MO) 
and menthol (Sigma-Aldrich; St Louis, MO) were made in DMSO (Calbiochem; Darmstadt, 
Germany). Master stock solutions of m-3M3FBS, U73122, ACA, BEL (Sigma-Aldrich; St Louis, 
MO), AMTB (kindly synthesized and provided by Dr Simon Lewis; Bath University) and PP2 
(Tocris Bioscience; Bristol, UK) were also made in DMSO (Calbiochem; Darmstadt, 
Germany). All master stock solutions were aliquotted and stored at -20°C. Dilutions from 




3.3.3 Osmosensitivity studies  
In microscope based imaging experiments investigating the osmosensitivity of mouse 
dorsal root and trigeminal ganglion neurons (background studies), solutions were made 
hyperosmotic by addition of NaCl to a physiological or slightly hypotonic extracellular 
solution (267 mosm kg-1) unless stated otherwise. These experiments were conducted at 
28°C using calcium imaging methods described in section 2.2.2. Neuronal responses to 
osmotic or agonist solutions were determined by direct observation of Fura-2 intensity 
changes in individual neurons. Additionally, neurons were screened visually for a 
discontinuity in the Fura-2 ratio time-course indicative of a response.  
In 96-well plate experiments investigating the osmosensitivity of TRP channel transfected 
CHO cell lines, solutions were made hyperosmotic by addition of sucrose to a slightly 
hypotonic extracellular solution (267 mosm kg-1) unless stated otherwise. All assays were 
carried out at 25°C, except where stated otherwise, using calcium imaging methods 




3.3.4 Temperature activation threshold studies  
Microscope-based imaging experiments investigating the effect of osmolality on 
temperature activation thresholds were conducted on mouse TRPM8 transfected CHO cells 
and rat dorsal root ganglion (DRG) neurons (using calcium imaging experiment methods 
described in section 2.2.2). 
3.3.4.1 Heterologously expressed TRPM8 
Mouse TRPM8 CHO cells were exposed to a linear cooling temperature ramp (~37-21°C) 
and time-points of temperature decrease at 2°C intervals were recorded. For each 
population of cells tested a mean temperature activation threshold was determined.  
The impact of osmolality on the temperature thresholds of cells was measured by 
controlling the osmolality of the perfusing solution. Perfusing solutions had an osmolality of 
either: 227, 267, 287, 307, 327, 367, 517 or 767 mosm kg-1. A solution with a reduced 
osmolality of 227 mosm kg-1 was made using 100mM NaCl, 5mM KCL, 10mM glucose, 
10mM HEPES, 2mM CaCl2, and 1mM MgCl2. Other solutions were made hyperosmotic by 
addition of sucrose to a slightly hypotonic extracellular solution (267 mosm kg-1). 
Solutions were applied to cells 3 minutes prior to the beginning of the cooling temperature 
ramp. Before and after exposure to a cooling temperature ramp the temperature of the 
perfusate was held at a constant temperature (~38°C).  
3.3.4.2 Natively expressed TRPM8 
In rat DRG neuron experiments, two cooling temperature ramps (~37-18°C) were 
conducted. All neurons were perfused with a slightly hypotonic extracellular solution (267 
mosm kg-1) before being exposed to a first cooling temperature ramp. In control 
experiments there was no change to the perfusate solution before exposing the neurons to 
a second cooling temperature ramp. In other experiments the slightly hypotonic 
extracellular solution was replaced with a hyperosmotic solution (either 367 or 517 mosm 
kg-1) before exposure (3 minutes prior) to a second cooling temperature ramp. 
Temperature activation thresholds for the first and second cold challenges were compared 
in individual rat DRG neurons. Before and after exposure to a cooling temperature ramps 
the temperature of the perfusate was held at a constant temperature (~38°C). After 
exposure to the cooling ramps, neurons were exposed to a maximally-effective 
concentration of the TRPM8 agonist Icilin (1µM) in order to identify TRPM8-expressing 
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neurons. Neurons were distinguished from non-neuronal cells by a final depolarising 
challenge with a solution containing 50mM KCl.  
Neuronal responses to cold and icilin application were determined by direct observation of 
Fura-2 intensity changes in individual neurons. Additionally, neurons were screened visually 
for a discontinuity in the Fura-2 ratio time-course indicative of a temperature threshold or 
agonist-induced response.  
3.3.4.3 Activation thresholds 
To determine the temperature activation thresholds, time-points of temperature decrease 
at 2°C intervals were recorded during cooling temperature ramps. The rate of cooling was 
linear over most of the temperature range used. The Fura-2 ratios for cold-sensitive cells 
were exported into Microsoft Excel (Microsoft). The time-points were then converted into 
temperatures and were plotted against log Fura-2 ratios using Origin (Origin Lab, version 
7.5). The temperature at which the log ratio deviated from baseline, identified as the point 
of intersection between two lines fitted to the 2 phases of the Fura-2 ratio, was used as the 





Normality of data was tested using the Shapiro-Wilk Test and homogeneity of variances 
was tested using Levene’s test. Differences in normally distributed data means between 
two groups were analysed using an independent samples t-test. Differences in normally 
distributed data means between three groups or more were analysed using a one-way 
ANOVA, followed by a Tukey’s HSD post-hoc test (for datasets with equal variances) or a 
Dunnett’s T3 post-hoc test (for datasets with unequal variances). Differences in non-
normally distributed data means between two groups were analysed using a Mann-
Whitney U test. Differences in non-normally distributed data means between three groups 
or more were analysed using a Kruskal-Wallis test, followed by a Dunn-Bonferroni’s 







Microscope-based imaging experiments (performed by N. Vastani and E. Horridge) 
examining the [Ca2+]i responses of dorsal root and trigeminal ganglion neurons to 
hypertonic stimuli led to the identification of TRPM8 as a candidate transduction channel 
for increased osmolality. The data presented in this section provides the experimental 
backdrop to the characterisation of TRPM8 as a cellular osmosensor.  
3.4.1 Sensory neurons are activated by hyperosmotic solutions  
Changes in [Ca2+]i within isolated DRG and TG neurons were monitored using the calcium 
indicator dye Fura-2, to identify the presence of osmosensitive neurons. This technique was 
suitable to detect calcium influx mechanisms as well as mechanisms involving release of 
Ca2+ from intracellular stores.  
Increasing the osmolality of the extracellular solution from 307 to 367 mosm kg-1 evoked an 
increase in [Ca2+]i in a small percentage of DRG neurons (1.65%; n= 19/1154 neurons, 4, 1). 
Interestingly, some neurons displayed oscillatory baseline [Ca2+]i responses at physiological 
osmolality (307 mosm kg-1) which were attenuated upon reduction of the extracellular 
osmolality (267 mosm kg-1). In order to avoid these responses, experiments starting at a 
slightly hypotonic osmolality (267 mosm kg-1) were conducted.  
In experiments where neurons were exposed to an increase in osmolality from 267 to 367 
mosm kg-1 [Ca2+]i responses were observed in 3.6% (n= 81/2240 neurons, 13, 2) of DRG 
neurons and 4.1% (n= 35/846, 5, 1) of TG neurons. These responses were the result of a 
Ca2+ entry pathway, as shown by the absence of the responses when experiments were 
performed in Ca2+ free conditions (in the presence of 1mM EGTA in the external solution). 
These responses exhibited little desensitisation with repeated hyperosmotic challenges.   
3.4.2 Hyperosmotically activated neurons express TRPM8 
In order to identify whether there was any correlation between the osmosensitivity of a 
neuron and TRP channel expression, isolated DRG and TG neurons were exposed to a series 
of TRP channel agonists following a hyperosmotic challenge. This approach examined 
whether the osmosensitive neurons displayed characteristics of a particular functional class 
of neuron. The TRP channel agonists were used to identify some of the possible neuronal 
sub-populations (cold activated, nociceptors, non-nociceptors). The panel of agonists 
included icilin for TRPM8, allyl isothiocyanate (AITC) for TRPA1, and capsaicin for TRPV1. 
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Remarkably 69.1% (n= 56/81 neurons, 13, 2) of DRG neurons and 86% (n= 30/35 neurons, 
5, 1) of trigeminal neurons that showed an increase in [Ca2+]i when exposed to a 367 mosm 
kg-1 hyperosmotic solution (from 267 mosm kg-1) subsequently responded to icilin, 
suggesting that these osmosensitive neurons also express TRPM8 (see Figure 3-1a). In 
order to investigate whether TRPM8 was acting as a transducer of increased osmolality, the 
effect of a TRPM8 antagonist was investigated. Sensory neurons were exposed to 
consecutive hyperosmotic challenges, first in the absence and then in the presence of the 
TRPM8 antagonist, AMTB (30µM). AMTB completely inhibited the hyperosmotic responses 
in over 75% of DRG neurons (n= 62/81 neurons, 13, 2) and 80% of TG neurons (n= 28/35 
neurons, 5, 1) and reduced the mean amplitude of the Fura-2 responses by 92% in DRG 
neurons (from 35.5 ±1.6% to 2.8 ±0.9% of the KCl evoked amplitude, n=62) and 91% (from 
36.8 ±3.5% to 3.4 ±1.2%, n= 28) in TG neurons. This is in contrast to the similar sized 
responses (1st response 35.6 ±2.6%, 2nd response 39.5 ±3.9% n= 29) evoked by two 
sequential hyperosmotic stimuli in control conditions (Figure 3-1b). Next, neurons isolated 
from animals lacking functional TRPM8 channels (Trpm8-/- mice) were investigated. 
Hyperosmotic stimuli (367 mosm kg-1) did not evoke responses in neurons from Trpm8-/- 
mice (0.3%, n= 4/1453 responsive DRG neurons, 6, 2; 0%, n= 0/460 responsive TG neurons, 
7, 1, Figure 3-1c) in contrast to neurons from wildtype littermates (2.8%, n= 52/1843 
responsive DRG neurons, 7, 2; 4.1%, n= 35/846 responsive TG neurons, 5, 1). 
In summary, only TRPM8 expressing DRG and TG neurons responded to small elevations in 
extracellular osmolality. These hyperosmotic responses could be inhibited by a TRPM8 
antagonist, AMTB, and were absent from sensory neurons isolated from animals lacking 







Figure 3-1 Hyperosmotically activated sensory neurons express TRPM8 
(a) Pseudocoloured images illustrating the Fura-2 responses of DRG neurons to a sequential challenge with a 
hyperosmotic solution (517 mosm kg
-1
) followed by icilin and depolarisation with a high KCl concentration 
(50mM). The white arrow highlights a small, icilin-sensitive neuron which was activated by the hyperosmotic 
stimulus. (b) [Ca
2+
]i responses monitored by Fura-2 in an icilin-sensitive neuron. AMTB (30µM) completely 
inhibited responses evoked by hyperosmotic solutions. AMTB application indicated by the grey bar. Note that 
the reversible TRPM8 antagonist AMTB was removed before the challenge with icilin. Neurons were identified 





mice responsive to a hypertonic stimulus (367 mosm kg
-1
). Absence of 
TRPM8 reduced the percentage of hyperosmotically activated DRG neurons from 2.6% (n=52/1843 neurons, 7, 
2) to 0.3% (n=4/1453 neurons, 6, 2) and TG neurons from 4.1% (n=86/846 neurons, 5, 1) to 0% (n=0/460 




3.5 Results  
3.5.1 Osmotic sensitivity of TRPM8  
In order to examine whether the TRPM8 channel is sufficient to confer osmosensitivity or 
whether some element(s) present in the sensory neuron environment are required, the 
responses of CHO cells heterologously expressing TRPM8 to increases in osmolality were 
examined. In the experiments described changes in [Ca2+]i were monitored using the 
calcium indicator dye Fura-2 using a 96-well plate assay format.   
An extracellular saline solution with a slightly reduced osmolality was used to reduce the 
level of constitutive TRPM8 activity observed at physiological osmolalities (see Table 3-3). 
Figure 3-2 shows the responses of mouse TRPM8 CHO cells to increases in osmolality 
(addition of 10-200 mosm kg-1) from a baseline osmolality of 267 mosm kg-1. Solutions were 
made hyperosmotic by addition of sucrose to the extracellular solution.  
Hyperosmotic stimuli evoked a concentration-dependent increase in [Ca2+]i with a mean 
EC50 value of 318 ± 5 mosm kg
-1 (mean ± SEM; n= 9 independent experiments). The 
physiological osmolality for mouse extracellular fluid (311 mosm kg-1) lies on the steep part 
of the curve indicating that TRPM8 is highly sensitive to changes around the physiological 
set-point (Bourque, 2008). The osmolality-response relationship reached a plateau at final 
osmolalities above 367 mosm kg-1 (see Figure 3-2b). Smaller increases in osmolality evoked 
slower responses which took longer to reach their maximum response amplitude (see 
Figure 3-2a).  
Experiments were conducted to determine whether the hyperosmotically evoked 
responses were independent of the agent added to the extracellular solution. Similar [Ca2+]i 
responses were observed when solutions were made hyperosmotic by addition of sucrose 
(Figure 3-2) and NaCl (Figure 3-3, EC50 value - 313 ±8 mosm kg
-1; mean ± SEM; n= 5 
independent experiments). The relationship between the increase in [Ca2+]i and the final 
osmolality was similar to that observed  with sucrose. The osmolality-response relationship 
reached a plateau at final osmolalities above 367 mosm kg-1 and responses evoked by 
lower osmolalities took longer to reach their maximum response amplitude (see Figure 3-
3). However, in experiments where NaCl was added to increase the osmolality of the 
extracellular solution, the maximum amplitudes of the [Ca2+]i responses evoked were 
consistently lower than in experiments using sucrose. This could be due to the increased 
extracellular Na+ ion concentration when NaCl is used as the hyperosmotic agent. As 
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TRPM8 is a non-selective cation channel, Na+ ions will also flow through the activated 
TRPM8 channel and these ions will compete with Ca2+ ions for entry into the cell thus 
resulting in a lower influx of Ca2+ at higher external Na+ concentrations. These findings 
demonstrate that TRPM8 is sensitive to modest increases in osmolality around the 





Figure 3-2 Mouse TRPM8 is activated by increases in osmolality 
(a) Time courses of [Ca
2+
]i responses elicited by challenges with different osmolalities (osmolality altered by 
addition of sucrose) in CHO cells transfected with mouse TRPM8 (mTRPM8) in a 96-well plate experiment. 
Baseline signals were collected before cells were challenged with osmotic solutions at 20 seconds. Traces 
shown are mean ratios from triplicate wells from a representative experiment (b) Increases in osmolality 
evoked [Ca
2+
]i (Δ Fura-2 340/380) responses in mTRPM8-expressing CHO cells with an EC50 of 318 ± 5 mosm kg
-1
 
(mean ± SEM; n=9 independent experiments) in 96-well plate experiments. Hyperosmotic (sucrose) solutions 
failed to increase [Ca
2+
]i in untransfected CHO cells. Representative plots shown, data points are the mean ratio 
of triplicate wells ± SEM. The arrow on the graph points to the physiological osmolality of mouse extracellular 
solution (311 mosm kg
-1
). Hyperosmotic (sucrose) solutions failed to increase [Ca
2+
]i in untransfected control 




Figure 3-3 NaCl-induced increases in osmolality activate TRPM8 
(a) Time courses of [Ca
2+
]i increases evoked by challenges with different osmolalities (osmolality altered by 
addition of NaCl) in CHO cells transfected with mTRPM8 in a 96-well plate experiment. Baseline signals were 
collected before cells were challenged with osmotic solutions at 20 seconds. Traces shown are mean ratios from 
triplicate wells from a representative experiment (b) Increases in osmolality evoked [Ca
2+
]i (Δ Fura-2 340/380) 
responses in mTRPM8-expressing CHO cells with an EC50 of 313 ±8 mosm kg
-1
 (mean ±SEM; n=5 independent 
experiments) in 96-well plate experiments. Hyperosmotic (NaCl) solutions failed to increase [Ca
2+
]i in 




3.5.2 TRPM8 is required for osmotic sensitivity  
The [Ca2+]i responses of untransfected CHO cells exposed to hyperosmotic solutions, over 
the range that activated TRPM8 CHO cells (up to 467 mosm kg-1 final concentration), were 
examined to test whether expression of TRPM8 is required for osmosensitivity. 
Hyperosmotic solutions did not evoke [Ca2+]i responses in Fura-2 loaded untransfected CHO 
cells; suggesting that expression of TRPM8 is necessary for osmotic sensitivity (Figure 3-2b, 
Figure 3-3b).  
In order to investigate whether functional TRPM8 channels are required for the 
hyperosmotic responses, the effect of a TRPM8 antagonist, AMTB, was investigated. AMTB 
inhibits the activation of TRPM8 by the prototypical TRPM8 agonist menthol with an IC50 
value of 3.18 ± 0.33µM (mean ± SEM; n=3 independent experiments; Figure 3-4c). TRPM8 
CHO cells were exposed to a hyperosmotic stimulus (367 mosm kg-1) in the presence of 
increasing concentrations of AMTB (0.5-50µM). AMTB inhibited the hyperosmotic 
responses of TRPM8 CHO cells in a concentration dependent manner with an IC50 value of 
3.98 ± 0.25µM (mean ± SEM; n=3 independent experiments; Figure 3-5b). Furthermore, in 
the presence of a maximal concentration of AMTB (20µM) responses to hyperosmotic 
solutions (267-367 mosm kg-1) were abolished (reduction in average maximum amplitude 
from 1.86 ± 0.21 to 0.17 ± 0.04; mean ± SEM; n=3 independent experiments; Figure 3-5b). 
These findings demonstrate that functional TRPM8 expression is necessary for CHO cell 
sensitivity to increases in extracellular osmolality.  
3.5.3 Osmosensitivity is conserved between species  
Sensitivity to increases in osmolality were found not to be dependent on the species of 
TRPM8 channel expressed, CHO cells expressing human TRPM8 evoked similar [Ca2+]i 
responses to those expressing mouse TRPM8 with responses reaching a plateau at final 





3.5.4 Other sensory neuron TRP channels are not activated by hyperosmotic solutions  
Significant proportions of sensory neurons express other TRP channels (TRPV1, TRPV2, 
TRPA1, TRPM3, TRPC3/6, and TRPC1), some of which have been suggested to mediate 
responses to osmotic or mechanical stimulation (Ciura and Bourque, 2006; Corey et al., 
2004; Grimm et al., 2003; Maroto et al., 2005; Muraki et al., 2003; Quick et al., 2012; Zhang 
et al., 2008).  To determine the osmosensitivity for some of these channels, experiments 
were performed on CHO cells expressing TRPA1, TRPV1, TRPV3 or TRPM3.  
Measurement of Ca2+ influx in TRPV3 assay systems is complicated by Ca2+ mediated 
inactivation of the channel (Peier et al., 2002a; Xiao et al., 2008). In order to circumvent 
Ca2+ mediated inhibition of TRPV3 an extracellular solution containing BaCl2 as a 
replacement for CaCl2 (120 mM NaCl, 5 mM KCL, 10 mM glucose, 10 mM HEPES, 2 mM 
BaCl2, and 1 mM MgCl2) was used in experiments examining CHO cells stably transfected 
with mTRPV3; and [Ba2+]i responses were measured.  
Increasing the osmolality (by addition of sucrose or NaCl) up to ~467 mosm kg-1 failed to 
evoke any significant increases in [Ca2+]i or [Ba
2+]i in these cell lines (Figure 3-7). However 
activation of the channels by their respective agonists induced robust [Ca2+]i or [Ba
2+]i 
responses. The maximum amplitudes for responses evoked by hyperosmotic stimulation 
were below 12.5% of the maximum response amplitude evoked by the respective channel 
agonists.  
These findings suggest that other sensory neuron TRP channels (TRPA1, TRPV1, TRPV3, or 
TRPM3), unlike TRPM8, are not responsible for mediating neuronal responses to modest 






Figure 3-4 Menthol evoked [Ca
2+
]i responses are inhibited by AMTB 
(a) Time courses of [Ca
2+
]i increases evoked by different concentrations of menthol (0.2-50µM) in CHO cells 
transfected with mTRPM8 in a 96-well plate experiment. Baseline signals were collected before cells were 
challenged with osmotic solutions at 20 seconds. (b) Menthol evoked concentration-dependent [Ca
2+
]i (Δ Fura-2 
340/380) responses in mTRPM8-expressing CHO cells with an EC50 of 4.28 ± 0.47µM (n=3 independent 
experiments) in 96-well plate experiments. Representative plot shown, data points are the mean ratio of 
triplicate wells ± SEM. (c) Activation of TRPM8 by menthol (5µM) was inhibited by AMTB in a concentration 
dependent manner, IC50 - 3.18 ± 0.33µM (n=3 independent experiments). Representative plot shown, data 
points are the mean ratio of triplicate wells ± SEM. (d) AMTB (20µM) suppressed menthol (0.2-50µM) evoked 
[Ca
2+
]i (Δ Fura-2 340/380) responses. Representative plots shown, data points are the mean ratio of triplicate 




Figure 3-5 Osmolality evoked [Ca
2+
]i responses are inhibited by AMTB 
(a) [Ca
2+
]i responses of mTRPM8 CHO cells to a hyperosmotic stimulus (367 mosm kg
-1
) in the presence of 
increasing concentrations of a TRPM8 antagonist, AMTB (0.5-50µM). Activation of TRPM8 by a hyperosmotic 
solution (367 mosm kg
-1
) was inhibited by AMTB in a concentration dependent manner, IC50 – 3.98± 0.25µM 
(n=3 independent experiments). Representative plot shown, data points are the mean ratio of triplicate wells ± 
SEM (b) AMTB (20µM) abolished hyperosmotic evoked [Ca
2+
]i (Δ Fura-2 340/380) responses (267-367 mosm kg
-
1





Figure 3-6 Human TRPM8 is activated by increases in osmolality 
(a) Time courses of [Ca
2+
]i responses elicited by challenges with different osmolalities (osmolality altered by 
addition of sucrose) in CHO cells transfected with human TRPM8 (hTRPM8). Baseline signals were collected 
before cells were challenged with osmotic solutions at 20 seconds. Traces shown are mean ratios from triplicate 
wells from a representative experiment (b) Increases in osmolality evoked [Ca
2+
]i (Δ Fura-2 340/380) responses 
in hTRPM8-expressing CHO cells with an EC50 - 291 ± 16 mosm kg
-1
 (n=3 independent experiments).  







Figure 3-7 Other sensory neuron TRP channels are not activated by hyperosmotic solutions 
Δ Fura-2 (340/380) responses of CHO cells stably transfected with (a,b) rat TRPV1, (c,d) mouse TRPV3*, (e,f) 




]i responses were evoked by channel agonists 
(Capsaicin – TRPV1, 2-APB – TRPV3, Pregnenolone Sulphate – TRPM3, Allyl isothiocyanate – TRPA1) but not by 
hyperosmotic solutions (made by addition of sucrose or NaCl)  in 96-well plate experiments n=3 independent 
experiments for each cell line and treatment. Representative plots shown, data points are the mean ratio of 
triplicate wells ± SEM. 
* In experiments examining CHO cells stably transfected with mTRPV3 (c,d), extracellular solutions containing 
BaCl2 were used as a substitute for CaCl2 and the [Ba
2+




3.5.5 Regulation of osmotic responses 
3.5.5.1 Regulation by lysophospholipids and polyunsaturated fatty acids  
Lysophospholipids (LPLs) and polyunsaturated fatty acids (PUFAs) are endogenous lipids 
liberated downstream of phospholipase A2 (PLA2) activation which have been shown to 
modulate TRPM8 channel activity. Application of LPLs has been shown to activate the 
TRPM8 channel whereas application of PUFAs inhibits TRPM8 channel activation by cold, 
and TRPM8 agonists, icilin and menthol (Abeele et al., 2006; Andersson et al., 2007). The 
net effect of PLA2 inhibition has previously been observed to be inhibition of channel 
activity suggesting the potentiating effect of LPLs is more powerful than the inhibitory 
effect of PUFAs (see Figure 3-8).  
 
 
Figure 3-8 Modulation of TRPM8 by products of PLA2 
Phospholipase A2 (PLA2) enzymes hydrolyse the sn-2 acyl bond of membrane phospholipids releasing 
lysophospholipids (LPLs) and polyunsaturated fatty acids (PUFAs). Arachidonic acid (AA) is an example of PUFA 
which is released by PLA2 activity. Both LPLs and PUFAs can modulate TRPM8 activity (red + indicates positive 
modulation of TRPM8 activity and – represents negative modulation). Observation of the effects of PLA2 
inhibition on TRPM8 activation has suggested that the potentiating effect of LPLs outweighs the negative effect 
exerted by PUFAs (Andersson et al., 2007).  
Two main groups of intracellular PLA2 enzyme exist, namely cytosolic PLA2 (cPLA2/group IV 
PLA2) and calcium insensitive PLA2 (iPLA2/group VI PLA2). The former is selective for 
phospholipids which contain arachidonic acid (AA) in the sn-2 position whilst the latter will 




In order to examine the effects of PLA2 activation on the hyperosmotic activation of 
TRPM8, mouse TRPM8 CHO cells were exposed to hyperosmotic stimuli (267-467 mosm kg-
1) in the presence and absence of a cell permeable, non-selective PLA2 inhibitor (N-(p-
amylcinnamoyl)anthranilic acid, ACA, 1.5 hour pre-incubation) (Figure 3-9a). Hyperosmotic-
evoked [Ca2+]i responses were consistently reduced in cells which were treated with 10µM 
ACA in comparison to untreated cells, with an average reduction in maximum amplitude of 
75% from 2.16 ± 0.06 Δ Fura-2 ratio to 0.53 ± 0.11 Δ Fura-2 ratio (mean ± SEM; P<0.001, t-
test; n=4 independent experiments). However there was no significant change in the EC50 
values for activation by hyperosmotic stimuli (mean ± SEM; control, 311 ± 1 mosm kg-1; 
ACA, 400 ± 35 mosm kg-1; NS, t-test; n=4 independent experiments). 
To identify any regulation by lipids generated by the iPLA2 isoform the effects of a cell 
permeable iPLA2 inhibitor, bromoenol lactone (BEL), were investigated. Treatment with 
20µM BEL (1.5 hour pre-incubation) resulted in a modest reduction of hyperosmotic 
evoked responses with an average reduction in maximal response amplitude of 27% when 
compared to the responses of untreated cells (from 2.16 ± 0.06 Δ Fura-2 ratio to 1.57 ± 
0.07 Δ Fura-2 ratio; mean ± SEM; P<0.01, t-test; n=4 independent experiments; Figure 3-9b) 
and no change in the EC50 values for activation (mean ± SEM, control - 311 ± 1 mosm kg
-1; 
BEL – 296 ± 16 mosm kg-1; NS, t-test; n=4 independent experiments). 
These results demonstrate that hyperosmotic activation of TRPM8 can be modulated by 
intracellular lipids downstream of PLA2 activation. These results suggest that increased PLA2 
activity and the consequential increased production of LPLs (and PUFAs) could lead to 




Figure 3-9 PLA2 modulates osmotic responses 
(a) The non-selective PLA2 inhibitor, ACA (1.5 hour pre-incubation) supressed [Ca
2+
]i responses evoked by 
hyperosmotic solutions (267-367 mosm kg
-1
) in CHO cells transfected with mTRPM8 (n=4 independent 
experiments). Representative plots shown, data points are the mean ratio of triplicate wells ± SEM (b) 
Treatment with the selective iPLA2 inhibitor, BEL (1.5 hour pre-incubation) lead to a modest reduction in the 
hyperosmotic evoked [Ca
2+
]i responses (267-367 mosm kg
-1
) of mTRPM8 CHO cells (n=4 independent 




3.5.5.2 Regulation by pathways downstream of PLC activation  
Activation of receptors coupled to Gαq proteins, by mediators such as bradykinin and 
histamine, has been shown to inhibit TRPM8 activity (Zhang et al., 2012). Receptor 
activation triggers phospholipase C (PLC)-mediated hydrolysis of the membrane 
phospholipid phosphatidylinositol 4,5-bisphosphate (PIP2) releasing the second 
messengers; diacyl-glycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) as hydrolysis 
products (Figure 3-10). Previous reports have demonstrated that PIP2 can activate the 
TRPM8 channel in the absence of chemical or thermal stimuli and that in the presence of 
menthol or cold PIP2 acts as a positive modulator of TRPM8 activation (Liu and Qin, 2005; 
Rohács et al., 2005).  
In order to investigate the relationship between PIP2 hydrolysis and hyperosmotic 
activation of TRPM8, the hyperosmotic-evoked [Ca2+]i responses of mouse TRPM8 CHO 
cells treated with an activator of PLC, m-3M3FBS (10µM, 15 minute pre-incubation) were 
examined and compared to the [Ca2+]i responses of untreated cells. m-3M3FBS treated cells 
exhibited a significantly reduced [Ca2+]i response to hyperosmotic stimuli in comparison to 
untreated cells, with an average reduction in maximum amplitude of 68% from 1.73 ± 0.16 
Δ Fura-2 ratio to 0.55 ± 0.06 Δ Fura-2 ratio (mean ± SEM; P<0.01, t-test; n=3 independent 
experiments; Figure 3-11a). Furthermore the EC50 value for activation was shifted to 
significantly higher osmolalities in the presence of m-3M3FBS (mean ± SEM; control, 297 ± 
4 mosm kg-1; m-3M3FBS, 355 ± 6 mosm kg-1; p<0.01, t-test; n=3 independent experiments; 
Figure 3-11a). These findings demonstrate that the breakdown of PIP2 negatively 
modulates hyperosmotic activation of TRPM8, and are consistent with reports on the 
effects of PIP2 on other modes of TRPM8 activation.  
Next the effects of m-3M3FBS on osmotic responses were examined in mouse TRPM8 CHO 
cells co-treated with a PLC inhibitor, U71322 (5µM, 15 minute pre-incubation). The 
presence of a PLC inhibitor was not able to reverse the inhibition achieved with m-3M3FBS 
treatment. Remarkably the inhibition was exacerbated and the [Ca2+]i responses to 
hyperosmotic stimuli were completely abolished  (average reduction of 82% from 1.73 ± 
0.16 Δ Fura-2 ratio to 0.32 ± 0.10 Δ Fura-2 ratio; mean ± SEM; P<0.01, t-test; n=3 
independent experiments; Figure 3-11b).  
In order to ascertain whether U73122 treatment alone was having an effect on the 
hyperosmotic responses of the cells, the hyperosmotic-evoked [Ca2+]i responses of mouse 
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TRPM8 CHO cells treated with U73122 alone (5µM, 15 minute pre-incubation) were 
examined and compared to the [Ca2+]i responses of untreated cells. Interestingly, 
treatment with U73122 lead to a reduction in the hyperosmotic evoked [Ca2+]i responses 
(average reduction of 25% from 1.73 ± 0.16 Δ Fura-2 ratio to 1.29 ± 0.77 Δ Fura-2 ratio; 
mean ± SEM; NS, t-test; n=3 independent experiments Figure 3-11c). However there was 
no significant change in the EC50 values for activation (control - 297 ± 4 mosm kg
-1; m-
3M3FBS – 314 ± 12 mosm kg-1; mean ± SEM; NS, t-test; n=3 independent experiments; 
Figure 3-11c).  
 
Figure 3-10 Modulation of TRPM8 by Gαq-coupled GPCRs and PLC 
Activation of Gαq coupled receptors by agonists such as bradykinin and histamine results in activation of the G 
protein by allowing the exchange of a molecule of GDP for GTP at the Gα subunit (which is inactive when bound 
to GDP). The activated Gαq-GTP monomer and a βγ dimer (not shown) dissociate from the receptor, allowing 
Gαq to activate phospholipase C (PLC). PLC cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into diacyl 
glycerol (DAG) and inositol 1,4,5-trisphosphate (IP3). IP3 releases Ca
2+
 from intracellular stores and DAG 
activates protein kinase C (PKC). Activation of Gαq coupled receptors by agonists has been shown to negatively 
modulate (red arrow) TRPM8 activity whilst PIP2 has been shown to positively modulate (blue arrow) TRPM8 
activity (Rohács et al., 2005; Zhang et al., 2012). Activated Gαq proteins (GTP bound) have also been shown to 







Figure 3-11 PLC modulates osmotic responses 
(a) The effects of a PLC activator m-3M3FBS on hyperosmotically evoked [Ca
2+
]i responses of mTRPM8-
transfected CHO cells. m-3M3FBS (10µM, 15 minute pre-incubation) inhibited responses evoked by 
hyperosmotic solutions (267-467 mosm kg
-1
) in mTRPM8 CHO cells (mean reduction in maximum amplitude of 
68% from 1.73 ± 0.16 Δ Fura-2 ratio to 0.55 ± 0.06 Δ Fura-2 ratio; mean ± SEM; P<0.01, t-test; n=3 independent 
experiments). Representative plot shown, data points are the mean ratio of triplicate wells ± SEM (b) The 
effects of co-treatment with m-3M3FBS (10µM) and a PLC inhibitor, U73122 (5µM, 15 minute pre-incubation) 
on hyperosmotic activation of mTRPM8 CHO cells. Co-treatment of cells with m-3M3FBS and U71322 abolished 
[Ca
2+
]i responses evoked by hyperosmotic solutions (mean reduction in maximum amplitude of 82% from 1.73 ± 
0.16 Δ Fura-2 ratio to 0.32 ± 0.10 Δ Fura-2 ratio; mean ± SEM; P<0.01, t-test; n=3 independent experiments). 
Representative plot shown, data points are the mean ratio of triplicate wells ± SEM (c) The effects of U71322 
alone on hyperosmotically-induced [Ca
2+
]i mTRPM8 CHO cells. Treatment of cells with U73122 (5µM, 10 minute 
pre-incubation) alone lead to a reduction in the hyperosmotic evoked [Ca
2+
]i responses (mean reduction in 
maximum amplitude of 25% from 1.73 ± 0.16 Δ Fura-2 ratio to 1.29 ± 0.77 Δ Fura-2 ratio; mean ± SEM; NS, t-
test; n=3 independent experiments). Representative plot shown, data points are the mean ratio of triplicate 




3.5.5.3 Regulation by pathways downstream of Src family tyrosine kinase activation  
Hypo- and hypertonic conditions have been associated with tyrosine kinase activation 
(Alessandri-Haber et al., 2003; Junger et al., 1997; Xu et al., 2003). Tyrosine 
phosphorylation of TRPV4 channels by Src family tyrosine kinases was observed to be 
crucial for cellular transduction of hypotonic stimuli and nociceptive responses to 
hypertonic saline injection mediated by TRPV4 (Alessandri-Haber et al., 2005; Xu et al., 
2003). 
In order to examine whether inhibition of Src family tyrosine kinases modulates TRPM8 
activity, the responses of mouse TRPM8 CHO cells treated with a selective inhibitor of Src 
family tyrosine kinases, PP2 (10µM, 15 minute pre-incubation) to menthol (0.2-50µM) were 
studied. PP2 treatment had no effect on the menthol-evoked [Ca2+]i responses of mouse 
TRPM8 CHO cells (Figure 3-12a). The maximum amplitudes of the [Ca2+]i responses of the 
PP2 treated cells were not significantly different from the maximum amplitudes of 
untreated cells (control – 4.21 ± 0.07 Δ Fura-2 ratio; PP2 – 3.97 ± 0.20 Δ Fura-2 ratio; mean 
± SEM; NS, t-test; n=3 independent experiments). Furthermore there was no change in EC50 
values for activation (control – 4.28 ± 0.47µM; PP2 – 5.61 ± 1.73µM; mean ± SEM; NS, 
Mann-Whitney U test; n=3 independent experiments). 
Next the effect of PP2 treatment on the hyperosmotic induced responses of mouse TRPM8 
CHO cells was tested. Hyperosmotic stimuli evoked similar responses in untreated and PP2 
treated mouse TRPM8 CHO cells (Figure 3-12b). The maximum amplitudes of the [Ca2+]i 
responses of the untreated and treated cells were not significantly different (control, 1.86 ± 
0.21 Δ Fura-2 ratio; PP2, 1.64 ± 0.12 Δ Fura-2 ratio; mean ± SEM; NS, Mann-Whitney U test; 
n=3 independent experiments) and there was no change in EC50 values for activation 
(control, 307 ± 6 mosm kg-1; PP2, 311 ± 2 mosm kg-1; mean ± SEM; NS, t-test; n=3 




Figure 3-12 Src family tyrosine kinases do not modulate TRPM8 activity 
(a) The effect of a selective Src family tyrosine kinase inhibitor PP2 on menthol-evoked [Ca
2+
]i responses of  
mTRPM8 CHO cells. PP2 (10µM, 15 minute pre-incubation) had no effect on the [Ca
2+
]i responses evoked by 
menthol (0.2-50µM) in mouse TRPM8 CHO cells. Representative plot shown, data points are the mean ratio of 
triplicate wells ± SEM (b) The effect of PP2 (10µM, 15 minute pre-incubation) on hyperosmotic activation of 
mTRPM8 CHO cells. Mouse TRPM8 CHO cells treated with PP2 displayed similar hyperosmotic-evoked [Ca
2+
]i 





3.5.6 Interactions between cold and osmolality  
3.5.6.1 Osmolality modulates temperature activation of heterologously expressed TRPM8 
TRPM8 is an established cold-transduction channel and cool temperatures can modulate 
voltage- and menthol-dependent activation of TRPM8. In order to investigate the 
relationship between osmotic activation of TRPM8 and temperature, the hyperosmotically-
evoked [Ca2+]i responses of TRPM8 CHO cells were examined at different temperatures. A 
clear temperature sensitivity was noted as the relationship between osmolality and the 
evoked [Ca2+]i responses was increasingly shifted to the right as the temperature was 
increased towards 37°C, resulting in significantly raised EC50 values for activation (25°C, 318 
± 5 mosm kg-1; 29°C, 345 ± 6 mosm kg-1; 33°C, 362 ± 6 mosm kg-1; 37°C, 365 ± 8 mosm kg-1; 
mean ± SEM; n=9 independent experiments; Figure 3-13). As temperature increased there 
was also an accompanying decrease in maximum amplitude of the osmotic responses 
(25°C, 1.16 ± 0.09 Δ Fura-2 ratio; 29°C, 0.95 ± 0.06 Δ Fura-2 ratio; 33°C, 0.72 ± 0.07 Δ Fura-2 
ratio; 37°C, 0.52 ± 0.07 Δ Fura-2 ratio; mean ± SEM; n=9 independent experiments; Figure 
3-13a).  
Next the effects of osmolality on the temperature threshold for TRPM8 activation were 
examined. Microscope-based imaging experiments were conducted which allowed the 
temperature of the perfusate to be changed in a controlled manner. Populations of mouse 
TRPM8 CHO cells were exposed to cooling temperature ramps (~37-20°C) at different 
osmolalities and the thresholds of their responses were determined by plotting the log 
mean Fura-2 (340/380) ratio against temperature (Figure 3-14b).  
In an extracellular solution with a physiologically normal osmolality (~307 mosm kg-1), 
TRPM8 CHO cells responded to a cooling ramp with an increase in [Ca2+]i at an average 
threshold temperature of 27.2 ± 1.0°C, (mean ± SEM, n=4 coverslips). Reducing the 
osmolality of the external solution to 227 mosm kg-1 lowered the average threshold 
temperature to 25.9 ± 0.1°C (mean ± SEM; n=4 coverslips) while increasing osmolality (517 
mosm kg-1) elevated the average threshold temperature to 31.9 ± 0.1°C (mean ± SEM; NS; 
comparison to 307 mosm kg-1; ANOVA followed by Dunnett’s T3 test; n= 4-5 coverslips; 
Figure 3-15a). 
A relationship between osmolality of the extracellular solution and temperature activation 
thresholds can be seen clearly when observing pseudocoloured images of experiments 
examining cell temperature thresholds at two different osmolalities (Figure 3-15b). In a 
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population of mouse TRPM8 CHO cells perfused with a 367 mosm kg-1 solution, many cells 
are activated at 27°C in comparison to only a small fraction of cells in a population perfused 
with a 267 mosm kg-1 solution. These experiments demonstrate that increasing the 
extracellular osmolality raises the threshold for TRPM8 activation towards more 




Figure 3-13 Cool temperatures potentiate osmotic activation of TRPM8 
(a) [Ca
2+
]i Responses of mTRPM8 CHO cells to hyperosmotic stimuli (267-467 mosm kg
-1
) at increasing 
temperatures (25-37°C). Osmolality-evoked [Ca
2+
]i responses were shifted to the right as the temperature was 
increased with an accompanying depression in maximum amplitude (25°C, 1.16 ± 0.09 Δ Fura-2 ratio; 29°C, 0.95 
± 0.06 Δ Fura-2 ratio; 33°C, 0.72 ± 0.07 Δ Fura-2 ratio**; 37°C, 0.52 ± 0.07 Δ Fura-2 ratio***; mean ± SEM; P 
values represent comparison to 25°C.** P < 0.01, *** P <0.001; ANOVA followed by Tukey’s HSD test; n=9 
independent experiments). (b) The EC50 for activation of mTRPM8 CHO cells by hyperosmotic solutions was 
increased as the temperature was elevated (mean ± SEM; P values represent comparison to 25°C.** P < 0.01; 





Figure 3-14 Cooling activates mouse TRPM8 CHO cells 
(a) Trace illustrating a [Ca
2+
]i response evoked by a cooling temperature ramp (37-21°C) in a mTRPM8 CHO cell 
population. In this experiment the osmolality of perfusate was changed from 267 mosm kg
-1
 to 367 mosm kg
-1
 3 
minutes prior to the cold ramp (b) Temperature activation thresholds were determined by plotting the log Fura-
2 (340/380) ratio against temperature. The temperature at which the log ratio begins to deviate from baseline 
is used as the temperature activation threshold. The graph illustrates the threshold determination for the 





Figure 3-15 Osmolality influences temperature thresholds of heterologously expressed TRPM8 
(a) Temperature thresholds of mTRPM8 CHO cells were determined at different osmolalities. Activation 
thresholds of mTRPM8 CHO cells were increased when cells were challenged with solutions of higher 
osmolalities (mean ± SEM; NS; comparison to 307 mosm kg
1
; ANOVA followed by Dunnett’s T3 test; n= 4-5 
coverslips, 2-3) (b) Pseudocoloured images illustrating the Fura-2 responses of mouse TRPM8 CHO cell 
populations to 35, 27, 23 and 20°C; the upper and lower panels represent cell populations which were perfused 
with 267 and 367 mosm kg
-1




3.5.6.2 Osmolality modulates temperature activation of DRG neurons 
An interaction between osmolality and temperature thresholds for cold activation was also 
seen in sensory neurons. TRPM8 is natively expressed in 5-10% of DRG neurons (McKemy 
et al., 2002; Peier et al., 2002b), so microscope-based imaging experiments similar in 
nature to the experiments conducted on heterologously expressed TRPM8 were conducted 
on preparations of rat DRG neurons to allow [Ca2+]i to be monitored in individual neurons 
Isolated rat DRG neuron cultures were exposed to two consecutive cooling ramps (~37-
18°C) and the temperature thresholds of individual cold-sensitive neurons for both cooling 
ramps were determined using the method previously described (Figure 3-16b). In control 
experiments cells were superfused with a 267 mosm kg-1 solution during both cooling 
ramps, while in other experiments cells were perfused with a 267 mosm kg-1 solution 
during the first cooling ramp before being perfused with a solution of a higher osmolality 
(367 or 517 mosm kg-1) and exposed to the second cooling temperature ramp (Figure 3-
16a). 
Under control conditions, without a change in osmolality, it was noted that temperature 
thresholds of neurons were shifted to lower temperatures for the second cold ramp, 
suggesting some degree of desensitization (average reduction in temperature threshold of 
1.3 ± 0.3°C; mean ± SEM; n= 38 neurons; Figure 3-16c).  However, under conditions where 
osmolality was increased to 367 mosm kg-1 for the second cold challenge no reduction was 
evident and temperature thresholds of both cold-evoked responses were similar (average 
increase in temperature threshold of 0.1 ± 0.2°C; mean ± SEM; n= 85 neurons; Figure 3-
16c). In experiments where the osmolality during the second cold challenge was increased 
even further (517 mosm kg-1), the activation thresholds were elevated towards warmer 
temperatures (average increase in temperature threshold of 1.6 ± 0.4°C; mean ± SEM; n=55 
neurons; Figure 3-16c).  
A subsequent application of a maximally effective concentration of the TRPM8 agonist Icilin 
(1µM) caused an increase in [Ca2+]i in the majority  (57%, n=115/178) of cold sensitive 
neurons; consistent with expression of TRPM8 in this neuronal subset. These data 
demonstrate that osmolality can influence temperature sensitivity in sensory neurons in 






Figure 3-16 Osmolality influences temperature thresholds of TRPM8-expressing DRG neurons 
(a) Trace illustrating the [Ca
2+
]i (Fura-2 340/380) response of a rat DRG neuron to two consecutive cooling 
ramps (~37-18°C). The neuron was perfused with a 267 mosm kg
-1
 solution during the first cold challenge and 
this solution was replaced with a solution of higher osmolality (567 mosm kg
-1
) 3 minutes prior to the second 
cold challenge (b) Graph depicting the threshold analysis for the cooling-evoked responses. Increasing the 
osmolality of the perfusate from 267 to 517 mosm kg
-1
 shifted the neuron activation threshold to a warmer 
temperature. (c) Graph showing temperature threshold changes (from first temperature threshold to second 
temperature threshold) at different osmolalities. Negative values represent a shift in temperature threshold 
towards colder temperatures and positive values represent a shift to warmer temperature thresholds. Neurons 
exposed to hyperosmotic solutions prior to a second cold challenge exhibited shifts in activation thresholds to 
warmer temperatures (mean ± SEM; P values represent comparison to 267 mosm kg
-1
; ** P < 0.01, *** P 
<0.001; Kruskal-Wallis followed by Dunn-Bonferroni’s pairwise post-hoc test; 267 mosm kg
-1
, n= 38 neurons, 10, 
2; 367 mosm kg
-1
, n= 85 neurons, 13, 7; 517 mosm kg
-1




3.6 Discussion  
3.6.1 TRPM8 is a cellular osmosensor functioning at physiologically relevant 
osmolalities 
The studies presented in this chapter have established a role for TRPM8 as a mammalian 
cellular osmosensor. TRPM8 is expressed in a population of osmosensitive neurons and 
functional TRPM8 channels are required for neuronal responses to hyperosmotic stimuli as 
the responses of cultured DRG and TG neurons to hyperosmotic stimulation were inhibited 
by AMTB and were absent in neurons from Trpm8-/- mice. In addition, the studies 
presented here have shown that the sensory neuron environment is not required for 
osmotic activation of TRPM8. The expression of TRPM8 in a recombinant cell line resulted 
in robust [Ca2+]i responses to hyperosmotic solutions which were blocked by a TRPM8 
antagonist, and absent in untransfected cells, strongly suggesting that TRPM8 expression is 
sufficient to confer osmosensitivity. 
TRPM8 is sensitive to changes in osmolality and the increases in osmolality required to 
induce responses are modest. The average EC50 for activation of mouse TRPM8 (318 ± 5 
mosm kg-1) is close to the physiological set point for the extracellular fluid of mice which 
lies around 311 mosm kg-1 (Bourque, 2008). For human TRPM8 the EC50 for activation was 
slightly lower (291 ± 16 mosm kg-1) and this correlates well with a lower physiological 
osmolality in humans of around 288 mosm kg-1 (Bourque, 2008). These data demonstrate 
that TRPM8 is highly sensitive to increases in osmolality in the physiological range, making 
its osmosensing capabilities highly relevant in a physiological setting.  
Activation of TRPM8 by hyperosmotic solutions was independent of the solute used to alter 
extracellular osmolality. Hyperosmotic solutions made with sucrose and NaCl activated 
TRPM8 with a similar potency. This demonstrates that the [Ca2+]i responses evoked by 
hyperosmotic solutions are not due to an agonist action of a sugar or NaCl on the TRPM8 
expressing cells. Instead the responses are a reaction of the TRPM8 channel to an increased 
concentration of extracellular solutes.  
In experiments where NaCl was added to increase the osmolality of the extracellular 
solution, the maximum amplitudes of the [Ca2+]i responses evoked were consistently lower 
than in experiments using sucrose. It is likely that this is due to the increased extracellular 
Na+ ion concentration when NaCl is used as the hyperosmotic agent. TRPM8 is a non-
selective cation channel and both Na+ and Ca2+ ions will flow through activated channels. 
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The Na+ ions will compete with Ca2+ ions for entry into the cell thus resulting in a lower 
influx of Ca2+ at higher external Na+ concentrations. As well as a difference in the maximum 
amplitude of the responses induced by hyperosmotic NaCl solutions, the time-course 
profiles of the [Ca2+]i responses induced by sucrose and NaCl were also different. The Fura-
2 (340/380) responses evoked by high osmolality sucrose solutions (367 and 467 mosm kg-
1) began to decline after reaching a maximum peak response. However, this pattern was 
not observed in the Fura-2 (340/380) responses evoked by high osmolality NaCl solutions, 
where responses began to plateau after reaching a maximum peak response. This could be 
explained by the fact that sucrose solutions evoked larger [Ca2+]i responses than NaCl 
solutions. High [Ca2+]i concentration reached in sucrose experiments may have led to Ca
2+ 
dependent desensitisation of TRPM8 (Ca2+ mediated activation of PLC and subsequent PIP2 
depletion) which is not evident with reduced influxes of Ca2+ (Almaraz et al., 2014).  
3.6.2 Other sensory neuron TRP channels are insensitive to increases in osmolality  
Deviations in extracellular osmolality above the physiological set-point (up to 467 mosm kg-
1) did not evoke responses in cell lines transfected with other sensory neuron TRP channels. 
An N-terminal splice variant of TRPV1 has been implicated in the responses of central 
osmosensory neurons to increases in osmolality and Trpv1-/- mice have been shown to have 
impaired physiological (vasopressin release) and behavioural (water consumption) 
responses to hyperosmotic conditions (Ciura and Bourque, 2006; Naeini et al., 2006). 
Furthermore, a study by Nishihara and colleagues examining HEK293 cells transfected with 
full-length TRPV1, reported that TRPV1 was sensitive to hyperosmotic stimulation (330-350 
mosm kg-1) at 36°C (Nishihara et al., 2011). The osmosensitivity of TRPV1 was temperature-
dependent and hyperosmotic stimulation (350 mosm kg-1) of TRPV1 at 24°C did not evoke 
[Ca2+]i responses (Nishihara et al., 2011). The hyperosmotic responses described in the 
report by Nishihara and colleagues (2011) were slow in onset, beginning ~2 minutes after 
stimulus application and are therefore likely not to be the result of direct channel 
activation but rather activation of a second messenger pathway. In contrast activation of 
TRPM8 induces rapid elevations in [Ca2+]i which are evident seconds after application of a 
hyperosmotic stimulus.  
Interestingly, TRPV1 heterologously expressed in a CHO cell line was not sensitive to 
increases in extracellular osmolality over the range which activated TRPM8. Moreover, it 
has been reported that osmotic activation of the TRPV1 N-terminal splice variant 
(expressed in Xenopus oocytes) does not generate inward currents and a role of the splice 
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variant as an inhibitory modulator of TRPV1 responses to noxious heat, protons, capsaicin 
and resiniferatoxin (RTX) has been suggested (Eilers et al., 2007).  
A study by Zhang and colleagues (2008) reported that hyperosmotic solutions (330-600 
mosm kg-1) induced [Ca2+]i responses in HEK293 cells heterologously expressing rat TRPA1 
but did not evoke responses in mock-transfected cells. However, solutions with an 
osmolality greater than 600 mosm kg-1 would have been needed to determine a maximal 
response and these could not be used due to non-specific effects; therefore an EC50 for 
activation could not be determined (Zhang et al., 2012). The findings presented in this 
chapter demonstrate that mouse TRPA1 heterologously expressed in a CHO cell line is not 
sensitive to increases in osmolality over the range which activates TRPM8. Furthermore the 
sensitivity of TRPM8 to hyperosmotic stimuli is greater than that demonstrated for TRPA1 
in the study by Zhang et al, as TRPM8 is maximally activated by osmolalities just over 367 
mosm kg-1. 
A human variant of TRPM3 has previously been reported to be sensitive to changes in 
extracellular osmolality (Grimm et al., 2003). Grimm and colleagues (2003) reported that 
TRPM3 was activated by decreases in osmolality and inhibited by increases in osmolality. In 
the current study, no changes in [Ca2+]i levels were noted in CHO cells transfected with 
mouse TRPM3 when extracellular osmolality was increased, consistent with a channel 
which is insensitive to hyperosmotic stimuli. Furthermore, expression of another sensory 
neuron TRP channel, TRPV3, in a CHO cell line had no effect on osmosensitivity. Moreover, 
although TRPV4 has been implicated in PGE2 sensitised responses to hypertonic stimuli, 
studies (not presented here) have shown that TRPV4 expressed in a HEK293 cell line is 
activated by the TRPV4 agonist, GSK1016790A, but not by hyperosmotic stimuli (N. 
Vastani). 
It is also important to note that neurons from animals lacking functional TRPM8 channels 
do not respond to hyperosmotic stimulation, suggesting that at the sensory neuron level 




3.6.3 Osmotic responses are modulated by PLA2 and PLC but not Src family tyrosine 
kinases   
3.6.3.1 Modulation by PLA2 
Inhibition of PLA2 activity reduced [Ca
2+]i responses evoked by hyperosmotic stimuli in cells 
transfected with mouse TRPM8. These findings suggest that, as found for activation of 
TRPM8 by cold, icilin and menthol (Abeele et al., 2006; Andersson et al., 2007), PLA2 activity 
is needed for maximal activation of the channel.  
It is possible that a product liberated by PLA2 activation is required for this potentiating 
effect. Lysophospholipids produced by activation of PLA2 enzymes have previously been 
shown to stimulate TRPM8 activity (Abeele et al., 2006; Andersson et al., 2007). The actions 
of lysophospholipids on TRPM8 have been shown to depend on the length of the fatty acyl 
chain and the properties of the head group. These lipid products could bind to the TRPM8 
channel directly to exert an effect or they could interfere with other proteins or the plasma 
membrane indirectly affecting TRPM8.  
Targeting both the cytosolic (cPLA2) and calcium-insensitive PLA2 (iPLA2) enzyme subtypes 
led to a greater reduction in hyperosmotically-evoked responses than targeting the iPLA2 
subtype alone, suggesting that hyperosmotic activation of TRPM8 can be regulated by both 
enzyme subsets; or that block of iPLA2 by the selective inhibitor, BEL, is not as effective as 
the block achieved with the non-selective inhibitor, ACA. The findings presented in this 
chapter demonstrate that PLA2 is tonically active and this tonic activity is required for full 
activation of TRPM8 by hyperosmotic stimuli. Furthermore the results shown are 
consistent with a more powerful positive modulatory role of lysophospholipids over the 
negative modulatory role of PUFAs on TRPM8 activity evoked by cold, icilin and menthol.  
It has been argued that the effect of ACA on the activity of TRPM8 and other TRP channels 
is due to a direct effect of the compound on the channels rather than a result of PLA2 
activation and downstream signalling effects. In a study by Kraft and colleagues, 
investigating the effects of ACA on a closely related channel, TRPM2, block of TRPM2 by 
ACA could only be achieved when the compound was applied extracellularly and not when 
the compound was applied to the cytoplasmic side (Kraft et al., 2006). Furthermore the 
authors showed that although ACA was able to inhibit TRPM2 and TRPM8 channels this 
inhibition was not achieved with structurally unrelated blockers of PLA2. In contrast, a study 
by Andersson and colleagues (2007) found that PLA2 inhibitors which are structurally 
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unrelated to ACA (e.g. ETYA and BEL) inhibit TRPM8 activation by cold and icilin. Consistent 
with these findings, both BEL and ACA inhibited hyperosmotic activation of TRPM8, 
suggesting that the inhibitory effects seen are at least in part PLA2 dependent.  
3.6.3.2 Modulation by PLC 
Activation of TRPM8 by hyperosmotic stimuli was significantly inhibited by the PLC 
activator m-3M3FBS suggesting that the PIP2 concentration modulated the TRPM8 osmotic 
response. This finding is consistent with studies which have reported that TRPM8 sensitivity 
is regulated/controlled by PIP2 availability (Liu and Qin, 2005; Rohács et al., 2005).  
Stimulation of receptors which activate the PLCγ isoform and therefore induce PIP2 
hydrolysis, such as the TrkA receptor and the platelet-derived growth factor (PDGF) β-
receptor, reduced menthol-induced currents in TRPM8 expressing cells (Liu and Qin, 2005; 
Rohács et al., 2005). Moreover, stimulation of a Gq-coupled GPCR receptor, M1, which 
results in PIP2 depletion via activation of the PLCβ isoform, also significantly inhibited 
menthol-induced currents in TRPM8 expressing cells (Rohács et al., 2005). Studies have also 
shown that application of purified PIP2 or a PIP2 analogue to the cytosolic side of TRPM8-
expressing oocytes reverses the rundown of menthol-induced channel activity which occurs 
after establishment of an inside-out patch configuration (Liu and Qin, 2005; Rohács et al., 
2005). In addition exposure of the cytosolic membrane of TRPM8-expressing cells to 
purified PIP2 or a PIP2 analogue caused channel activity in the absence of any other stimuli. 
Furthermore, the second messengers DAG and IP3 which are liberated by PLC have been 
reported to have no effect on TRPM8 channel activity (Almaraz et al., 2014; Rohács et al., 
2005).  
Notably, in the current study, the effects of 3M3FBS-induced PLC activation could not be 
reversed by the PLC inhibitor U73122 which caused inhibition of the hyperosmotic 
responses when applied alone. In a study by Zhang and colleagues (2012) it was reported 
that activation of TRPM8 could be inhibited by the Gαq linked GPCR agonist bradykinin. 
This inhibition was not reversed by U73122 leading the authors to conclude that the 
process was PLC-independent (Zhang et al., 2012). This effect of bradykinin was explained 
by a direct inhibitory effect of Gαq on TRPM8 (Zhang et al., 2012).  
There are three main subfamilies of PLC enzymes: PLCβ, PLCγ and PLCδ. Gαq linked GPCRs 
are coupled to the PLCβ subfamily of enzymes, whilst activation of the PLCγ subfamily is 
coupled to receptor tyrosine kinases, and it is likely that Ca2+ influx/high intracellular Ca2+ 
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activates the PLCδ subfamily of enzymes (Rohacs, 2009). The PLC-activating compound, m-
3M3FBS, used in the experiments described in the results section stimulates the β2, β3, γ1, 
γ2, and δ1 isoforms of PLC (Bae et al., 2003).  
Surprisingly, a study examining the effects of the U73122 on human PLC isoforms 
discovered that U73122 (10μM) increased the activity of hPLCβ3, hPLCβ2 and hPLCγ1 
isoenzymes (Klein et al., 2011). Furthermore U73122 had no action on PLCδ1. Activation of 
a PLC isozyme by U73122 with a consequent hydrolysis of PIP2 could explain the increased 
inhibition of hyperosmotic responses when cells were pre-treated with m-3M3FBS and 
U73122, and the inhibitory effects of U73122 alone.  
Alternatively, a direct action of U73122 on TRPM8 or another protein involved in the 
osmosensory transduction pathway, could be responsible for the inhibitory effects with 
U73122. U73122 contains an electrophilic maleimide group which reacts with thiol-
containing nucleophiles such as cysteine (Wilsher et al., 2007). U73122 could thus modify 
TRPM8 activity or the activity of other proteins involved in the TRPM8 osmotransduction 
pathway by covalently modifying cysteine residues.  
3.6.3.3 Src family tyrosine kinases have no effect on osmotic activation of TRPM8 
Hypo- and hypertonicity can result in the activation of Src kinases (Evans, 2008). Moreover, 
phosphorylation of TRPV4 by Src kinases has been suggested to be required for 
hypotonicity-induced activation of TRPV4 expressed in HEK293 cells (Xu et al., 2003).  
The Src family of tyrosine kinases comprises a group of 9 tyrosine kinase enzymes: Src, Yes, 
Fyn, Fgr, Blk, Lck, Hck, Lyn, and Yrk; three of which are ubiquitously expressed (Src, Fyn and 
Yes) (Cohen, 2005). Incubation of cells expressing TRPM8 with a non-selective Src family 
tyrosine kinase inhibitor, PP2, was unable to modulate TRPM8 activation by hyperosmotic 
stimulation or by the prototypical TRPM8 agonist menthol. These findings suggest that 
hyperosmotic activation of TRPM8 does not occur through and is not reliant upon tyrosine 
phosphorylation by Src family kinases.  
In contrast to the findings presented in this chapter, a recently published study showed 
that increases in [Ca2+]i in human TRPM8 expressing SH-SY5Y cells evoked by a TRPM8 
agonist (WS-12) could be inhibited by PP2 (Morgan et al., 2014). Notably, the effects of PP2 
on TRPM8-expressing HEK293 cells could not be studied due to TRPM8-independent 
increases in [Ca2+]i. These findings suggest that the effects of PP2 are dependent on the cell 
line being used and this could explain the discrepancy between the findings presented in 
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the report by Morgan and colleagues and the results discussed in this chapter (the findings 
reported in this chapter are based on experiments using CHO cells). Alternatively, the 
difference in results could be due to the use of a different species of TRPM8 or the 
different mode of activation used to stimulate TRPM8 channels. Moreover, Morgan and 
colleagues reported half maximal inhibition of WS-12 responses by PP2 at 24µM. At such 
high concentrations it is possible that PP2 is beginning to inhibit non-Src tyrosine kinases 
(Hanke et al., 1996). 
3.6.4 How does a hyperosmotic stimulus activate TRPM8?   
TRPM8 is activated by increases in extracellular osmolality, but precisely how the channel is 
stimulated by changes in osmotic pressure is not clear. During hyperosmotic stimulation 
cell shrinkage occurs with deformation of the membrane and cell volume is decreased. For 
this reason, hyperosmotic solutions are often used to probe for mechanosensitive channels 
(Delmas et al., 2011). Activation of TRPM8 by hyperosmotic stimulation could be a 
mechanical process. Scaffolds within the phospholipid bilayer which are tethered to 
TRPM8, could pull the channel into an open conformation during cell shrinkage and cause 
the channel to close when physiological osmolality is restored. Studies examining centrally-
located osmosensitive neurons have found that in contrast to non-osmosensitive neurons, 
the membrane surface area does not change with fluctuations in cell volume (Zhang and 
Bourque, 2003). This finding indicates that changes in cell volume are accompanied by 
transformations in membrane shape, and it has been suggested that these changes could 
be involved in the mechanical gating of osmosensory channels (Bourque, 2008). A recent 
study demonstrated that disruption of microtubules by nocodazole abolished 
hyperosmotically-induced and mechanosensory-induced (negative pressure to the 
recording pipette) increases in membrane conductance and action potential firing in 
centrally-located osmosensory neurons (Prager-Khoutorsky et al., 2014). Tubulin was found 
to interact with TRPV1 channels (purported to be an osmosensory transduction channel in 
centrally located osmosensitive neurons) on the surface of osmosensory neurons and 
treatment with nocodazole decreased the number of sights of interaction. Furthermore, 
proteins which blocked presumptive TRPV1 binding domains for tubulin (located within the 
C terminal), diminished mechanically-evoked increases in membrane conductance and 
action potential firing in isolated osmosensory neurons (Prager-Khoutorsky et al., 2014). 
The authors of the study suggest that microtubules cause activation of TRPV1 via a pushing 
force which is exerted during cell shrinkage.  
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The opening of TRPM8 channels could be secondary to activation of a separate 
mechanosensitive/osmosensitive protein or an intracellular pathway. A study examining 
mechanosensory responses of TRPC6, established that TRPC6 channels are not directly 
mechanosensitive and that responses mediated by TRPC6 require an interaction with 
GPCRs (Mederos y Schnitzler et al., 2008). These authors showed that mechanical 
stimulation (hypotonic solutions, positive pipette pressure) causes caused ligand-
independent activation of mechanosensitive Gq-linked GPCRs which are coupled to TRPC6 
channels in a G-protein and PLC-dependent manner.  A multimeric protein complex could 
exist for TRPM8, whereby a mechanosensitive or osmosensitive protein gates the TRPM8 
channel.  
Studies using a HeLa cell line have shown that during hyperosmotic conditions (high 
extracellular NaCl or sucrose), phosphatidylinositol 4-phosphate 5-kinase β isoform 
(PIP5KIβ) is recruited to the plasma membrane and activated (by serine/threonine 
dephosphorylation) (Yamamoto et al., 2006). PIP5KIβ phosphorylates PI4P leading to 
increased levels of PIP2. Interestingly, this increase in PIP2 levels is not observed when a 
cell-permeable reagent which raises osmolality but does not induce cell shrinkage is used 
(Yamamoto et al., 2006). As previously discussed PIP2 is a positive modulator of TRPM8 
activity and can activate the channel in the absence of other stimuli (Liu and Qin, 2005; 
Rohacs, 2009). PIP2 could be a component of an osmosensory transduction pathway which 
results in activation of TRPM8. The findings presented in this chapter have shown that 
activation of PLC causes an almost complete inhibition of hyperosmotically induced TRPM8 
responses. These results establish a relationship between PLC linked breakdown of PIP2 and 
hyperosmotic activation of TRPM8 which could be consistent with an osmosensory 
transduction pathway involving PIP2. Alternatively, PIP2 could be essential for TRPM8 
channel function and activation of TRPM8 might be prevented by low levels of PIP2.  
3.6.5 A relationship exists between cold and osmotic responses 
TRPM8 is well characterised as a thermosensitive channel which is activated by cool 
temperatures (Almaraz et al., 2014; McKemy et al., 2002; Peier et al., 2002b). Activation of 
TRPM8 by hyperosmotic stimuli is positively modulated by decreases in temperature. Cool 
temperatures shifted the EC50 for activation to lower osmolalities and increased the 
maximum amplitudes of hyperosmotic responses. Moreover, osmotic activation of TRPM8 
was associated with warmer temperature activation thresholds. Hyperosmotic stimuli 
raised temperature thresholds closer to estimates for physiological temperatures of the 
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skin and cornea, organs which are innervated with TRPM8-expressing nerve afferents 
(Dhaka et al., 2008; Parra et al., 2010; Takashima et al., 2007). Furthermore, activation 
thresholds of cold-sensitive sensory neurons were also increased to warmer temperatures 
in hyperosmotic conditions, suggesting a similar interaction between cold and osmotic 
responses for natively expressed TRPM8 channels.  
Although the majority of cold-sensitive sensory neurons responded to the TRPM8 agonist 
icilin, not all did. This discrepancy could be due false-negative identification of icilin 
responders. Icilin responses are typically slow oscillations in [Ca2+]i that occur with a 
variable latency which can sometimes hamper the identification of responding neurons 
during the limited observation period. Furthermore, all neurons were exposed to two prior 
cold challenges before being exposed to icilin and previous studies have shown that icilin 
responses are prone to desensitisation (Chuang et al., 2004).  
A previous study has identified expression of TRPM8 channels on sensory nerves 
innervating the superficial epithelial layers of the cornea (Parra et al., 2010). The report 
proposed that TRPM8 channels expressed on cold-sensing neurons in the cornea can 
regulate lacrimation by detecting the decreases in temperature which occur at the ocular 
surface due to evaporative cooling during inter-blink periods. The study found that Trpm8-/- 
mice had a significantly lower basal tearing rate than WT mice and that increases in corneal 
temperature lead to significantly decreased tear production in WT but not Trpm8-/- mice 
(Parra et al., 2010).  
During inter-blink periods a decrease in temperature will also be accompanied by an 
increase in extracellular osmolality. This change will be exacerbated in conditions where 
the osmolality of the ocular fluid is already higher, for example in patients with dry-eye 
syndrome. Therefore it is possible that combined activation of TRPM8 by decreased 
temperature and increased osmolality is required for excitation of corneal afferent neurons 
during evaporation of the ocular film. A study by Hirata and Oshinsky (2012) confirmed that 
the responses (increase in firing rate) of rat corneal afferents to ‘dry’ stimuli (removal of a 
well containing artificial tears enclosing an entire anterior eye and removal of excess 
artificial tears using filter paper in anesthetised rats) could not be entirely accounted for by 
corneal temperature fluctuations (Hirata and Oshinsky, 2012). Furthermore, they found 
that application of the TRPM8 antagonist BCTC (20µM) significantly inhibited corneal 




3.7 Conclusion  
TRPM8 functions as a cellular osmosensor in addition to its already established roles as a 
thermosensor and receptor for cooling compounds. It is able to detect subtle fluctuations 
in extracellular osmolality around the physiological norm. Hyperosmotic responses 
mediated by TRPM8 can be modulated by activation of phospholipase enzymes and 
temperature. This novel role for TRPM8 as an osmosensory transduction channel could 
have implications for TRPM8 channels expressed in areas which are exposed to variations 





Chapter 4. TRPM3 is a sensory-neuron expressed, heat-sensitive 
channel which is modulated by activation of GPCRs   
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4.1 Introduction  
4.1.1 Introduction to TRPM3  
TRPM3 is one member of the melastatin TRP family which has not been extensively 
studied. Proteins encoded by the TRPM3 gene form non-selective cation channels which 
are widely expressed in mammalian tissues. TRPM3 is activated by the endogenous 
neurosteroid pregnenolone sulphate (PS), which has been utilised as a pharmacological 
tool for channel characterisation and as a probe for TRPM3 expression (Wagner et al., 
2008). Expression of TRPM3 has been observed in the mammalian central nervous system 
and sensory neuron ganglia, and studies have suggested roles for TRPM3 in thermosensing 
and nociception (Jang et al., 2012; Kunert-Keil et al., 2006; Lee et al., 2003; Oberwinkler et 
al., 2005; Staaf et al., 2010; Vandewauw et al., 2013; Vriens et al., 2011).  
4.1.2 TRPM3 gene 
The TRPM3 gene transcript encodes a large number of isoforms which occur predominantly 
through alternative splicing (Oberwinkler and Philipp, 2014). Six different splice variants (a-
f) of the human TRPM3 gene were identified by Lee and colleagues (2003). The TRPM3a 
variant was found to localise to the plasmalemmal compartment of HEK293 cells 
overexpressing the channel, as well as to intracellular compartments (Lee et al., 2003). 
Grimm and colleagues (2003) described another human TRPM3 variant, composed of 1325 
amino acid residues (later referred to as TRPM31325 variant), which possessed a shorter 
carboxyl terminus and longer amino terminus than the variants previously described and 
was activated by cell swelling (Grimm et al., 2003).   
A further 5 splice variants, TRPM3α1-5, from the mouse TRPM3 gene were described by 
Oberwinkler and colleagues (2005). The sequences were between 1699-1721 amino acids 
long and were encoded by exons 1, 3-7, and 9-28 (Oberwinkler et al., 2005). Similar to the 
human a-f variants, the described mouse splice variants lack an amino terminal sequence 
encoded by exon 2 which is present in the hTRPM31325 variant; however, they contain a 
novel amino terminal sequence encoded by exon 1 which is not present in any of the 
previously discovered TRPM3 variants (Oberwinkler et al., 2005). A high amino acid identity 
(~97%) exists between the mouse TRPM3 proteins (α1-5) described by Oberwinkler and 
colleagues (from residue 156 onwards), and the human TRPM3 (a-f) proteins described by 
Lee and colleagues. Each mouse variant corresponds to an analogous human variant 
(mouse TRPM3α1- TRPM3c, mTRPM3α2- hTRPM3a, mTRPM3α3- hTRPM3b, mTRPM3α4- 
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hTRPM3e and mTRPMα5- hTRPM3d). These findings demonstrate that splice events are 
highly conserved between mice and humans (Oberwinkler et al., 2005). 
4.1.3 Expression of TRPM3 
Analysis of TRPM3 RNA and protein levels has revealed expression of TRPM3 in a wide 
range of mammalian tissues (see Table 4-1 and Table 4-2 for summaries). The human 
TRPM3a variant is predominately expressed in the human kidney but is also present in the 
brain, spinal cord and testis (Lee et al., 2003). Further analysis of TRPM3a expression in the 
human kidney established expression in the collecting tubular epithelium in the medulla, 
medullary rays, and periglomerular regions (Lee et al., 2003). More detailed analysis of 
expression within the brain revealed the highest levels of TRPM3a transcripts were present 
in the cerebellum, locus coeruleus, posterior hypothalamus and substantia nigra. 
Expression of the TRPM31325 transcript was also found in the human kidney and brain, and 
additionally in human ovaries and pancreas (Grimm et al., 2003). TRPM31325 RNA was also 
present in the mouse brain but not in the mouse kidney (Grimm et al., 2003). Further 
examination of TRPM3 expression in immunoblotting studies found bands of 160 kDa 
(calculated mass of TRPM3 is 157 kDa) in human kidney and brain, and bovine kidney. In 
the mouse brain samples, bands were detected around 130 and 220 kDa which were 
attributed to alternatively spliced variants of the gene (Grimm et al., 2003). Expression of 
TRPM3 in the human brain, pancreas and kidney was confirmed in a study by Fonfria and 
colleagues (2006). This study also identified high levels of TRPM3 expression in the pituitary 
and lower levels of expression in adipose tissue, prostate and bone.   
One study examining expression of TRPM3 mRNA in mice, established expression of TRPM3 
transcripts at multiple brain sites including; the dentate gyrus, the intermediate lateral 
septal nuclei, the indusium griseum and the tenia tecta (Oberwinkler et al., 2005). 
However, the strongest expression of TRPM3 was present in the epithelial cells of the 
choroid plexus. In addition to TRPM3 expression in the central nervous system, TRPM3 
transcripts were also found in the mouse eye (Oberwinkler et al., 2005).   
A separate study confirmed expression of TRPM3 in the mouse brain with high expression 
levels in the cerebrum, cerebellum, basal ganglia and hippocampus of C57Bl/10 mice 
(Kunert-Keil et al., 2006). Interestingly, analysis of TRPM3 expression in other mouse strains 
revealed that the high expression levels of TRPM3 observed in the cerebrums of C57Bl/10 
mice were not seen in tissue from NOD or Balb/c mice (Kunert-Keil et al., 2006). In 
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corroboration with findings from Grimm and colleagues, extensive expression of TRPM3 
was not found in the mouse kidney  (Kunert-Keil et al., 2006).   
TRPM3 has been found to be expressed at glutamatergic synapses in neonatal Purkinje cells 
(Zamudio-Bulcock et al., 2011). Activation of TRPM3 by a TRPM3 agonist (pregnenolone 
sulphate) was reported to increase glutamate release and this effect was found to be 
inhibited by a TRPM3 antagonist (mefenamic acid). TRPM3 expression has also been 
identified in pancreatic β cells and treatment of these cells with a TRPM3 agonist 
(pregnenolone sulphate) resulted in intracellular Ca2+ signals and was found to potentiate 
glucose-induced insulin secretion (Wagner et al., 2008) 
TRPM3 expression has been identified in the rodent aorta and pulmonary artery, and has 
been reported to modulate contraction of the mouse aorta (Naylor et al., 2010; Yang et al., 
2006). In the vascular smooth muscle cells of the human saphenous vein, TRPM3 has been 
reported to mediate a Ca2+ entry pathway. In proliferating vascular smooth muscle cells, 
inhibition of TRPM3 (by a TRPM3-blocking antibody) resulted in increased IL-6 secretion 
suggesting that TRPM3 activity is negatively coupled to secretion of some cytokines (Naylor 
et al., 2010). Furthermore, TRPM3 expression has been identified in fibroblast-like 
synoviocytes of rheumatoid arthritis patients; here TRPM3 activity has been reported to be 
negatively coupled to the secretion of hyaluronan (Ciurtin et al., 2010). TRPM3 expression 
has also been reported in oligodendrocytes (Hoffmann et al., 2010). 
Importantly for the current study, TRPM3 expression has also been identified in rodent 
sensory neurons in the dorsal root, trigeminal and nodose ganglia (Jang et al., 2012; Nealen 




Table 4-1 Human tissues expressing TRPM3 
Tissue  Detection Method   Reference 
Brain RT-qPCR/Western 
blot + Northern 
blot +  RT-PCR/ RT-
qPCR 
(Fonfria et al., 2006; 
Grimm et al., 2003; 
Lee et al., 2003) 
- Cerebellum 
 
RT-qPCR (Lee et al., 2003) 
- Locus coeruleus 
 
RT-qPCR (Lee et al., 2003) 
- Posterior hypothalamus 
 
RT-qPCR (Lee et al., 2003) 
- Substantia nigra  
 
RT-qPCR (Lee et al., 2003) 
Spinal Cord 
 
RT-qPCR (Lee et al., 2003) 
Kidney RT-qPCR/ Western 
blot + Northern 
blot +  RT-PCR /RT-
qPCR 
(Fonfria et al., 2006; 
Grimm et al., 2003; 
Lee et al., 2003) 
- Collecting tubule epithelium  
 
RT-qPCR (Lee et al., 2003) 
- Medullary rays  
 
RT-qPCR (Lee et al., 2003) 
- Periglomerular regions 
 
RT-qPCR (Lee et al., 2003) 
Pancreas  RT-qPCR/ RT-PCR (Fonfria et al., 2006; 
Grimm et al., 2003) 
Pituitary gland 
 




RT-PCR (Grimm et al., 2003) 
Testis 
 
RT-qPCR (Lee et al., 2003) 
Prostate 
 








RT-qPCR (Fonfria et al., 
2006) 





Table 4-2 Mouse/rat tissues expressing TRPM3 
Tissue  Detection Method  Reference 
Brain Western blot + 




(Grimm et al., 
2003; Jang et al., 
2012; Kunert-Keil 
et al., 2006; 
Oberwinkler et al., 
2005) 
- Forebrain RT-qPCR/ISH (Kunert-Keil et al., 
2006; Oberwinkler 
et al., 2005) 
o Cerebrum  RT-qPCR (Kunert-Keil et al., 
2006) 
 Basal ganglia RT-qPCR (Kunert-Keil et al., 
2006) 
 Hippocampus  RT-qPCR (Kunert-Keil et al., 
2006) 
 Dentate gyrus ISH (Oberwinkler et al., 
2005) 
 Septal nuclei ISH (Oberwinkler et al., 
2005) 
 Indusium griseum  ISH  (Oberwinkler et al., 
2005) 
 Tenia tecta ISH  (Oberwinkler et al., 
2005) 
- Cerebellum RT-qPCR (Kunert-Keil et al., 
2006) 
- Choroid plexus  ISH (Oberwinkler et al., 
2005) 
DRG RT-PCR/RT-qPCR/ 
RT-qPCR + ISH + 
Western blot + 
Function 
(Jang et al., 2012; 
Vandewauw et al., 
2013; Vriens et al., 
2011) 
TG RT-PCR/ RT-PCR/ 
RT-qPCR/ RT-qPCR 
+ ISH + Western 
blot + Function 
(Jang et al., 2012; 
Nealen et al., 2003; 
Vandewauw et al., 
2013; Vriens et al., 
2011) 
NG RT-qPCR (Staaf et al., 2010) 
Eye Northern blot (Oberwinkler et al., 
2005) 
Testis RT-qPCR (Jang et al., 2012) 
Aorta RT-PCR + Function/ 
RT-qPCR 
(Naylor et al., 2010; 
Yang et al., 2006) 





4.1.4 Activation of TRPM3 
4.1.4.1 ᴅ-erytho-sphingosine 
TRPM3 has been shown to be activated by the sphingolipid, ᴅ-erytho-sphingosine (DeSPH). 
DeSPH evoked large increases in [Ca2+]i in TRPM3-transfected HEK293 cells, but not 
untransfected cells, with an EC50 value of 12µM (Grimm et al., 2005). Other sphingolipids, 
namely dihydro-ᴅ-erythro-sphingosine (DHS) and N,N-dimethyl-ᴅ-erythro-sphingosine 
(DMS), also lead to activation of TRPM3 expressed in HEK293 cells, although the responses 
evoked by these compounds were smaller than those induced by DeSPH (Grimm et al., 
2005).  
In contrast to these findings, Wagner et al., (2008) found that a one minute application of 
DeSPH did not activate INS1 cells endogenously expressing TRPM3 or TRPM3-transfected 
HEK293 cells. Although prolonged exposure to DeSPH resulted in large currents in INS1 cells 
and TRPM3-transfected HEK293 cells, this response was also observed in untransfected 
HEK293 cells; suggesting a TRPM3-independent mechanism (Wagner et al., 2008). 
However, before the onset of the large non-specific current, a small outwardly rectifying 
current was observed in TRPM3-transfected HEK293 cells, which was not seen in 
untransfected cells (Wagner et al., 2008). Although it is likely that this small current was 
due to activation of TRPM3, the authors of the study proposed that the non-specific effects 
of DeSPH limit its use for functional identification of TRPM3 channels.  
4.1.4.2 Pregnenolone sulphate and structurally related compounds 
The neuroactive steroid pregnenolone sulphate (PS) has been identified as a TRPM3 agonist 
that is active within the micromolar range (Wagner et al., 2008). Application of PS induced 
concentration-dependent activation of outwardly rectifying currents and increases in [Ca2+]i 
in TRPM3 expressing HEK293 cells, which were reliant on extracellular calcium and absent 
in untransfected cells (Wagner et al., 2008). PS activates TRPM3 with an EC50 value of 12-
23µM and is able to activate TRPM3 channels in <100ms. The binding site for PS is thought 
to be located on extracellular side of the channel due to a lack of effect when PS is applied 
to the cytosolic surface of inside-out membrane patches (Wagner et al., 2008). PS also 
evoked responses in INS1 cells and pancreatic islet cells endogenously expressing TRPM3 
(Wagner et al., 2008). Interestingly, PS can reversibly insert into the plasma membrane 
thereby altering membrane capacitance (Mennerick et al., 2008). In order to test whether 
PS activates TRPM3 via a receptor operated mechanism or indirectly via membrane 
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interactions, experiments were conducted assessing activation of TRPM3 by a synthetic 
enantiomer of PS, ent-PS, which causes the same change in membrane capacitance as the 
naturally occurring enantiomer of PS. Ent-PS was much less effective at evoking [Ca2+]i 
responses and whole cell currents than the naturally occurring enantiomer of PS (in 
TRPM3-transfected cells), suggesting a direct, chirally-selective, PS binding site (Drews et 
al., 2014). PS has also been shown to be an activator of recombinantly-expressed TRPM1 
channels. PS (35µM) induced inward and outward currents in HEK293 cells overexpressing 
TRPM1, however due to variability in PS responses between transfections and small current 
amplitudes the authors of the study were not able to provide a full characterisation of 
activation (Lambert et al., 2011).  
Structurally related compounds such as pregnenolone, DHEA and DHEA sulphate, were also 
shown by Wagner et al to be activators of TRPM3 channels, albeit less efficacious than PS 
(Wagner et al., 2008). A later study by Majeed and colleagues (2010) determined that 
pregnenolone, DHEA and DHEA sulphate are partial agonists of TRPM3 (Majeed et al., 
2010).  
Other steroids which are closely related to PS have also been identified as agonists of 
TRPM3: these include epipregnanolone sulphate, epiallopregnanolone sulphate, 
pregnenolone glucuronidate and pregnenolone hemisuccinate (Drews et al., 2014). 
Activation of TRPM3 by epipregnanolone sulphate indicates that the double bond between 
C5-C6 present in PS is not required for activation of TRPM3. However, the β-orientation of 
the sulphate group at the C3 position has been shown to be important for activation of 
TRPM3 as a compound which lacks the C5-C6 double bond and has the sulphate group in α-
orientation (pregnanolone sulphate) was ineffective at activating TRPM3 channels (Drews 
et al., 2014). In addition to being in the β-orientation, it is also important for the group at 
the C3 position to carry a negative charge, as compounds which have an uncharged group 
at the C3 position such as pregnenolone acetate and pregnenolone methyl ether were 
unable to effectively stimulate TRPM3. In contrast, compounds containing glucuronidate 
and hemisuccinate in the C3 position were able to activate TRPM3 transfected cells (Drews 
et al., 2014).  
4.1.4.3 Nifedipine 
The dihydropyridine calcium channel blocker, nifedipine is also an agonist at TRPM3 
channels. Application of nifedipine induced concentration-dependent increases in [Ca2+]i 
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and outwardly rectifying currents, in TRPM3 expressing HEK293 cells which were absent in 
untransfected cells (Wagner et al., 2008). Similar to PS, nifedipine also evoked responses in 
INS1 cells and pancreatic islet cells endogenously expressing TRPM3. Combined application 
of PS (maximally effective concentration) and nifedipine to TRPM3 transfected CHO cells 
caused a supra-additive effect indicating that these two substances cause activation of 
TRPM3 by interaction at different binding sites (Drews et al., 2014).  
4.1.4.4 Hypotonicity 
In addition to chemical activation of TRPM3, decreases in osmolarity have also been shown 
to activate TRPM3 channels. Exposure of TRPM3-transfected, but not un-transfected 
HEK293 cells, to a hypotonic solution (200 mosmol liter-1) resulted in a rise of [Ca2+]i (Grimm 
et al., 2003). This hypotonic response was inhibited in Ca2+ free conditions and was 
reversed by washing with an isotonic solution.  
4.1.5 Inhibition of TRPM3 
4.1.5.1 Dihydropyridines  
Although nifedipine has been found to activate TRPM3, other dihydropyridines can inhibit 
TRPM3 channel activity. Joint application of nimodipine with PS caused an inhibition of PS-
induced [Ca2+]i responses and a reduction in PS-induced current amplitude (Drews et al., 
2014). Similar inhibitory effects were observed with nicardipine and nitrendipine (Drews et 
al., 2014).  
4.1.5.2 Non-selective TRP inhibitors 
The promiscuous TRP channel antagonist, 2-APB as well as Gd3+ and La3+ ions have also 
been shown to inhibit TRPM3 activity (Grimm et al., 2003; Lee et al., 2003; Xu et al., 2005).  
4.1.5.3 Divalent and monovalent cations  
Physiological concentrations of Mg2+ ions have also been shown to inhibit the activity of 
TRPM3 channels (Oberwinkler et al., 2005). Furthermore, extracellular Na+ and K+ ions 
inhibit currents through channels composed of the TRPM3α2 variant but not the TRPM3α1 




4.1.5.4 Fenamates  
The fenamate, non-steroidal anti-inflammatory (NSAID) drug, mefenamic acid has been 
identified as a potent, selective inhibitor of TRPM3 (Klose et al., 2011). Mefenamic acid 
inhibits TRPM3 in a pH-dependent manner by interacting with an extracellular site on the 
channel. It has been shown to inhibit PS evoked activation of TRPM3 channels expressed by 
HEK293 cells with an IC50 value of 6.6 ± 1.8µM (Klose et al., 2011). Experiments with INS-1E 
cells showed that mefenamic acid was able to inhibit PS-induced Ca2+ influx and insulin 
secretion (Klose et al., 2011). In addition to mefenamic acid, other fenamate drugs such as: 
DCDPC, tolfenamic acid, meclofenamic acid, flufenamic acid and niflumic acid, act as less 
potent, non-selective inhibitors of TRPM3 (Klose et al., 2011). 
4.1.5.5 Progesterone and structurally related compounds 
TRPM3 activity can also be inhibited by the endogenous steroid progesterone, 
progesterone metabolites and 17β-oestradiol (Majeed et al., 2012). Progesterone (0.01-
10µM) inhibited PS- and nifedipine-evoked [Ca2+]i responses of TRPM3 transfected HEK293 
cells, while dihydrotestosterone (50µM) inhibited PS-induced responses but only caused a 
small inhibition of nifedipine-induced responses (Majeed et al., 2012). Furthermore, 
progesterone but not dihydrotestosterone, was able to inhibit constitutive activity of 
TRPM3 (in a Ca2+ add back protocol). Progesterone inhibited PS-induced responses in the 
presence of a progesterone receptor antagonist,  indicating that inhibition of TRPM3 by 
progesterone does not involve the progesterone receptor and suggesting a direct effect of 
progesterone on either TRPM3 or a protein which is closely associated with TRPM3 
(Majeed et al., 2012).  
4.1.5.6 Thiazolidinediones  
Rosiglitazone, a PPAR-γ agonist has also been shown to inhibit TRPM3 activity evoked by 
both PS and nifedipine, with IC50 values (calcium assay) of 4.6µM and 9.5µM respectively 
(Majeed et al., 2011). This inhibition was not affected by PPAR-γ antagonist suggesting it is 
not PPAR-γ-mediated. The inhibitory effects of rosiglitazone were mirrored by troglitazone 
and pioglitazone, which also belong to the thiazolidinedione class of drugs (Majeed et al., 
2011). However, TRPM3 was not inhibited by the endogenous PPAR-γ agonist, 15d-PGJ2 
again suggesting a lack of PPAR-γ involvement in rosiglitazone inhibition of TRPM3 (Majeed 




4.1.5.7 Flavonoids and ononetin 
The flavonoids naringenin, hesperetin and eriodictyol which are found in citrus fruits have 
also been identified as inhibitors of TRPM3, alongside the deoxybenzoin compound, 
ononetin (Straub et al., 2013a). Naringenin, hesperetin, eriodictyol and ononetin potently 
inhibited PS activation of TRPM3 expressed in HEK293 cells in a calcium flux assay, with IC50 
values of 0.5 ± 0.07µM, 2.0 ± 0.1µM, 1.0 ± 0.07µM and 0.3 ± 0.03µM, respectively (Straub 
et al., 2013a). More detailed electrophysiological examination of the inhibition by 
naringenin and ononetin concluded that the inhibition was reversible. In addition to block 
of PS-induced currents, naringenin and ononetin also inhibited nifedipine-induced currents 
and caused partial block of heat-evoked currents (Straub et al., 2013a). Similar to 
mefenamic acid, naringenin and ononetin are thought to interact with TRPM3 channels via 
an extracellular binding site. Naringenin and ononetin were not able to inhibit PS-induced 
currents when applied intracellularly (Straub et al., 2013a). Interestingly, the IC50 value 
observed with ononetin, but not with naringenin, could be shifted according to the 
concentration of PS used to activate TRPM3; a higher concentration of PS resulted in a 
higher IC50 value. This suggests that ononetin is acting as a competitive inhibitor of PS in 
contrast to naringenin which appears to be acting as a non-competitive inhibitor.  
Naringenin also exerted effects on TRPV1, TRPM7 and TRPM8; causing partial inhibition of 
capsaicin-induced activation of TRPV1 expressing HEK293 cells, partial block of TRPM7-
mediated currents and both activation and inhibition of TRPM8 (Straub et al., 2013a). 
Furthermore, ononetin inhibited PS-induced TRPM1 activation and activated TRPA1 (Straub 
et al., 2013a).  
Another citrus fruit product, isosakuranetin, has been identified as a potent TRPM3 
antagonist (Straub et al., 2013b). Isosakuranetin, a flavanone present in blood oranges and 
grapefruits, inhibited activation of TRPM3 transfected HEK293 cells by PS with an IC50 value 
of 50 ± 6nM (calcium assay). Isosakuranetin also blocked inward and outward currents 
induced by PS in TRPM3 HEK293 cells and partially inhibited TRPM3 mediated heat-evoked 
currents (Straub et al., 2013b). In contrast to PS, mefenamic acid, ononetin and naringenin, 
which are all thought to interact with TRPM3 through an extracellular binding site, 
isosakuranetin is thought to bind to TRPM3 intracellularly (Klose et al., 2011; Straub et al., 
2013a, 2013b; Wagner et al., 2008). Another flavanone, liquiritigenin, was identified as a 
TRPM3 inhibitor with a lower potency than isosakuranetin (Straub et al., 2013b). When 
tested for selectivity liquiritigenin had no effect on PS-induced TRPM1 activation, however 
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isosakuranetin caused a small inhibition of TRPM1-mediated PS responses. Neither 
compound inhibited  TRPM8 or TRPV1, but both isosakuranetin and liquiritigenin caused 
partial activation of TRPA1 at low micromolar concentrations (Straub et al., 2013b).   
 
Figure 4-1 Activators and inhibitors of TRPM3  
TRPM3 channels can be activated by the sphingolipid, ᴅ-erytho-sphingosine (DeSPH) and the dihydropyridine, 
nifedipine. The most potent and selective activator of TRPM3 is the endogenous neurosteroid, pregnenolone 
sulphate (PS) which is a useful pharmacological tool for the study of TRPM3. TRPM3 channel activity is 
purportedly increased by heat and hypotonic solutions. TRPM3 can be inhibited by many different compounds; 
including the fenamate NSAID drug, mefenamic acid and the deoxybenzoin compound, ononetin. In addition 
some citrus fruit flavonoids (naringenin, isosakuranetin, liquiritigenin) are inhibitors of TRPM3. The non-




 and 2-APB also block TRPM3 as do the dihyrdropyridines, nimodipine 
and nicardipine. 
4.1.6 Permeation of TRPM3 
Grimm and colleagues (2003) established that the human TRPM31325 variant has a greater 
permeability for Ca2+ ions over both Na+ ions (permeability ratio of 1.57 ± 0.31 for PCa/PNa) 
and Cs+ ions (1.14 ± 0.10 for PCa/PCs). The TRPM3α2 variant was also shown to have a higher 
permeability for divalent cations over monovalent cations and the order of conductivity for 
divalent cations was found to be Ca2+ > Zn2+ > Mg2+ > Ni2+ (Wagner et al., 2010). 
Interestingly, channels formed from the mouse TRPM3α2 variant are much more 
permeable to Ca2+ and Mg2+ ions in comparison to channels formed from the TRPM3α1 
variant, which are poorly permeable to these divalent cations (Oberwinkler et al., 2005). 
Alternative splicing in exon 24, results in an extra amino acid domain (containing 12 amino 
acids) in mouse TRPM3α1 variants which is located between the postulated fifth and sixth 
transmembrane domains (predicted pore-region). In addition, an alanine residue is 
replaced with a proline residue. This amino acid domain is absent in the mouse TRPM3α2 
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variant and all other variants excluding the hTRPM3c variant (Oberwinkler et al., 2005). 
Oberwinkler et al (2005) suggest that the introduction of this amino acid domain, which 
contains positively charged amino acid residues, to TRPM3α1 variants might lead to a 
decreased Ca2+ permeability due to increased electrostatic repulsion.  
Vriens and colleagues (2014) established that ions could flow through TRPM3 channels via 
two pathways, the first through a centrally located pore and the second through an 
alternative pore located partly in the TM4 region of the channel (Vriens et al., 2014b). This 
alternative pathway could be opened by combined application of PS and clotrimazole (an 
anti-fungal medication) or clotrimazole structural analogues. Influx through this alternative 
permeation pathway resulted in an inwardly rectifying current which is insensitive to La2+ 
block and could be abolished by a mutation in the TM4 domain which swapped tryptophan 
for arginine (W982R) (Vriens et al., 2014b). 
4.1.7 Modulation of TRPM3 activity  
Despite a large array of agonists and antagonists described for TRPM3 there has been little 
study into the mechanisms which regulate or sensitise the channel. Many TRP channels are 
regulated by signalling pathways associated with activation of G-protein coupled receptors 
(GPCRs). However, the activity of the human TRPM31325 variant expressed in HEK293 cells 
was not modulated by activation of the histamine H1 receptor or by activation of 
endogenously expressed muscarinic receptors by carbachol (Grimm et al., 2003). In 
addition, the emptying of intracellular stores induced by the Ca2+-ATPase inhibitor, 
thapsigargin, did not affect the activity of  TRPM31325 (Grimm et al., 2003). In contrast, 
application of both thapsigargin and carbachol to HEK293 cells expressing the human 
TRPM3a variant stimulated Ca2+ entry (Lee et al., 2003). These findings suggest that 
different splice variants of the human TRPM3 gene can be differently modulated.  
4.1.8 Role of TRPM3 in thermosensation   
TRPM3 channels have been reported to be heat-sensitive, one study showed that heat 
(40°C) evoked increases in [Ca2+]i in HEK293 cells transiently expressing TRPM3 and 
repetitive applications of heat resulted in desensitisation of the [Ca2+]i responses (Vriens et 
al., 2011). Furthermore, heating activated an outwardly rectifying current in TRPM3 
HEK293 cells with a Q10 value of 7.2 (Vriens et al., 2011). In addition, a synergistic effect was 
observed between chemical and thermal activation of TRPM3. The TRPM3 agonist, PS 
(10µM), shifted the activation of TRPM3 by heat to lower temperatures and increased 
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temperatures potentiated PS responses so that sub-threshold concentrations of PS at room 
temperature evoked responses at 37°C (Vriens et al., 2011).  
Vriens and colleagues (2011) also found that 82% of Trpm3+/+ DRG neurons were heat-
sensitive and responded to a 43°C heat stimulus and 53% of those neurons were sensitive 
to both PS and the prototypical TRPV1 agonist, capsaicin. A further 41% of DRG neurons 
were PS-sensitive but not capsaicin-sensitive and 4% were sensitive to capsaicin but not PS, 
leaving 3% of neurons which were insensitive to both agonists. Despite a large overlap in 
heat and PS sensitivity, the number of neurons from Trpm3-/- mice responding to a 43°C 
heat stimulus was only modestly reduced, from 82% of WT DRG neurons to 59% of KO DRG 
neurons, and from 79% of WT TG neurons to 63% of KO TG neurons (Vriens et al., 2011). A 
similar percentage of heat-responsive neurons were noted in preparations from Trpv1-/- 
and Trpm3-/- mice. Interestingly, a TRPV1 antagonist only partially reduced the percentage 
of heat sensitive neurons remaining in Trpm3-/- DRG cultures. The authors concluded an 
involvement of both TRPM3 and TRPV1 in heat sensing but also note the existence of other 
heat sensing mechanisms independent of TRPM3 and TRPV1 (Vriens et al., 2011).  
TRPM3 appears to a play a role in heat sensing in vivo. Vriens et al (2011) stated that 
Trpm3-/- mice showed a reduced preference for a 30°C plate over warmer plates (38°C or 
45°C), in comparison to their wildtype counterparts. However, this statement is 
contradicted by graphical representation of these results which suggest that Trpm3-/- mice 
had a greater preference for the 30°C plate over the 38°C plate in comparison to wildtype 
counterparts.  
4.1.9 Role of TRPM3 in pain 
Activation of TRPM3 channels in vivo has been shown to evoke nociceptive behaviour and 
mice without functional TRPM3 channels exhibited compromised responses to noxious 
heat and failed to develop heat hyperalgesia associated with inflammation (Vriens et al., 
2011). Injection of the TRPM3 agonist, PS (2.5 and 5 nmol/paw) into the plantar skin of the 
hindpaws of Trpm3+/+ and Trpv1-/-/Trpa1-/- mice evoked paw licking and lifting. However, 
this nocifensive behaviour was absent when PS was injected into the hindpaws of Trpm3-/- 
mice (Vriens et al., 2011). A later study showed that nocifensive behaviour induced by 
intraplantar injection of PS (5 nmol/paw) in wildtype mice could be inhibited by the TRPM3 
antagonist isosakuranetin (Straub et al., 2013b). Furthermore, Vriens and colleagues (2014) 
121 
 
showed that clotrimazole was able to potentiate PS-evoked nocifensive responses in Trpv1-
/- mice (Vriens et al., 2014b).  
TRPM3 has also been implicated in mechanisms of trigeminal nociception. Supplementing 
drinking water with PS (750µM), resulted in a small but significant aversion to water 
consumption in Trpm3+/+ mice that was absent in Trpm3-/- mice (Vriens et al., 2011).   
Trpm3-/- mice exhibit normal responses in the tail clip assay and respond to intense tail 
pinch with a similar latency to their WT counterparts (Vriens et al., 2011) demonstrating 
that they retain normal mechanical sensitivities. Trpm3-/- mice have increased tail flick 
latencies between the temperatures of 45-57°C and increased response latencies in 
comparison to WT mice in the hot plate test (temperatures 52-58°C) (Vriens et al., 2011). 
Straub and colleagues (2013) also showed that response latencies of WT mice to a 52°C hot 
plate stimulus could be significantly increased by treatment with the TRPM3 antagonists, 
hesperetin and isosakuranetin (Straub et al., 2013b). 
Furthermore Trpm3-/- mice, unlike Trpm3+/+ mice, do not experience heat-hyperalgesia 
which characteristically appears after injection of Freund's adjuvant (CFA) into the 
hindpaw, whilst cold hyperalgesia remained unaffected in these mice (Vriens et al., 2011). 
These behavioural results are consistent with a role for TRPM3 in noxious temperature 
sensing. 
4.1.10 How is the activity of TRPM3 regulated?  
Research examining the impact of intracellular signalling pathways on the activity of TRP 
channels has revealed that their activity can be adjusted to reflect changes in the 
physiological environment (Wang and Woolf, 2005). For example, during periods of 
inflammation, mediators are able to indirectly sensitise TRP channels by binding to 
receptors that activate signalling pathways. This can result in decreased thresholds for 
nociceptor activation leading to pain hypersensitivity (Schaible, 2007). In order to 
understand how the activity of TRPM3 can be altered by changes in the local environment 
it is important to explore how intracellular signalling pathways modulate TRPM3-mediated 
activity; an area which has not yet been explored in detail.   
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4.2 Aims of the present study 
i) One aim of the study was to characterise TRPM3 expressed in a cell line, examining its 
responsiveness to heat and known agonists and antagonists, and to determine if TRPM3 
plays an important role in the detection of heat.  
ii) A second aim was to investigate the mechanisms of TRPM3 channel modulation. In 
particular, to investigate how activation or inhibition of intracellular pathways can either 
positively or negatively modulate TRPM3 channel activity and to determine the effects of 
CB1 and opioid receptor activation on the activity of TRPM3 channels in sensory neurons.  
iii) A third aim was to investigate the role played by TRPM3 as a mediator of persistent and 
visceral pain.  
These three experimental aims were investigated using single cell and cell population Ca2+ 
measurements of CHO cells heterologously expressing the TRPM3 channel and isolated 
DRG neurons from Trpm3+/+  mice endogenously expressing TRPM3 and from Trpm3-/- mice 
lacking functional TRPM3 channels. The behavioural responses of Trpm3+/+ and Trpm3-/- 




4.3 Materials and Methods 
4.3.1 Solutions and reagents  
Unless stated otherwise, experiments were conducted in a physiological extracellular 
solution (see Table 3-2) buffered to pH 7.4 (NaOH). For Ca2+-free experiments CaCl2 was 
omitted from the buffer and 1mM EGTA was added. 
Master stock solutions of pregnenolone sulphate, capsaicin, mefenamic acid, ononetin, 
forskolin; IBMX, m-3M3FBS, U73122, PMA, PDBu, KT5720 (Sigma-Aldrich; St Louis, MO), 
staurosporine (Cayman Chemical; Ann Arbour, MI), WIN 55212-2 and AM251 (Tocris 
Bioscience; Bristol, UK) were made in DMSO (Calbiochem; Darmstadt, Germany). Master 
stock solutions of morphine, naloxone (Sigma-Aldrich; St Louis, MO) and H-8 (Cayman 
Chemical; Ann Arbour, MI) were made in H2O. Master stock solutions of DAMGO, SB205607 
and U50488 (Tocris Bioscience; Bristol, UK) were made in physiological extracellular 
solution. A master stock solution of 8-bromo cAMP (Sigma-Aldrich; St Louis, MO) was made 
in H2O titrated with NaOH. Master stock solutions were aliquotted and stored at -20°C. 
Dilutions from these aliquots into physiological extracellular solution were made daily for 
their use in experiments.  
PTX (lyophilised powder; Sigma-Aldrich; St Louis, MO) was reconstituted in H2O and was 




4.3.2 TRPM3 CHO cell line  
A Chinese hamster ovary (CHO) cell line stably expressing the mouse TRPM3α2 variant was 
made by Dr David Andersson (King’s College London). CHO cells were transfected with a 
TRPM3α2 plasmid (pcDNA3.1) DNA (provided by Dr Stephan Philipp; University of Saarland, 
Homburg, Germany) using Lipofectamine® 2000 transfection reagent (Invitrogen). The 
culture medium was supplemented with G418 (0.5mg/ml) 24 hrs after transfection to 
select for stable transfectants. Single clones were identified by limiting dilution and 
expansion. Expression of TRPM3 in the clones was assessed functionally (pregnenolone 
sulphate sensitivity, Fura-2). 
Experiments using the TRPM3 transfected CHO cell line were performed using calcium 




4.3.3 GFP-tagged CB1 receptor experiments   
Subcloning EfficiencyTM DH5α competent E. coli cells (Invitrogen) were transformed with 
CB1-GFP DNA. The CB1-GFP plasmid (pcDNA1) was provided by Dr Andrew J. Irving 
(University of Dundee). The resulting bacterial culture was grown according to Qiagen 
HiSpeedTM Plasmid Purification handbook guidelines. The CB1-GFP plasmid DNA was then 
isolated by following maxipreparation guidelines in the Qiagen HiSpeedTM Plasmid 
Purification handbook and the DNA concentration was measured by UV spectrophotometry 
at 260 nm. CHO cells expressing mouse TRPM3 were transfected with the purified CB1-GFP 
DNA using Lipofectamine® 2000 transfection reagent and plated on to glass coverslips for 
microscope-based imaging experiments. Additionally some coverslips were fixed and 
mounted onto slides for visualisation of GFP.  
4.3.3.1 Cell transformation and plasmid purification  
Subcloning EfficiencyTM DH5α competent E. coli cells (Invitrogen) were transformed 
according to Invitrogen protocol guidelines. DH5α cells (50µl) were thawed on ice and CB1-
GFP plasmid DNA (1µl) added with gentle mixing. The cells were incubated on ice for 30 
minutes and then heat shocked at 42°C for 20 seconds. The cells were then placed on ice 
for 2 minutes prior to addition of 950µl S.O.C medium. The cells were then incubated for 1 
hour at 37°C with shaking (225 rpm). The transformed cells (20µl) were spread onto pre-
warmed agar plates containing 100µg/ml ampicillin and incubated overnight at 37°C.  
Plasmid purification was carried out according to the guidelines in the HiSpeedTM Plasmid 
Purification handbook (Qiagen). A single bacterial colony was picked from the streaked agar 
plate and incubated in LB broth containing 100µg/ml ampicillin (5mls) for 6-8 hours at 37°C 
with vigorous shaking (~300rpm). 1ml of this culture was added to 250ml of LB broth 
containing 100µg/ml ampicillin and further incubated for 12-16 hours at 37°C with vigorous 
shaking (~300rpm). Cells were harvested by centrifugation (6000 x g, 15 minutes, 4°C), 
lysed and the plasmids isolated using a QIAfilter Maxi kit (Qiagen).  
The CB1-GFP DNA concentration was determined using UV spectrophotometry at 260 nm 
(NanoDropTM spectrophotometer, Thermo Fisher Scientific).  
4.3.3.2 Transfection of CHO cells already expressing mouse TRPM3 
12-24 hours before transfection CHO cells expressing mouse TRPM3 were plated onto 
sterile 13mm glass coverslips previously coated with 10µgml-1 poly-D-lysine (contained in a 
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4-well plate). Cells were plated at a high density to ensure 90-95% confluency on the day of 
transfection.  
Transfection was carried out according to the Invitrogen Lipofectamine® 2000 transfection 
protocol. Opti-MEM (200µl) was combined with CB1-GFP DNA (0.8µg per well) and the 
mixture incubated for 5 minutes at room temperature. In a separate bottle Opti-MEM 
(200µl) was combined with Lipofectamine® 2000 reagent (8µl) and the mixture incubated 
for 5 minutes at room temperature. The diluted DNA mixture was combined with the 
diluted Lipofectamine® 2000 mixture and incubated for 20 minutes at room temperature. 
The mixture was then added drop-wise to the surface of the coverslips (100µl per 
coverslip/well). The cells were incubated at 37°C for 24 hours before the medium was 
changed to normal growth medium. Transfected cells were used one day after transfection 
for microscope-based [Ca2+]i imaging experiments or fixed and mounted onto slides for 
visualisation.  
4.3.3.3 Visualisation of cells expressing CB1-GFP using fluorescence microscopy  
CB1-GFP transfected mouse TRPM3 CHO cells were fixed in 10% p-formaldehyde in 0.1M 
phosphate-buffered saline (PBS – 500µl) for 15 minutes at room temperature. Coverslips 
were then washed twice with 0.1M PBS (500µl) and incubated with Hoechst 33342 (Sigma-
Aldrich; 1:10,000) in 0.1M PBS for 5 minutes at room temperature (for visualisation of 
cellular nuclei and total cell counts), followed by three washes with 0.1M PBS (500µl). 
Coverslips were mounted onto slides using Mowiol mounting solution and viewed with an 
Apotome Zeiss microscope (20x objective with a numerical aperture of 0.75). Images were 
captured using AxioVision (Carl Zeiss Microscopy) and the number of GFP stained cells 
counted and expressed as a percentage of total cells (total number of stained nuclei). The 
exposure used to capture images of GFP-positive cells was kept constant for all fields of 
view and set to a duration where no fluorescence was observed in mock-transfected cells. 





4.3.4 Heat studies  
Microscope-based imaging experiments investigating the heat sensitivity of mouse TRPM3 
transfected CHO cells and mouse dorsal root ganglion (DRG) neurons were performed using 
calcium imaging experiment methods described in section 2.2.2. 
CHO cells stably expressing mouse TRPM3 and mouse DRG neurons were exposed to a 
linear heating temperature ramp (~24-51°C). Time-points of temperature increase at 2°C 
intervals were recorded. Before and after exposure to the heating temperature ramp the 
temperature of the perfusate was held at a constant temperature (~23.5°C). In these 
experiments changes in [Ca2+]i were monitored using the calcium indicator dye Fura-2. In 
CHO cell experiments activation by PS was used for functional identification of cells 
expressing mouse TRPM3. In DRG experiments activation by PS and capsaicin was used for 
functional identification of neurons expressing TRPM3 and TRPV1, respectively. Neurons 
were distinguished from non-neuronal cells by a final depolarising challenge with a solution 
containing 50mM KCl.  
4.3.4.1 Identification of PS- and capsaicin- sensitive neurons  
Neurons were defined as displaying a PS- or capsaicin-induced response if during exposure 
to the drug they exhibited a change in Δ Fura-2 ratio which was greater than 0.15. 
Additionally, Fura-2 ratio time courses for individual neurons were screened visually for 
confirmation of a ratio change consistent with the typical waveform of a response.  
4.3.4.2 Identification of heat-sensitive neurons  
Neurons were defined as heat-sensitive if they displayed a change in [Ca2+]i (Δ Fura-2 ratio) 
which was which was two standard deviations higher than the change in [Ca2+]i (Δ Fura-2 
ratio) exhibited by a group of non-responsive neurons (heat response <15% of maximal 
response). Additionally, neurons were screened visually for a discontinuity in the Fura-2 
ratio time-course indicative of a threshold temperature.  
4.3.4.3 Activation thresholds 
To determine the temperature activation thresholds, time-points of temperature increase 
at 2°C intervals were recorded during heating temperature ramps. The observed rate of 
heating was linear over most of the temperature range used. The Fura-2 ratios of mTRPM3 
CHO cells and heat-sensitive DRG neurons were exported into Microsoft Excel. The 
temperature at which the ratio deviated from the initial rate of increase was used as the 
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temperature activation threshold, either by visual identification or from the point of 




4.3.5 RNA extraction and RT-PCR for quantification of TRPM3 mRNA levels in mouse 
tissues  
Tissues (lumbar DRG, dorsal lumbar spinal cord, olfactory bulb, cerebellum, midbrain and 
kidney) from C57Bl6 mice were dissected by Clive Gentry (King’s College London) and flash-
frozen. The frozen tissues were then weighed and homogenised. Homogenisation of tissues 
was achieved using a glass-Teflon hand homogeniser followed by a QIAshredder (Qiagen). 
RNA was then extracted and purified from homogenised tissue samples using the RNeasy 
Mini kit (Qiagen) according to the manufacturer’s protocol guidelines for purification of 
total RNA from animal tissues. The RNA concentration of each tissue was determined using 
UV spectrophotometry at 260 nm (NanoDropTM spectrophotometer, Thermo Fisher 
Scientific).  
Next, RNA samples were converted to cDNA by reverse transcription (RT). A RT master mix 
was prepared using reagents from the AB Applied Biosystems high capacity cDNA reverse 
transcription kit according to kit guidelines. RNA samples (maximum of 1µg) were added to 
autoclaved 0.2ml tubes containing 10µl RT master mix and the RT reaction was allowed to 
proceed for 2 hours at 37°C.  
PCR was then performed to amplify TRPM3 and GAPDH (reference gene) cDNA transcripts 
using the LightCycler® Carousel-Based System (Roche). A PCR master mix was prepared 
using reagents from the LightCycler® TaqMan® Master kit (Roche) and TaqMan® (GAPDH and 
TRPM3) probes, according to kit guidelines. Next, cDNA (5ng) samples were added to pre-
cooled LightCycler® capillaries containing 18µl PCR master mix and centrifuged at 700 × g 
for 5 s. The capillaries were then transferred to the LightCycler® instrument and the 
reaction was allowed to proceed for 45 cycles.  
Relative quantification of TRPM3 transcript in each tissue was performed using the 2-ΔΔCT 
method (Livak and Schmittgen, 2001). TRPM3 CT values were normalised to GAPDH (see 
calculation 1), to compensate for differences in the amount of RNA template. ΔΔCT values 
were obtained by calculation 2. The relative mRNA levels compared to lumbar DRG were 
calculated (see calculation 3).  
1. Average TRPM3 CT - Average GAPDH CT =  ΔCT   
2. ΔCT test tissue - ΔCT reference tissue (DRG) = ΔΔCT  




4.3.6 Behavioural tests  
All animal behaviour studies were carried out according to the U.K. Home Office Animal 
Procedures (1986) Act and were approved by the King’s College London Ethical Review 
Panel. Mice were housed in a temperature-controlled environment on a 12-hour light/dark 
cycle with access to food and water ad libitum. Data shown in this chapter are from female 
C57BL/6 mice or from male and female homozygote Trpm3-/- C57BL/6 mice were obtained 
from Charles River UK Ltd. Trpm3-/- mice were bred from homozygotic mice provided by Dr 
Stephan Philipp (University of Saarland, Homburg, Germany). All behavioural tests were 
conducted with Clive Gentry (King’s College London). 
4.3.6.1 Hot-plate test  
Heat sensitivity was assessed using a calibrated hot-plate (Ugo Basile, Milan) at 53°C. 
Before testing, the mice were kept in their holding cages to acclimatize (10-15 minutes) to 
the experimental room. Mice were placed onto the hot-plate within a perspex enclosure 
and the time to ipsilateral paw lift or lick was recorded as the paw withdrawal latency.  A 
maximum, cut-off paw withdrawal latency of 100 seconds was used to prevent unnecessary 
tissue damage and trauma. 
4.3.6.2 Formalin test                                                                   
Mice were habituated to perspex observation chambers for 15 minutes. Each animal 
received a 20μl subcutaneous injection of a 2.5% formalin solution into the plantar surface 
of the left hindpaw. The animals were returned to the observation chamber and total pain 
related behaviours (paw shaking, licking or biting) were timed in 5 min bins for a period of 
45 min.  
4.3.6.3 Acetic acid-induced writhing test 
Mice were habituated to perspex observation chambers for 15 minutes. Each animal 
received an intraperitoneal injection of dilute acetic acid (0.6% acetic acid solution) which 
induced stereotyped nociceptive behaviour (abdominal writhing). The intensity of pain 
evoked in both mouse genotypes was measured by counting the number of abdominal 





Normality of data was tested using the Shapiro-Wilk Test and homogeneity of variances 
was tested using Levene’s test. Differences in normally distributed data means between 
two groups were analysed using an independent samples t-test. Differences in normally 
distributed data means between three groups or more were analysed using a one-way 
ANOVA, followed by a Tukey’s HSD post-hoc test (for datasets with equal variances) or a 
Dunnett’s T3 post-hoc test (for datasets with unequal variances). Differences in non-
normally distributed data means between two groups were analysed using a Mann-
Whitney U test. Differences in non-normally distributed data means between three groups 
or more were analysed using a Kruskal-Wallis test, followed by a Dunn-Bonferroni’s 
pairwise post-hoc test. Differences in the frequencies of a specific effect between different 
groups were assessed by a Pearson Chi-Square test or Fisher’s exact test. All statistical 




4.4.1 Characterisation of heterologously-expressed TRPM3 
In order to study the pharmacological properties of TRPM3 channels, a CHO cell line 
heterologously expressing mouse TRPM3α2 splice variant was created. The aim of the 
current study was to fully characterise this newly-established cell line.  
4.4.1.1 Activation of TRPM3 by pregnenolone sulphate 
The [Ca2+]i responses of CHO cells heterologously expressing mouse TRPM3α2 (will be 
referred to as TRPM3) were examined. Channels formed from the TRPM3α2 variant are 
permeable to divalent cations making it well suited to investigation using fluorometric Ca2+ 
measurements (Oberwinkler et al., 2005). In the experiments described in this section 
changes in [Ca2+]i were monitored using the calcium indicator dye Fura-2 using a 96-well 
plate assay.  
It has previously been reported that the endogenous neurosteroid, pregnenolone sulphate 
(PS), acts as an agonist at TRPM3 channels (Wagner et al., 2008). In order to test whether 
PS causes opening of recombinantly expressed TRPM3 channels resulting in Ca2+ influx, PS 
(1-200µM) was applied to mouse TRPM3 CHO cells and changes in [Ca2+]i were measured. 
Application of PS evoked a concentration-dependent increase in [Ca2+]i with a mean EC50 
value of 9.65 ± 1.97 µM (mean ± SEM; n= 3 independent experiments; Figure 4-2). The 
concentration response relationship for PS reached a plateau at concentrations above 
100µM.  
In contrast, application of PS (1-200µM) to untransfected CHO cells did not evoke an 
increase in [Ca2+]i, demonstrating that TRPM3 channels are required for PS-evoked [Ca
2+]i 
responses (maximum amplitude of PS response for TRPM3 transfected cells, 0.80 ± 0.18 Δ 
Fura-2 ratio compared to untransfected cells, 0.08 ± 0.01 Δ Fura-2 ratio; Figure 4-2b). 
Furthermore, PS did not evoke increases in [Ca2+]i in Ca
2+ free conditions (in the presence of 
1mM EGTA in the external solution) indicating that the increases in [Ca2+]i observed in 








Figure 4-2 Pregnenolone sulphate is a TRPM3 agonist 
 
(a) Time courses of [Ca
2+
]i increases evoked by different pregnenolone sulphate concentrations in Fura-2 loaded 
CHO cells stably transfected with mouse TRPM3 (mTRPM3). Baseline signals were collected before cells were 
challenged with PS at 20 seconds. Traces shown are mean ratios from triplicate wells from a representative 
experiment (b) PS evoked a concentration dependent increase in [Ca
2+
]i (Δ Fura-2 340/380) in mTRPM3-
expressing CHO cells with an EC50 of 9.65 ± 1.97 µM (mean ± SEM; n= 3 independent experiments). PS failed to 
increase [Ca
2+
]i in untransfected CHO cells. Representative plots shown, data points are the mean ratio of 
triplicate wells ± SEM. (c) PS evoked a concentration dependent increase in [Ca
2+
]i (Δ Fura-2 340/380) in 
extracellular solutions containing Ca
2+




solutions. Representative plots shown, data points 




4.4.2 Inhibition of TRPM3  
Mefenamic acid is a non-steroidal anti-inflammatory, fenamate, drug which has been 
reported as a potent inhibitor of TRPM3 (Klose et al., 2011). The characteristics of 
mefenamic acid antagonism of PS-evoked [Ca2+]i responses were studied by challenging 
mouse TRPM3 CHO cells with a sub-maximally effective concentration  of PS (20µM) in the 
presence of increasing concentrations of mefenamic acid (0.03-100µM). Mefenamic acid 
inhibited PS-evoked responses with an IC50 value of 3.41 ± 0.82µM (mean ± SEM; n=3 
independent experiments; Figure 4-3a). Concentrations above 30µM mefenamic acid 
caused complete inhibition of PS-evoked [Ca2+]i responses (see Figure 4-3a).  
PS-evoked [Ca2+]i responses were also inhibited by ononetin, a structurally unrelated 
antagonist of TRPM3 (Straub et al., 2013a). Ononetin inhibited PS-evoked responses more 
potently than mefenamic acid with an IC50 value of 0.50 ± 0.10µM (mean ± SEM; n=3 
independent experiments; Figure 4-3b). These results are consistent with previously 
published findings showing that mefenamic acid and ononetin are antagonists of TRPM3 
(Klose et al., 2011; Straub et al., 2013a).  
 
Figure 4-3 Mefenamic acid and ononetin are antagonists of TRPM3 
(a) [Ca
2+
]i (Δ Fura-2 ratio) responses of mTRPM3 CHO cells stimulated with 20µM PS in the presence of 
increasing concentrations of mefenamic acid (0.03-100µM). Activation of mTRPM3 CHO cells by PS was 
inhibited by mefenamic acid in a concentration dependent manner, IC50 - 3.41 ± 0.82µM (mean ± SEM; n=3 
independent experiments). Representative plot shown, data points are the mean ratio of triplicate wells ± SEM. 
(b) [Ca
2+
]i (Δ Fura-2 ratio) responses of mTRPM3 CHO cells stimulated with 20µM PS in the presence of 
increasing concentrations of ononetin (0.01-2µM). Activation of mTRPM3 CHO cells by PS was inhibited by 
ononetin in a concentration dependent manner, IC50 – 0.50 ± 0.1µM (mean ± SEM; n=3 independent 
experiments). Representative plot shown, data points are the mean ratio of triplicate wells ± SEM.  
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4.4.3 TRPM3 is expressed in multiple areas of the nervous system  
The relative levels of TRPM3 mRNA expression were examined in wildtype DRG, spinal 
cord, olfactory bulb, cerebellum, midbrain and kidney using RT-qPCR (Figure 4-4).  
Robust levels of TRPM3 mRNA transcripts were detected in all of the neural tissues 
sampled. TRPM3 mRNA was expressed in the DRG consistent with the findings of functional 
TRPM3 channels in these neurons (Vriens et al., 2011). The highest level of TRPM3 mRNA 
was found in the spinal cord, where it was on average 3.5-fold higher than the level in the 
DRG (n= 3 mice). Levels of TRPM3 expression in the olfactory bulb, cerebellum and 
midbrain were close to that observed in the DRG (n= 3 mice). The levels of TRPM3 mRNA in 
the mouse kidney were also examined (n = 2 mice) and, consistent with previous findings, 
revealed very low levels of expression (Kunert-Keil et al., 2006).  
These findings confirm expression of TRPM3 mRNA in the mouse peripheral nervous 
system but also demonstrate expression of TRPM3 transcripts in the central nervous 
system. The presence of TRPM3 channels in areas such as the olfactory bulb, cerebellum 
and midbrain indicates the likelihood of other roles for TRPM3 in addition to the ones 
already described (e.g. sensory transduction channel for noxious heat, modulator of insulin 
release and vascular smooth muscle contraction).  
 
Figure 4-4 TRPM3 is expressed in the brain and spinal cord in addition to sensory neurons  
Quantitative RT-PCR was performed on mouse tissues. Relative levels of TRPM3 mRNA expression were 
quantified using the 2-
ΔΔC
T method. Column graph showing normalised TRPM3 mRNA expression (normalised to 
GAPDH), relative to lumbar DRG expression, in the mouse dorsal lumbar spinal cord, olfactory bulb, cerebellum, 
midbrain and kidney. Columns represent mean ± SEM (kidney, n= 2 animals; all other tissues, n= 3 animals).  
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4.4.4 TRPM3 channels are functionally expressed in sensory neurons  
The findings of the current study have revealed expression of TRPM3 in DRG neurons and 
are consistent with previous findings which have identified expression of TRPM3 in rodent 
sensory neurons (Jang et al., 2012; Nealen et al., 2003; Vandewauw et al., 2013; Vriens et 
al., 2011). To examine functional expression of TRPM3 channels in sensory neurons, PS-
induced changes in [Ca2+]i within isolated DRG neurons were monitored using the calcium 
indicator dye Fura-2.  
Isolated DRG neurons were exposed to PS at a concentration of 10, 20, 50 or 100µM. 
Neurons were identified by application of a depolarising concentration of KCl. PS evoked 
increases in [Ca2+]i in a large population of DRG neurons as shown in Figure 4-5, which 
illustrates the responses to sequential application of increasing concentrations of PS. 
Activation by PS was concentration-dependent; 12% (n= 70/587; 3; 2) of neurons tested 
were activated by 10µM PS, and this was increased to 27% (n= 106/390; 2; 2) with 20µM 
PS, 36% (n= 179/492; 3; 2) with 50µM PS and 55% (n= 275/504; 3; 2) with 100µM PS (Figure 
4-5c). 
In addition to the number of neurons responding, the response amplitudes also followed a 
concentration-dependent pattern. Lower PS concentrations induced responses with 
smaller maximum response amplitudes in comparison to responses evoked by higher 
concentrations of PS (10µM, 43 ± 2%; 20µM, 45 ± 3%; 50µM, 52 ± 2%; 100µM, 62 ± 2%; 
mean ± SEM; % of KCl response; Figure 4-5b).  
However, in experiments using isolated DRG neurons from Trpm3-/- animals increases in 
[Ca2+]i in response to 50µM PS were only evident in 1% of neurons (9/712). These findings 
demonstrate that TRPM3 channels are functionally expressed in a large population of DRG 
neurons and are consistent with previous findings (Vriens et al., 2011). Furthermore, these 
findings show that PS-evoked DRG responses are dependent on expression of functional 





Figure 4-5 Pregnenolone sulphate activates DRG neurons in a concentration-dependent manner 
(a) [Ca
2+
]i responses monitored by Fura-2 (R denotes Fura-2 ratio) in PS-sensitive DRG neurons using 
microscope-based imaging. Representative traces displaying neuronal [Ca
2+
]i responses to sequential PS 
challenges (10, 20, 50 and 100µM) followed by depolarisation with high K
+
 (50mM KCl). (b) Column graph 
displaying the average maximum response amplitudes evoked by different concentrations of PS in responsive 
DRG neurons. PS response amplitudes were calculated as a % of the KCl-evoked amplitude (10µM PS, n= 70, 3, 
2; 20µM PS, n= 106, 2, 2; 50µM PS, n= 179, 3, 2; 100µM PS, n= 275, 3, 2). Columns represent mean ± SEM. (c) 
Column graph displaying the percentage of DRG neurons which responded to PS with an increase in [Ca
2+
]i. The 
numbers shown above the columns represent the total number of PS responsive neurons/total number of 





4.4.5 Heterologously-expressed TRPM3 is activated by heat  
TRPM3 channels have previously been reported to be activated by heat and have been 
implicated in the heat sensing mechanisms of sensory neurons (Vriens et al., 2011). In 
order to examine whether TRPM3 channels stably-transfected in a CHO cell line could be 
activated by heat, microscope-based imaging experiments were conducted. In these 
experiments, the temperature of the superfusate can be controlled allowing heating 
temperature ramps to be conducted.  
Populations of untransfected and mouse TRPM3 transfected CHO cells were exposed to a 
heating temperature ramp (24-51°C) which was followed by application of the TRPM3 
agonist, PS (50µM). In these experiments changes in [Ca2+]i were monitored using the 
calcium indicator dye Fura-2.  
PS-sensitive TRPM3 CHO cells exposed to heat (24-51°C) responded with robust, reversible 
increases in [Ca2+]i with an average maximum response amplitude of 0.82 ± 0.01 Δ Fura-2 
ratio (mean ± SEM; n= 1379 cells, 10, 3; see Figure 4-6) and an average temperature 
threshold of 44 ± 0.4°C (mean ± SEM; n= 10 coverslips, minimum of 53 cells per coverslip; 
see Figure 4-7). Heating evoked a much smaller increase in [Ca2+]i  in untransfected CHO 
cells with a maximum amplitude of 0.43 ± 0.01 Δ Fura-2 ratio (mean ± SEM; n= 2640 cells, 
9, 3; Figure 4-6). As shown in the previous 96-well plate experiments untransfected CHO 
cells displayed no response to PS application (average maximum PS amplitude = 0.00 ± 0.00 
Δ Fura-2 ratio; mean ± SEM; n= 895 cells, 3, 1); this was in contrast to mouse TRPM3 CHO 
cells which displayed large reversible [Ca2+]i responses upon application of PS (average 
maximum PS amplitude = 1.39 ± 0.01 Δ Fura-2 ratio; mean ± SEM; n= 1717 cells, 12, 4). The 
presence of a large [Ca2+]i response to heat in mouse TRPM3 transfected CHO cells but not 
untransfected control cells demonstrates that expression of TRPM3 channels confers 
sensitivity to heat.  
In order to determine whether TRPM3 channels are required for the large [Ca2+]i responses 
to heat, the effects of two TRPM3 antagonists on the heat-evoked responses of mouse 
TRPM3 transfected CHO cells were tested using microscope-based imaging. Populations of 
mouse TRPM3 CHO cells were perfused with either ononetin (10µM) or mefenamic acid 
(30µM) for 2 ½ minutes, before being exposed to a heating temperature ramp (24-51°C). 
After washout of the respective antagonist, cells were challenged with PS (50µM) to 
confirm TRPM3 expression. Cells treated with ononetin (10µM), responded to the heat 
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ramp with a modest increase in [Ca2+]i which was similar to the TRPM3-independent heat-
evoked responses observed in untransfected cells. The average maximum amplitude of the 
responses was reduced from 0.77 ± 0.02 Δ Fura-2 ratio in untreated TRPM3 CHO cells 
(mean ± SEM; n= 819 cells, 8, 3) to 0.41 ± 0.01 Δ Fura-2 ratio in ononetin treated TRPM3 
CHO cells (mean ± SEM; n= 642 cells, 6, 3; Figure 4-8). A similar inhibition was observed 
when cells were perfused with mefenamic acid (30µM). Heating evoked small increases in 
[Ca2+]i which were similar in amplitude to untransfected cells (0.33 ± 0.01 Δ Fura-2 ratio in 





Figure 4-6 Heterologously expressed TRPM3 channels are sensitive to heat 
[Ca
2+
]i responses were monitored by Fura-2 in untransfected and PS-sensitive TRPM3 transfected CHO cells 
using microscope-based imaging. Cells were exposed to a heating temperature ramp (24-51°C) followed by the 
application of PS (50µM). (a) Representative traces displaying [Ca
2+
]i responses evoked by a heating 
temperature ramp (24-51°C) in a population of untransfected CHO cells. Heating evoked a modest increase in 
[Ca
2+
]i in untransfected cells however application of PS (50µM) evoked no change in [Ca
2+
]i. R denotes Fura-2 
ratio. (b) Representative traces displaying [Ca
2+
]i responses evoked by a heating temperature ramp (24-51°C) 
and 50µM PS in a population of mTRPM3 CHO cells. Both heating and PS (50µM) evoked large reversible [Ca
2+
]i 
increases in a population of mTRPM3 CHO cells. R denotes Fura-2 ratio. (c) Column graph showing the average 
maximum response amplitudes to the heating temperature ramp in untransfected (plain bar) and mTRPM3 
transfected CHO cells (striped bar). Columns represent mean ± SEM (untransfected, n= 2640 cells, 9, 3; 




Figure 4-7 Temperature activation thresholds for TRPM3  
(a) Representative traces displaying [Ca
2+
]i responses evoked by heating in mTRPM3 CHO cells . Vertical lines 
indicate the temperature (°C) of the superfusate at different time points. (b) Temperature activation thresholds 
were determined by plotting the Fura-2 (340/380) ratio against temperature. The temperature at the intersect 
of the two lines was used as the temperature activation threshold. The graph illustrates the threshold 




Figure 4-8 TRPM3 heat-evoked responses are inhibited by mefenamic acid and ononetin  
[Ca
2+
]i responses were monitored by Fura-2 in PS-sensitive TRPM3 transfected CHO cells using microscope-
based imaging. Cells were exposed to a heating temperature ramp (24-51°C) followed by the application of PS 
(50µM). (a) Representative traces displaying [Ca
2+
]i responses evoked by a heating temperature ramp (24-51°C) 
and 50µM PS in a population of mTRPM3 CHO cells (same data as shown in Figure 4-6b). Both heating and PS 
(50µM) evoked large reversible increases [Ca
2+
]i in a population of mTRPM3 CHO cells. R denotes Fura-2 ratio. 
(b) Representative traces displaying [Ca
2+
]i responses evoked by a heating temperature ramp (24-51°C) and 
50µM PS in a population of mTRPM3 CHO. Cells were perfused with ononetin (10µM) 2 ½ minutes prior to and 
during the heating temperature ramp (green horizontal bar indicates application of ononetin). Ononetin 
supressed the heat-evoked responses of TRPM3 CHO cells. R denotes Fura-2 ratio. (c) Representative traces 
displaying [Ca
2+
]i responses evoked by a heating temperature ramp (24-51°C) and 50µM PS in a population of 
mTRPM3 CHO. Cells were perfused with mefenamic acid (30µM) 2 ½ minutes prior to and during the heating 
temperature ramp (blue horizontal bar indicates application of mefenamic acid). Mefenamic acid inhibited the 
heat-evoked responses of TRPM3 CHO cells. R denotes Fura-2 ratio. (d) Column graph showing the average 
maximum response amplitudes to the heating temperature ramp in untreated mTRPM3 transfected CHO cells 
and cells treated with ononetin and mefenamic acid. Columns represent mean ± SEM (mTRPM3, n= 819 cells, 8, 




4.4.6 TRPM3 is expressed in heat-sensitive sensory neurons  
To examine whether TRPM3 is able to contribute to the heat-sensitivity of sensory neurons, 
the functional expression of TRPM3 channels on heat-sensitive, mouse, DRG neurons was 
investigated using microscope-based imaging.  
Isolated DRG neurons were first exposed to a heating temperature ramp (24-51°C) in order 
to establish heat-sensitivity, this was followed by challenges with PS (TRPM3 agonist) and 
capsaicin (TRPV1 agonist) and a depolarising concentration of KCl (to allow neurons to be 
identified).  
A large population of neurons displayed heat sensitivity, with 42% (n= 719/1701, 12, 4) of 
neurons responding to the heating temperature ramp (24-51°C) with an increase in [Ca2+]i. 
Heat-evoked [Ca2+]i responses had an average temperature threshold of 45 ± 0.4°C (mean ± 
SEM; n= 89 neurons, 2, 2). Functional expression of TRPM3 and TRPV1 channels on heat-
sensitive neurons was assessed by sensitivity to PS and capsaicin, respectively. The majority 
of heat-sensitive neurons appeared to co-express TRPM3 and TRPV1, with 64% (n= 
458/719) of neurons showing sensitivity to both PS and capsaicin (see Figure 4-9 for 
representative traces). A small population of heat-sensitive neurons appeared to express 
TRPM3 but not TRPV1, exhibiting PS sensitivity without sensitivity to capsaicin (10%; n= 
73/719). Conversely, another population of heat-sensitive neurons did not respond to PS 
but were sensitive to capsaicin (19%; n= 140/719). In addition to these sub-populations, a 
small group (7%; n= 48/719) of heat-sensitive neurons displayed no sensitivity to PS or 
capsaicin, suggesting a lack of both TRPM3 and TRPV1 expression on these neurons (Figure 
4-9). The majority (57%, n= 531/925) of PS-sensitive neurons were heat-sensitive. The 
percentage of capsaicin sensitive neurons which were sensitive to heat was higher (76%, n= 
598/788).  
The average temperature thresholds of heat-sensitive neurons which were responsive both 
PS and capsaicin (45 ± 0.5°C; mean ± SEM; n= 51 neurons), to PS but not capsaicin (44 ± 
1.4°C; mean ± SEM; n= 10 neurons), to capsaicin but not PS (47 ± 0.4°C; ; mean ± SEM; n= 
23 neurons) or to neither agonist (45 ± 0.8°C; mean ± SEM; n= 5 neurons) were similar (NS, 





Figure 4-9 Heat-sensitive neurons express TRPM3 alongside TRPV1 
Changes in [Ca
2+
]i were monitored by Fura-2 in isolated DRG neurons using microscope-based imaging. Neurons 
were exposed to a heating temperature ramp (24-51°C) followed by challenges with PS (50µM) and capsaicin 
(1µM) (a) Representative traces displaying [Ca
2+
]i responses of heat-sensitive DRG neurons which were sensitive 
to both PS and capsaicin. R denotes Fura-2 ratio. The inset graph displays the [Ca
2+
]i response of one of these 
neurons during the heating temperature ramp. Vertical lines indicate the temperature (°C) of the superfusate at 
different time points. (b) Representative trace displaying the [Ca
2+
]i response of a heat-sensitive DRG neuron 
which was sensitive to capsaicin but not PS. R denotes Fura-2 ratio. (c) Representative trace displaying the 
[Ca
2+
]i response of a heat-sensitive DRG neuron which was sensitive to PS but not capsaicin. R denotes Fura-2 
ratio. (d) Representative trace displaying the [Ca
2+
]i response of a heat-sensitive DRG neuron which was not 
sensitive to PS or capsaicin. R denotes Fura-2 ratio. (e) Column graph showing the percentage of heat-sensitive 
neurons which were sensitive PS, capsaicin, both PS and capsaicin, neither PS nor capsaicin, PS and not 
capsaicin, and, capsaicin and not PS (n= 719 neurons, 12, 4).  
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4.4.7 Heat sensitivity of neurons lacking functional TRPM3 channels  
In order to examine any role played by TRPM3 in the heat-sensitivity of sensory neurons, 
the heat-evoked responses of DRG neurons from Trpm3-/- mice were examined and 
compared to the heat-evoked responses of WT mice. As in the previous experiments, 
isolated DRG neurons were first exposed to a heating temperature ramp (24-51°C) in order 
to establish heat-sensitivity, this was followed by challenges with PS (TRPM3 agonist) and 
capsaicin (TRPV1 agonist) and a depolarising concentration of KCl (to identify all neurons).  
Isolated DRG neurons from Trpm3-/- mice had a smaller percentage of heat-sensitive 
neurons (34%, n= 243/712 neurons, 4, 2; see Figure 4-10) compared to WT DRG control 
experiments performed on the same day (44%, n= 472/1072 neurons, 7, 2; P<0.001, 
Pearson Chi-Square test). The majority of these heat-sensitive neurons were also capsaicin-
sensitive (90%, n= 219/243), indicating the expression of TRPV1 in these neurons, similar to 
WT neurons (81%, n= 383/472). 
Notably, the average temperature threshold for activation of heat-sensitive Trpm3-/- 
neurons (45 ± 0.4°C; n= 92 neurons, 2, 2) was the same to that measured for heat-sensitive 
wildtype neurons (45 ± 0.4°C; n= 89 neurons, 2, 2).  
 





]i were monitored by Fura-2 in isolated DRG neurons using microscope-based imaging. Neurons 
were exposed to a heating temperature ramp (24-51°C) followed by challenges with PS (50µM) and capsaicin 
(1µM) (a) Representative traces displaying [Ca
2+
]i responses of heat-sensitive Trpm3
-/-
 DRG neurons which were 
sensitive to capsaicin but not PS. R denotes Fura-2 ratio. (b) Column graph showing the percentage of heat-
sensitive neurons isolated from WT and Trpm3
-/-
. Columns represent mean ± SEM (*** P <0.001, Pearson Chi-
Square test; WT, n= 1072 neurons, 7, 2; Trpm3
-/-
, n= 712 neurons, 4, 2) 
147 
 
4.4.8 Mice lacking functional TRPM3 channels exhibit reduced sensitivity to noxious 
heat 
TRPM3 is heat sensitive when heterologously expressed in a recombinant cell line and is 
expressed in a large proportion of heat-sensitive sensory neurons which co-express the 
nociceptive thermosensor, TRPV1.  
In order to examine whether TRPM3 plays a role in noxious heat sensing in vivo the latency 
to paw withdrawal from a 53°C hot plate was measured in Trpm3+/+ and Trpm3-/- mice 
(Figure 4-11). Consistent with previous findings (Vriens et al., 2011), Trpm3-/- mice 
displayed significantly longer latencies to paw withdrawal than their wildtype counterparts, 
removing their paws from the hot plate on average 23.7 ± 1.1 s (n= 9) after exposure, 
compared to 15.9 ± 0.9 s (n=6) for Trpm3+/+ mice. This finding demonstrates that mice 





 mice are less sensitive to noxious heat  






mice had significantly longer latencies to paw withdrawal in comparison to their wildtype counterparts. 
Columns represent mean ± SEM (*** P <0.001; t-test; Trpm3
+/+
, n= 6 mice. Trpm3
-/-




4.4.9 Modulation of TRPM3 activity by intracellular signalling pathways 
4.4.9.1 Regulation of TRPM3 by cAMP-dependent mechanisms 
Many mechanisms exist to regulate ion channel function, and phosphorylation of channel 
proteins by protein kinases downstream of G protein coupled receptor (GPCR) activation 
constitutes one of the best characterised forms of regulation.    
The activity of one protein kinase subfamily, protein kinase A (PKA) is controlled by cellular 
levels of cyclic AMP (cAMP). Activation of Gαs linked GPCRs leads to an increase in cellular 
cAMP levels by stimulating adenylyl cyclase, an enzyme responsible for synthesis of cAMP 
from its precursor ATP (Berridge, 2012). This increase in cellular cAMP levels leads to 
activation of PKA (see Figure 4-12 for an illustrated summary of this pathway). Moreover, 
activation of Gαi/o linked GPCRs leads to a decrease in adenylyl cyclase activity and 
therefore lower levels of cAMP resulting in reduced PKA activity.  
In order to investigate whether cAMP dependent processes are able to regulate the activity 
of TRPM3, the effects of raised cAMP levels on PS-evoked responses were tested. PS-
evoked [Ca2+]i responses of mouse TRPM3 CHO cells treated with an activator of adenylyl 
cyclase, forskolin (10µM, 15 minute pre-incubation) and a non-selective phosphodiesterase 
(PDE) inhibitor, IBMX (100µM,  15 minute pre-incubation), were examined and compared 
to the [Ca2+]i responses of untreated cells. The amplitudes of PS-evoked [Ca
2+]i responses 
were consistently higher in cells treated with forskolin and IBMX than the responses of 
untreated cells. The average maximum amplitude of PS-evoked responses in untreated 
cells was 1.69 ± 0.27 Δ Fura-2 ratio and this was increased to 2.32 ± 0.33 Δ Fura-2 ratio, in 
cells treated with forskolin and IBMX (mean ± SEM; NS, t-test; n=3 independent 
experiments; Figure 4-13a). However, only a small potentiating shift of the PS EC50 value for 
activation was noted (control, 14.45 ± 3.99µM; forskolin + IBMX, 7.43 ± 1.00µM; NS, t-test; 
n=3 independent experiments). 
Next, the effects of a cAMP analogue, 8-bromo cAMP (1mM, 15 minute pre-incubation), on 
PS-evoked responses were examined. Similar to the effects of forskolin and IBMX, cells 
treated with 8-bromo cAMP had consistently larger responses to PS (control, 1.02 ± 0.34 Δ 
Fura-2 ratio; 8-bromo cAMP, 1.31 ± 0.34 Δ Fura-2 ratio; NS, t-test; n=3 independent 
experiments; Figure 4-13b). However, 8-bromo cAMP had no effect on PS EC50 values 




In order to test whether the effects observed were due to activation of PKA, cells were 
treated with 8-bromo cAMP in the presence of either a non-selective protein kinase 
inhibitor (10µM H8) or a PKA selective inhibitor (1µM KT5720). The increase in PS response 
amplitude achieved with 8-bromo cAMP treatment was not reversed by incubation with 
either H8 or KT5720 (see Table 4-3 for values; NS; ANOVA followed by Tukey’s HSD test; 
comparison to 8-bromo cAMP treatment alone). These findings suggest that the effects of 





Figure 4-12 Signal transduction pathways downstream of Gαs linked GPCR activation  
Activation of Gαs coupled receptors results in activation of the G protein by allowing the exchange of a 
molecule of GDP for GTP at the Gα subunit (which is inactive when bound to GDP). The activated Gαs-GTP 
monomer and a βγ dimer (not shown) dissociate from the receptor, allowing Gαs to activate the membrane 
associated enzyme, adenylyl cyclase. When activated adenylyl cyclase synthesises the intracellular messenger, 
cAMP, from molecules of ATP, cAMP can bind to and regulate ion channel function, and can also activate PKA. 
Decomposition of cAMP to AMP is catalysed by cAMP phosphodiesterase (cAMP PDE). Various pharmacological 
tools can be used to study this pathway and some of which are illustrated on the diagram (compounds which 
activate targets within the pathway are shown in blue and compounds which inhibit pathway components are 
shown in red). Forskolin, a diterpene from the Indian plant Coleus forskohli, stimulates adenylyl cyclase and can 
be used in combination with IBMX, a non-selective phosphodiesterase inhibitor, to amplify cellular cAMP levels 
(Beavo et al., 1971; Calixto et al., 2005). A brominated derivative of cAMP, 8-bromo cAMP which is resistant to 
degradation by cAMP PDE is also a useful pharmacological tool for studying the effects of cAMP. Furthermore 
PKA activity can be inhibited by KT-5720 (a potent and selective blocker of PKA) and H8 (a non-selective 





Figure 4-13 Increased levels of cAMP potentiate TRPM3 activity via a PKA-independent mechanism  
(a) The effects of an adenylyl cyclase activator (10µM forskolin, 15 minute pre-incubation) and a PDE inhibitor 
(100µM IBMX, 15 minute pre-incubation) on PS-evoked [Ca
2+
]i responses of CHO cells stably transfected with 
mTRPM3. Forskolin and IBMX treatment increased the maximum amplitude of PS-evoked responses (from 1.69 
± 0.27 Δ Fura-2 ratio and to 2.32 ± 0.33 Δ Fura-2 ratio; mean ± SEM; NS, t-test; n=3 independent experiments). 
Representative plot shown, data points are the mean ratio of triplicate wells ± SEM (b) The effects of a cAMP 
analogue, 8-bromo cAMP (1mM, 15 minute pre-incubation) on PS-evoked [Ca
2+
]i responses of CHO cells stably 
transfected with mTRPM3. 8-bromo cAMP treatment appeared to increase the maximum amplitude of PS-
evoked responses (from 1.02 ± 0.34 Δ Fura-2 ratio to 1.31 ± 0.34 Δ Fura-2 ratio; mean ± SEM; NS, t-test; n=3 
independent experiments). The effects of 8-bromo cAMP treatment could not be reversed by treatment (15 
minute pre-incubation) with a non-selective protein kinase inhibitor (10µM H8) or a selective PKA inhibitor 
(1µM KT-5720). Representative plot shown, data points are the mean ratio of triplicate wells ± SEM 
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Table 4-3 Effects of a cAMP analogue on PS evoked [Ca
2+
]i responses  
Table detailing the average EC50 values and maximum amplitudes for PS-evoked [Ca
2+
]i responses in the 
presence and absence of 8-bromo cAMP, 8-bromo cAMP + H8 and 8-bromo cAMP + KT-5720. Values listed are 
mean ± SEM (n= 3 independent experiments).  
 
 Control 1mM 8-bromo 
cAMP 
1mM 8-bromo 
cAMP + 10µM 
H8 
1mM 8-bromo 





9.36 ± 2.28 
 
6.01 ± 0.88 
 
9.01 ± 2.60 
 




(Δ Fura-2 ratio) 
 
 
1.02 ± 0.34 
 
 
1.31 ± 0.34 
 
 












4.4.9.2 Regulation of TRPM3 by pathways downstream of PLC activation 
Several TRP channels are regulated by phosphoinositides derived from phosphatidylinositol 
(PtdIns), which are located within the cytoplasmic leaflet of the plasma membrane (Rohacs, 
2007, 2009). Phosphatidylinositol 4,5-bisphosphate (PIP2) is the most well studied of these 
lipids within the domain of ion channel regulation (Rohacs, 2009). Activity of TRPV1 has 
been shown to be both activated and inhibited by PIP2 (Chuang et al., 2001; Klein et al., 
2008; Lukacs et al., 2007; Prescott and Julius, 2003; Ufret-Vincenty et al., 2011; Yao and 
Qin, 2009) whereas TRPV5, TRPM4, TRPM5, TRPM7 and TRPM8 have all been shown to be 
activated by PIP2 (Lee et al., 2005; Liu and Liman, 2003; Liu and Qin, 2005; Nilius et al., 
2006; Rohács et al., 2005; Runnels et al., 2002; Zhang et al., 2005). 
Breakdown of PIP2 occurs when PLCβ cleaves the lipid into the second messengers, diacyl 
glycerol (DAG) and inositol 1,4,5-trisphosphate (IP3) (Berridge, 2012). PLCβ isoforms are 
activated by Gαq/11-GTP monomers downstream of GPCR activation (Rohacs, 2013). DAG 
is the best known activator of the PKC family of serine/threonine kinases and as discussed 
earlier protein phosphorylation is one of the best characterised forms of ion channel 
regulation. In addition, DAG has been shown to activate some TRPC channels in a PKC-
independent manner (Rohacs, 2013). IP3 releases Ca
2+ from intracellular stores by binding 
to IP3 receptors present on the endoplasmic reticulum (see Figure 4-14 for an illustrated 
summary of this pathway).  
In order to investigate whether signalling pathways downstream of PLC activation are able 
to regulate the activity of TRPM3, PS-evoked [Ca2+]i responses of mouse TRPM3 CHO cells 
treated with an activator of PLC, m-3M3FBS (10µM, 15 minute pre-incubation) were 
examined and compared to the [Ca2+]i responses of untreated cells in 96-well plate 
experiments. Treatment with m-3M3FBS consistently elevated the maximum amplitudes of 
PS-evoked [Ca2+]i responses. The average maximum amplitude of PS-evoked responses in 
untreated cells was 1.91 ± 0.20 Δ Fura-2 ratio and this was increased to 2.42 ± 0.30 Δ Fura-2 
ratio, in cells treated with m-3M3FBS (mean ± SEM; NS, t-test; n=5 independent 
experiments; Figure 4-15a). However, there was no change in PS EC50 values for activation 
(control, 12.11 ± 2.61µM; m-3M3FBS, 12.78 ± 4.02µM; NS, t-test; n=5 independent 
experiments). 
In order to test whether the effects observed could be reversed by a PLC inhibitor, cells 
were treated with m-3M3FBS in the presence of U73122 (5µM, 15 minute pre-incubation). 
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The increase in PS response amplitude achieved with m-3M3FBS treatment was reversed 
by co-treatment with U73122. Co-treated cells had an average maximum response 
amplitude of 1.73 ± 0.35 Δ Fura-2 ratio which was even lower than the average maximum 
amplitude of untreated cells, suggesting some tonic activation of PLC (mean ± SEM; n=3 
independent experiments; Figure 4-15a).  
Next, the effects of direct PKC stimulation on TRPM3 activation were investigated. The PS-
evoked responses of cells treated with a PKC activator (1µM PMA, 15 minute pre-
incubation) were examined and compared to untreated cells. Interestingly, PS-evoked 
responses in cells treated with PMA were consistently inhibited, with the maximal response 
amplitudes reduced from 1.84 ± 0.30 Δ Fura-2 ratio in untreated cells, to 1.33 ± 0.25 Δ 
Fura-2 ratio in cells treated with PMA (mean ± SEM; NS, t-test; n=4 independent 
experiments; Figure 4-15b). However, there was no change in EC50 value (control, 13.73 ± 
3.32µM; PMA, 15.24 ± 2.31µM; mean ± SEM; n=4 independent experiments).  
To confirm whether the reduced activity of TRPM3 was due to PKC activation or a separate 
action of PMA, the effects of another PKC activator (1µM PDBu, 15 minute pre-incubation) 
were tested. Similar to PMA treatment, cells treated with PDBu had significantly smaller 
maximum responses to PS stimulation than untreated cells (control, 1.99 ± 0.08 Δ Fura-2 
ratio; PDBu, 1.41 ± 0.02 Δ Fura-2 ratio; mean ± SEM; P<0.05, t-test; n=3 independent 
experiments; Figure 4-15c). Again the EC50 values for activation were not affected (control, 
10.89 ± 4.19µM; PDBu, 12.34 ± 1.42µM; mean ± SEM; n=3 independent experiments).  
In order to test whether the effects of PDBu could be reversed with a protein kinase 
inhibitor, the PS-evoked responses of cells co-treated with PDBu and staurosporine (3μM) 
were examined. Unexpectedly, the combination of these compounds resulted in a greater 
inhibition of TRPM3 PS evoked responses (see Table 4-4 for values; comparison to control; 
NS, ANOVA followed by Dunnett’s T3 test; n= 3 independent experiments; Figure 4-15c). 
The effect of staurosporine treatment alone was then investigated, cells treated with 
staurosporine (without PDBu) had significantly inhibited PS-evoked responses, maximum 
response amplitudes were reduced from 2.12 ± 0.13 in untreated cells to 1.20 ± 0.15 Δ 
Fura-2 ratio in cells treated with staurosporine (mean ± SEM; P<0.01, t-test; n=4 
independent experiments; Figure 4-15d). EC50 values were slightly lower with staurosporine 
treatment (control, 11.30 ± 2.99µM; staurosporine, 7.69 ± 1.80µM; mean ± SEM; NS, t-test; 




Figure 4-14 Signal transduction pathways downstream of Gαq/11 linked GPCR activation  
Activation of Gαq coupled receptors results in activation of the G protein by allowing the exchange of a 
molecule of GDP for GTP at the Gα subunit (which is inactive when bound to GDP). The activated Gαq-GTP 
monomer and a βγ dimer (not shown) dissociate from the receptor, allowing Gαq to activate phospholipase C 
(PLC). PLC cleaves phosphatidylinositol 4,5-bisphosphate (PIP2) into diacyl glycerol (DAG) and inositol 1,4,5-
trisphosphate (IP3). IP3 releases Ca
2+
 from intracellular stores (ER/endoplasmic reticulum) and DAG activates 
protein kinase C (PKC). Various pharmacological tools can be used to study this pathway and some of which are 
illustrated on the diagram (compounds which activate targets within the pathway are shown in blue and 
compounds which inhibit pathway components are shown in red). A compound called m-3M3FBS can be used 
to activate PLC and a compound named U73122 can be used as a PLC inhibitor (Bae et al., 2003; Rohacs, 2009). 





Figure 4-15 Pathways downstream of PLC activation modulate TRPM3  
(a) The effects of a PLC activator (10µM m-3M3FBS, 15 minute pre-incubation) on PS-evoked [Ca
2+
]i responses 
of CHO cells stably transfected with mTRPM3. M-3M3FBS treatment increased the maximum amplitude of PS-
evoked responses and this effect was reversed by co-treatment with a PLC inhibitor (5µM U73122). 
Representative plot shown, data points are the mean ratio of triplicate wells ± SEM. (b) The effects of a PKC 
activator, PMA (1µM, 15 minute pre-incubation) on PS-evoked [Ca
2+
]i responses of CHO cells stably transfected 
with mTRPM3. PMA treatment inhibited PS-evoked responses. Representative plot shown, data points are the 
mean ratio of triplicate wells ± SEM. (c) The effects of another PKC activator, PDBu (1µM, 15 minute pre-
incubation) on PS-evoked [Ca
2+
]i responses of CHO cells stably transfected with mTRPM3. PDBu treatment 
significantly inhibited PS-evoked responses but this effect was not reversed by co-treatment with a PKC 
inhibitor, staurosporine (3µM), which caused responses to be inhibited even further. Representative plot 
shown, data points are the mean ratio of triplicate wells ± SEM. (d) The effects of staurosporine (3µM, 15 
minute pre-incubation) on PS-evoked [Ca
2+
]i responses of mTRPM3 CHO cells. Cells treated with staurosporine 
had significantly reduced maximum response amplitudes in comparison to untreated cells. Representative plot 
shown, data points are the mean ratio of triplicate wells ± SEM. 
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Table 4-4 Effects of a PKC activator on PS evoked [Ca
2+
]i responses     
Table detailing the average EC50 values and maximum amplitudes for PS-evoked [Ca
2+
]i responses in the 
presence and absence of PDBu and PDBu + Staurosporine. Values listed are mean ± SEM (n= 3 independent 
experiments). 
 





10.89 ± 4.19 
 
12.34 ± 1.42 
 
15.07 ± 4.45 
Average Maximum 
Amplitude 
(Δ Fura-2 ratio) 
 
1.99 ± 0.08 
 
1.41 ± 0.02 
 




4.4.10 Activation of the CB1 receptor inhibits TRPM3 
The findings of the previous section demonstrated that manipulation of cAMP levels 
resulted in modulation of TRPM3 activity: when cAMP levels were raised using 
pharmacological tools the activity of TRPM3 was potentiated. In order to investigate 
whether cAMP activity is needed for activation of TRPM3 the effect of decreased cAMP 
production on PS-induced TRPM3 activation was investigated.  
The cannabinoid receptor type 1 or CB1 is a GPCR which is expressed in a large proportion 
of peripheral sensory neurons (Ahluwalia et al., 2000; Binzen et al., 2006; Khasabova et al., 
2002). Activation of CB1 receptors causes inhibition of adenylyl cyclase by a process which 
is dependent on the activity of Gαi/o proteins, and leads to decreased cellular levels of 
cAMP (Turu and Hunyady, 2010).  
In order to test whether agonist-induced activation of a Gαi/o linked GPCR and the 
resulting decrease in cAMP levels could inhibit TRPM3; a GFP-tagged CB1 receptor was 
transiently transfected into CHO cells stably expressing the mouse TRPM3 channel (see  
Figure 4-16). Microscope-based imaging experiments were then used to investigate whether 
the PS evoked [Ca2+]i responses of individual cells were modulated by administration of a 
CB1 receptor agonist (WIN 55212-2) or antagonist (AM251). 
The TRPM3-CB1 transfected cells were exposed to two consecutive 20µM PS challenges 
with the second PS challenge occurring either in the presence or absence of a CB1 agonist 
or antagonist. A submaximally effective concentration of PS was used because subtle 
modulation of responses would be difficult to detect if TRPM3 channels were maximally 
activated.  
In control experiments where cells experienced two consecutive PS challenges without 
exposure to a CB1 agonist/antagonist, PS responses were repeatable and exhibited little 
desensitisation. On average cells responded to the second PS challenge with a maximum 
response amplitude which was 0.09 Δ Fura-2 ratio lower (from 0.78 ± 0.02 to 0.69 ± 0.02 Δ 
Fura-2 ratio) than the first PS response amplitude (mean ± SEM; n= 135 cells, 1, 1; Figure 4-
17a). However, in experiments where cells were perfused with a CB1 agonist, WIN 55212-2 
(1µM), 1.5 minutes before and during the second PS challenge, many cells displayed an 
inhibited response to PS (see Figure 4-17b). On average cells treated with WIN 55212-2 
responded to the second PS challenge with a maximum response amplitude which was 0.25 
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Δ Fura-2 ratio lower (from 0.78 ± 0.02 to 0.53 ± 0.02 Δ Fura-2 ratio) than the first PS 
response amplitude (mean ± SEM; n= 336 cells, 2, 1; Figure 4-17a).  
In contrast, in experiments where cells were perfused with a CB1 antagonist, AM251 
(0.5µM), many cells exhibited potentiated responses when challenged with a second PS 
response (Figure 4-17a). In some cases cells that exhibited no response to the first 
challenge responded to PS in the presence of the CB1 antagonist. However, on average the 
maximum response amplitude was unchanged (from 0.71 ± 0.02 to 0.70 ± 0.02 Δ Fura-2 
ratio; mean ± SEM; n= 307 cells, 2, 1).  
It is important to note that the CB1-GFP DNA will not have been successfully incorporated 
into all TRPM3 CHO cells and this can be seen when observing GFP fluorescence in 
transfected cells (see  
Figure 4-16). Only a fraction of the cells shown were fluorescent and these are the cells 
which will contain the GFP-tagged CB1 receptor (9% fluorescent, 388/ 4342). Modulation of 
responses is easier to observe in a scatterplot displaying the change in PS response 
amplitudes for cells in each experiment (Figure 4-17b). A trend for cells to have decreased 
maximum response amplitudes can be seen in cells treated with the CB1 agonist (WIN 
55212-2). In contrast a trend for potentiated responses is clear in experiments where cells 
were treated with a CB1 antagonist (AM251).  
Quantitatively, 4% (12/336) of cells exposed to the CB1 receptor agonist, responded to the 
second PS challenge with a response amplitude that was 1 Δ Fura-2 ratio lower than their 
first, control response amplitude. However, this was observed in 0% (0/135 cells) of cells in 
control experiments (P<0.05, Fisher’s exact test). Conversely, when cells were exposed to 
the CB1 receptor antagonist 7% (21/307) responded to the second PS challenge with a 
maximum response amplitude which was 1 Δ Fura-2 ratio higher than their response to the 
first PS challenge. This large increase in response amplitude was not observed in any cells 
(0/135 cells) in control experiments (P<0.001, Fisher’s exact test).  
It is highly likely that the cells which demonstrated this behaviour are the cells which 
contain the GFP-tagged CB1 receptor, and it is therefore possible to conclude that 
activation of the CB1 receptor inhibits TRPM3 responses whereas inhibition of CB1 















Figure 4-16 Images of mock- and CB1-GFP transfected TRPM3 CHO cells  
Verification of CB1-GFP
+
 TRPM3 CHO cells. Combined image demonstrating an overlap of GFP expression 
(green) with hoescht staining (blue) in CB1-GFP transfected TRPM3 CHO cells (bottom panel) but not mock-






Figure 4-17 CB1 modulates activation of recombinantly expressed TRPM3 
(a) [Ca
2+
]i responses monitored by Fura-2 (R denotes Fura-2 ratio) in PS-sensitive GFP-CB1 transfected TRPM3 
CHO cells using microscope-based imaging. Cells were exposed to two consecutive 20µM PS challenges. In 
control experiments (traces in the top panel) cells were not exposed to a CB1 receptor agonist or antagonist. In 
other experiments cells were perfused with a CB1 receptor agonist (1µM WIN 55212-2) 1.5 minutes before and 
during the second PS challenge (traces in the middle panel). In some experiments cells were perfused with a 
CB1 receptor antagonist (0.5µM AM251) 1.5 minutes before and during the second PS challenge (traces in the 
bottom panel). In control experiments PS responses were repeatable and exhibited little desensitisation. In 
experiments where cells were exposed to 1µM WIN 55212-2, some cells exhibited dramatically inhibited PS 
responses. In contrast, some cells exposed to 0.5µM AM251 displayed responses which were greatly 
potentiated. Selected traces from cells which displayed marked inhibition/potentiation are shown. (b) A scatter 
plot illustrating the change in maximum amplitude between responses to the first and second PS challenges. 
Negative values indicate cells which exhibited a reduced response to the second PS challenge and positive 
values indicate cells which displayed a potentiated response to the second PS challenge (Control, n= 135 cells, 
1, 1; 1µM WIN, n= 336 cells, 2, 1; 0.5µM AM251, n= 307 cells, 2, 1). Note that some cells treated with 1µM WIN 
showed large decreases in response amplitudes and exposure to 0.5µM AM251 resulted in large potentiation in 
some cells. These larger changes were not observed in control experiments. The change in response amplitudes 
was significantly different between control cells and cells treated with 1µM WIN but was not significantly 
different between control cells and cells treated with 0.5µM AM251 (*** P <0.001; Kruskal-Wallis test with 




4.4.11 CB1 modulation of TRPM3 channels expressed on sensory neurons 
The CB1 receptor is expressed in ~40-60% of DRG neurons with a high level of co-
expression with TRPV1 (Agarwal et al., 2007; Ahluwalia et al., 2000; Binzen et al., 2006; 
Khasabova et al., 2002). Moreover TRPM3 has also been found to be highly co-expressed 
with TRPV1 and its expression has been shown by one study to be restricted to small 
diameter sensory neurons (Vriens et al., 2011). These findings indicate that both CB1 
receptors and TRPM3 channels are expressed by the nociceptor subpopulation of sensory 
neurons. As activation of the CB1 receptor modulated the activity of TRPM3 channels 
expressed in a recombinant cell line, the effects of CB1 receptor agonists on TRPM3 
channels natively expressed in mouse DRG neurons were investigated.  
Isolated DRG neurons were exposed to two consecutive submaximally effective PS 
challenges (20µM) followed by a depolarisation by a high concentration of KCl, which 
allowed all neurons to be identified. The second PS challenge took place either in the 
presence or absence of the cannabinoid receptor agonist, WIN 55212-2 (1µM). In control 
experiments, PS evoked [Ca2+]i responses which exhibited some desensitisation. On average 
PS-responsive neurons responded to the second PS challenge with a maximum response 
amplitude which was 62 ± 2% that of the first PS response amplitude (mean ± SEM; n= 356 
neurons, 10, 6; Figure 4-18). However, in experiments where neurons were perfused with 
1µM WIN 55212-2 for 2 minutes before and during the second PS challenge, the maximum 
response amplitude was reduced to 51 ± 3 % (% of the first PS response; mean ± SEM; 
P<0.001, Mann-Whitney U test; n= 213 neurons, 7, 3;Figure 4-18).  
This finding suggested that application of WIN 55212-2 causes inhibition of PS-evoked 
responses in some DRG neurons. In order to test this, DRG neurons were exposed to three 
consecutive PS challenges (20µM). Following the protocol of previous experiments the first 
application of PS identified the PS-sensitive neurons and the second PS challenge was 
applied in the presence of 1µM WIN 55212-2, however the third PS challenge was applied 
in the presence of both 1µM WIN 55212-2 and 0.5µM AM251 (CB1 receptor antagonist). 
This experimental protocol allowed for detection of neurons whose responses were 
inhibited by co-application of PS with WIN 55212-2, and restored when a CB1 antagonist 
(AM251) was co-applied with WIN 55212-2 and PS. In these experiments, some neurons 
appeared to have a reduced PS response in the presence of WIN 55212-2 and in a small 
number of neurons (5%, n= 8/156 neurons, 4, 1) responses were increased 
(PS+WIN+AM251 amplitude/PS+WIN amplitude >250%) when WIN 55212-2 was 
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concomitantly applied with AM251 (see Figure 4-18b). These findings demonstrate that 
activation of natively expressed CB1 receptors might inhibit TRPM3 activity in a small 







Figure 4-18 CB1 modulates activation of TRPM3 expressed on sensory neurons 
[Ca
2+
]i responses were monitored by Fura-2 in PS-sensitive DRG neurons using microscope-based imaging. 
Neurons were exposed to two consecutive submaximal PS challenges (20µM), the second PS challenge took 
place either in the presence or absence of the cannabinoid receptor agonist WIN 55212-2 (1µM) (a) Column 
graph displaying average maximum response amplitudes for responses to the second PS challenge (as a % of 
the first PS response amplitude) for control experiments and experiments where neurons were perfused with 
1µM WIN 55212-2. Columns represent mean ± SEM (***P<0.001, Mann-Whitney U test; control, n= 356 
neurons, 10, 6; WIN, n= 213 neurons, 7, 3). (b) Representative traces displaying neuronal [Ca
2+
]i responses to 
three sequential PS challenges (20µM) followed by depolarisation with high K
+
 (50mM KCl). In some neurons 
(upper panel), PS-evoked increases in [Ca
2+
]i were unaffected by application by of WIN 55212-2 and AM251. In 
other neurons PS evoked increases in [Ca
2+
]i were inhibited by application of WIN 55212-2 (middle and bottom 
panels). This inhibition was prevented by concomitant AM251 application in some neurons (bottom panel) but 




4.4.12 Morphine inhibits TRPM3 channels expressed in sensory neurons  
Activation of opioid receptors expressed on sensory neurons causes inhibition of voltage-
gated calcium channels, and has also been shown to inhibit capsaicin-induced TRPV1 
currents; effects which are mediated by Gαi/o proteins (Endres-Becker et al., 2007; Stein et 
al., 2003).  
There are three main subtypes of opioid receptors (μ, δ and κ), which are all expressed by 
sensory neurons and signal through Gαi/o proteins (Stein et al., 2003). In order to examine 
whether activation of opioid receptors expressed on sensory neurons can modulate 
natively expressed TRPM3 channels, the effects of the prototypical opioid receptor agonist 
morphine on the PS-evoked [Ca2+]i responses of DRG neurons were investigated.  
Isolated DRG neurons were exposed to two consecutive submaximally effective PS 
challenges (20µM) followed by a depolarising concentration of KCl. The second PS 
challenge took place either in the presence or absence of 10µM morphine. As mentioned 
previously, in control experiments double application of PS evoked [Ca2+]i responses which 
were repeatable with some desensitisation. On average PS-responsive neurons responded 
to the second PS challenge with a response which was 62 ± 2% of the amplitude of the first 
PS response (mean ± SEM; n= 356 neurons, 10, 6; Figure 4-19). However, in experiments 
where neurons were perfused with 10µM morphine for 2 minutes before and during the 
second PS challenge, the response amplitude was strikingly reduced to 13 ± 1% of the first 
PS response (mean ± SEM; n= 641 neurons, 20, 6; significantly different to relative control 
amplitudes, P<0.001, Mann-Whitney U test). In the majority of neurons (57%) application 
of morphine completely abolished PS-evoked [Ca2+]i responses (<5% of first PS response; n= 
364/641; compared to 2%, n= 8/356 in control experiments). 
In order to test whether morphine could still exert its inhibitory effects in the presence of 
an opioid receptor antagonist, the effects of morphine (10µM) concomitantly applied with 
naloxone (1µM) were investigated. Naloxone prevented the inhibitory effects of morphine 
as the response amplitude evoked by the second PS challenge was 59 ± 5% in the presence 
of naloxone (% of the first PS response; mean ± SEM; n= 39 neurons, 2, 2; not significantly 
different to relative control amplitudes, Kruskal-Wallis test; Figure 4-20) which is similar to 
the relative amplitude in controls (62 ± 2%). This confirmed that morphine was exerting its 
inhibitory effects by binding to an opioid receptor present on DRG neurons.   
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Next, the involvement of Gαi/o proteins was investigated using pertussis toxin (PTX). PTX is 
an exotoxin which prevents signalling of G proteins belonging to the Gi family by catalysing 
ADP-ribosylation of α subunits. Isolated DRG neurons were pre-treated with PTX (~ 2 ½ 
hours) and then exposed to two consecutive PS challenges, the first without and the 
second with morphine. The inhibitory effects of morphine were reduced by pre-treatment 
of neurons with PTX, however not to the same extent as concomitant treatment with 
naloxone. The response amplitude of neurons pre-treated with PTX and exposed to 
morphine was 44 ± 3% in comparison to 13 ± 1% with morphine (% of the first PS response; 
mean ± SEM; n= 150 neurons, 5, 2; significantly different to relative morphine amplitudes, 
P<0.001, Kruskal-Wallis test; Figure 4-20). These findings suggest that activation of a 
sensory-neuron expressed opioid receptor and subsequent Gαi/o protein signalling is able 








Figure 4-19 Morphine inhibits TRPM3 channels expressed on sensory neurons  
[Ca
2+
]i responses were monitored by Fura-2 in PS-sensitive DRG neurons using microscope-based imaging. 
Neurons were exposed to two consecutive submaximal PS challenges (20µM); the second PS challenge took 
place either in the presence or absence of the opioid receptor agonist morphine (10µM). (a) Representative 
traces displaying neuronal [Ca
2+
]i responses to two sequential PS challenges (20µM) followed by depolarisation 
with high K
+
 (50mM KCl) in a control experiment. R denotes Fura-2 ratio. (b) Scatter and line plot showing the 
relationship between maximum response amplitudes (Δ Fura-2 ratio) for the first and second PS responses in a 
representative control experiment. (c) Representative traces displaying neuronal [Ca
2+
]i responses to two 
sequential PS challenges (20µM) followed by depolarisation with high K
+
 (50mM KCl). Neurons were perfused 
with 10µM morphine 2 minutes before and during the second PS challenge. PS-evoked increases in [Ca
2+
]i were 
inhibited by application of morphine. R denotes Fura-2 ratio. (d) Scatter and line plot showing the relationship 
between maximum response amplitudes (Δ Fura-2 ratio) for the first and second PS responses in a 
representative morphine experiment. (e) Column graph displaying average maximum response amplitudes for 
responses to the second PS challenge (as a % of the first PS response amplitude) for control experiments and 
experiments where neurons were perfused with 10µM morphine. Columns represent mean ± SEM; P <0.001; 
Mann-Whitney U test (control, n= 356 neurons, 10, 6; morphine, n= 641 neurons, 20, 6). (f) Representative 
traces displaying neuronal [Ca
2+
]i responses to three sequential PS challenges (20µM) followed by 
depolarisation with high K
+
 (50mM KCl). PS-evoked increases in [Ca
2+
]i are inhibited by application of morphine 
(10µM) but not by co-application of morphine with the opioid antagonist, naloxone (1µM). R denotes Fura-2 
ratio. (g) Column graph displaying average maximum response amplitudes for responses for the first, second 









]i responses were monitored by Fura-2 in PS-sensitive DRG neurons using microscope-based imaging. 
Neurons were exposed to two consecutive submaximal PS challenges (20µM). Column graph displaying average 
maximum response amplitudes for responses to the second PS challenge (as a % of the first PS response 
amplitude). Application of 10µM morphine inhibited PS-evoked responses; this effect was abolished by 
concomitant application of the opioid receptor antagonist naloxone (1µM) and was reduced by pre-treatment 
of neurons with PTX. Columns represent mean ± SEM. *** P <0.001, P values represent comparison to control. 
††† P <0.001, P values represent comparison to 10µM morphine. Kruskal-Wallis test (control, n= 356 neurons, 
10, 6; morphine, n= 641 neurons, 20, 6; morphine + naloxone, n= 39 neurons, 2, 2; morphine PTX treated, n= 




4.4.13 Activation of μ-opioid receptors inhibits TRPM3 
In order to examine which opioid receptor subtypes are important for morphine-induced 
inhibition of TRPM3, the effects of three selective opioid receptor agonists on the PS-
evoked [Ca2+]i responses of DRG neurons were investigated. Using the experimental format 
previously described, isolated DRG neurons were exposed to two consecutive submaximal 
PS challenges (20µM) followed by a depolarising concentration of KCl. The second PS 
challenge took place either in the presence or absence of 20nM U50488 (a κ opioid 
receptor agonist), 20nM SB205607 (a δ opioid receptor agonist) or 20nM DAMGO (a μ 
opioid receptor agonist). 
Exposure of neurons to a κ opioid receptor agonist did not inhibit PS-induced responses. 
The average PS response amplitude of neurons perfused with U50488 was 72 ± 3% 
compared to a response amplitude of 62 ± 2% in control experiments (% of the first PS 
response; mean ± SEM; control, n= 356 neurons, 10, 6; U50488, n= 140 neurons, 4, 2; not 
significantly different to relative control amplitudes, Kruskal-Wallis test; Figure 4-21).  
In contrast, neurons perfused with a δ opioid receptor agonist (SB205607) had a slightly 
reduced second response to PS in comparison to control experiments with a response 
amplitude of 52 ± 3% (% of the first PS response; mean ± SEM; n= 200 neurons, 5, 3; 
significantly different to relative control amplitudes, p<0.05, Kruskal-Wallis test; Figure 4-
21). This finding suggests that the PS-induced responses of some DRG neurons are inhibited 
by activation of δ opioid receptors; therefore the δ opioid receptor subtype could be 
responsible for a small part of the inhibition seen with morphine.  
Application of a μ opioid receptor agonist (DAMGO) produced an inhibition of PS-evoked 
responses which mimicked that of morphine, the average PS response amplitude was 
reduced to 18 ± 2% compared to 62 ± 2% in control experiments (% of the first PS response; 
mean ± SEM; control, n= 356 neurons, 10, 6; DAMGO, n= 184 neurons, 5, 3; significantly 
different to relative control amplitudes, p<0.001, Kruskal-Wallis test; Figure 4-21). 
Furthermore application of DAMGO caused complete inhibition of PS-induced [Ca2+]i 
responses in 41% of neurons (<5% of first PS response; n= 76/184; compared to 2%, n= 
8/356 in control experiments). These findings suggest that morphine exerts an inhibitory 





Figure 4-21 DAMGO inhibits TRPM3 channels expressed by sensory neurons  
[Ca
2+
]i responses were monitored by Fura-2 in PS-sensitive DRG neurons using microscope-based imaging. 
Neurons were exposed to two consecutive submaximal PS challenges (20µM); the second PS challenge took 
place either in the presence or absence of a selective opioid receptor agonist (DAMGO, μ opioid receptor 
agonist; SB205607, δ opioid receptor agonist; U50488, κ opioid receptor agonist) (a) Scatter and line plot 
showing the relationship between maximum response amplitudes (Δ Fura-2 ratio) for the first and second PS 
responses in a representative control experiment, (b) 20nM U50488 experiment, (c) 20nM SB205607 
experiment and (d) 20nM DAMGO experiment. (e) Column graph displaying average maximum response 
amplitudes for responses to the second PS challenge (as a % of the first PS response amplitude) for control 
experiments and experiments where neurons were perfused with a selective opioid receptor agonist (20nM). 
Columns represent mean ± SEM. P values represent comparison to control. * P < 0.05, ** P < 0.01, *** P 
<0.001; Kruskal-Wallis test (control, n= 356 neurons, 10, 6; DAMGO, n= 184 neurons, 5, 3; SB205607, n= 200 
neurons, 5, 3; U50488, n= 140 neurons, 4, 2). (f) Representative traces displaying neuronal [Ca
2+
]i responses to 
two sequential PS challenges (20µM) followed by depolarisation with high K
+
 (50mM KCl). Neurons were 
perfused with 20nM DAMGO 2 minutes before and during the second PS challenge. PS-evoked increases in 
[Ca
2+
]i were inhibited by application of DAMGO. R denotes Fura-2 ratio. 
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4.4.14 TRPM3 and Pain 
4.4.14.1 Persistent Pain  
Findings presented in this chapter have demonstrated that the absence of functional 
TRPM3 channels results in a reduced sensitivity to acute heat pain.  
In order to examine whether TRPM3 is involved in sensing ‘tonic’ or more persistent pain, 
Trpm3+/+ and Trpm3-/- mice were given an intraplantar injection of 2.5% formalin into their 
left hindpaw and their behavioural responses (time spent licking, shaking or biting the 
affected the paw) were measured and compared. This test characteristically induces two 
phases of pain, an immediate (~3 minutes after injection) initial phase which is followed by 
a period of inactivity, which leads into a later second phase (~20-30 minutes after injection) 
(Le Bars et al., 2001). Trpm3-/- mice exhibited similar behavioural responses to Trpm3+/+ 
mice in the first phase of pain but displayed significantly reduced nocifensive behaviour 
during the later phase of the behavioural response (Figure 4-22a).  
These results indicate that TRPM3 serves an important role in the detection of pain; in the 
absence of TRPM3, mice are less sensitive to both acute (see section 4.5.2.3) and persistent 
pain.  
4.4.14.2 Visceral pain 
In order to investigate whether TRPM3 is involved in other mechanisms of persistent pain, 
acetic acid induced-writhing was examined in Trpm3+/+ and Trpm3-/- animals. Mice were 
given an intraperitoneal injection of acetic acid which induces a characteristic behavioural 
response composed of stereotyped body movements or ‘writhing’ (Le Bars et al., 2001).  
The number of writhes exhibited by Trpm3+/+ and Trpm3-/- mice were measured and 
compared. Surprisingly, Trpm3-/- animals displayed more writhes on average than wildtype 
animals, suggesting an increased sensitivity of knockout animals although this effect was 
not significant (Figure 4-22b). These findings could indicate a divergence in the pain-sensing 










mice were given an intraplantar injection of 2.5% formalin into their left hindpaw and 
their nociceptive behaviour was measured in seconds. Nociceptive behaviour relates to licking, shaking or biting 
of the affected paw. Trpm3
-/- 
mice exhibited significantly reduced nociceptive behaviour in response to injection 
of formalin in comparison to wildtype mice. Data points represent mean ± SEM (* P < 0.05; Mann-Whitney U 




mice were given an intraperitoneal injection of 
acetic acid and the number of writhes exhibited by each animal was measured. Trpm3
-/- 
mice displayed more 






The findings presented in this chapter have characterised mouse TRPM3 expressed in CHO 
cells and confirmed activation of TRPM3 channels by the endogenous neurosteroid 
pregnenolone sulphate and by heating. In addition, a role for TRPM3 in noxious heat 
sensing has been demonstrated, DRG neurons from Trpm3-/- mice had a smaller percentage 
of heat-sensitive neurons than wildtype DRG neurons and Trpm3-/- mice exhibited a 
reduced sensitivity to noxious heat in behavioural experiments. Moreover, the findings 
presented in this chapter have demonstrated that TRPM3 activity, like that of other sensory 
TRP channels, can be regulated by intracellular pathways downstream of Gq, Gs and Gi/o 
linked GPCR activation. Importantly, the results presented in this chapter have shown that 
the activity of TRPM3 is regulated by activation of µ-opioid receptors in a Gi-dependent 
manner. Finally, the findings presented here have provided evidence for a pro-nociceptive 
role of TRPM3 in acute and persistent pain.  
4.5.1 Chemical activation and inhibition of TRPM3  
Recombinantly expressed TRPM3 channels exhibited robust [Ca2+]i responses to application 
of PS. Furthermore, PS-induced changes in [Ca2+]i were not evident in untransfected CHO 
cells (up to 200µM) consistent with selective-activation of TRPM3. PS activated 
recombinantly expressed TRPM3 channels in a concentration-dependent manner with an 
EC50 value of ~10µM which is similar to the values reported by Wagner et al (2008). In 
addition, PS (50µM)-evoked increases in [Ca2+]i were relatively absent in neurons from 
Trpm3-/- mice (evoked a response in 1% of Trpm3-/- neurons), demonstrating the utility of 
PS as a probe for TRPM3 expression and the presence of functional TRPM3 channels in a 
subset of sensory neurons, consistent with previous reports (Vriens et al., 2011). Measured 
plasma PS levels in adults lie within the mid to high (100-300) nanomolar range (Havlíková 
et al., 2002; de Peretti and Mappus, 1983) which is just below the threshold for TRPM3 
activation measured here. It is therefore unlikely that circulating levels of PS are sufficient 
to cause activation of TRPM3. However, measured concentrations of PS are increased in 
maternal serum at the time of birth and are even at higher in the umbilical cord serum at 
the time of delivery (Bičıḱová et al., 2002; Klak et al., 2003). If during these events, raised 




PS-induced responses were inhibited by both mefenamic acid and ononetin. Mefenamic 
acid inhibited responses in the TRPM3 CHO cell line with an IC50 value in the low 
micromolar range consistent with previous findings (Klose et al., 2011). Ononetin inhibited 
PS-induced responses with an IC50 value in the high nanomolar range which is consistent 
with the IC50 value reported in a previous study (Straub et al., 2013a). These compounds 
were the best available antagonists for inhibition of TRPM3.  
4.5.2 TRPM3 and heat sensitivity  
4.5.2.1 Recombinantly expressed TRPM3 channels are sensitive to heat  
Recombinantly expressed TRPM3 channels displayed robust [Ca2+]i responses to heating, 
consistent with previous findings (Vriens et al., 2011). Heat-evoked responses were 
inhibited, to the response level of untransfected cells, by both mefenamic acid and 
ononetin demonstrating the requirement of TRPM3 channels for these responses. These 
findings are consistent with the conclusion that TRPM3 is a thermosensitive channel which 
is opened by heating. Interestingly, recombinantly expressed TRPM3 channels responded 
to heat with an average threshold temperature of 44°C, which is almost identical to the 
activation threshold of TRPV1 and the threshold for heat pain in humans (Basbaum et al., 
2009; Caterina et al., 1997; Tominaga et al., 1998).  
4.5.2.2 Heat sensitivity of DRG neurons  
The majority of heat-sensitive wildtype DRG neurons (74%) were sensitive to PS and due to 
the relative absence of PS-evoked [Ca2+]i responses in neurons lacking functional TRPM3 
channels these neurons can be considered TRPM3-expressing. The majority of TRPM3-
expressing, heat-sensitive neurons co-expressed TRPV1 (86%) leaving only a small 
population of neurons which only expressed TRPM3 (14%). In the subpopulation of heat-
sensitive neurons which co-express TRPV1 and TRPM3 it is difficult to ascertain whether 
TRPM3 plays a role in the transduction of heat as it is possible that TRPV1 is acting as a 
heat-sensor in these neurons.   
The number of heat-sensitive neurons responding to both PS and capsaicin in the current 
study is similar to the number reported in an earlier study by Vriens and colleagues (2011). 
The same study reported that 41% of heat-sensitive neurons were sensitive to PS but not 
capsaicin; this differs from the findings presented in this chapter, where only 10% of heat-
sensitive neurons were identified as responsive to PS only. This discrepancy could be 
explained by a difference in the initial proportion of DRG neurons displaying heat 
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sensitivity. Vriens and colleagues reported that 82% of DRG neurons tested displayed heat-
evoked responses. This value is higher than the number found in both the study presented 
here (~44%) and previous studies (~34-51%) examining the heat sensitivity of cultured DRG 
neurons (Caterina et al., 2000; Noël et al., 2009).  
Importantly, the findings presented in this chapter showed that not all PS-sensitive neurons 
were heat-sensitive: 43% of neurons which responded to PS did not display heat sensitivity. 
This suggests that expression of TRPM3 alone by sensory neurons does not confer 
sensitivity to heat over the temperature range studied. It is possible that TRPM3 requires 
the presence or absence of an additional biochemical factor or protein for heat sensitivity, 
which is only present/absent in a subpopulation of TRPM3-expressing nerves. 
Notably, the temperature activation thresholds between different subpopulations of heat-
sensitive neurons (PS- and capsaicin-sensitive, just PS-sensitive, just capsaicin-sensitive) 
were not dissimilar. This finding is consistent with similar temperature activation 
thresholds for TRPM3 and TRPV1.   
Despite the majority of WT DRG neurons expressing TRPM3, neurons from mice lacking 
functional TRPM3 channels exhibited only a small reduction in heat-sensitivity. The number 
of heat-sensitive neurons was 10% lower in Trpm3-/- mice compared to Trpm3+/+ mice 
(p<0.001, Pearson’s Chi-Square test). It is possible that this reduction in heat-sensitivity 
represents the loss of the small subpopulation (10%) of heat-sensitive Trpm3+/+ neurons 
which were responsive to PS but not capsaicin. In the other, larger subpopulation of heat-
sensitive neurons (which responded to PS and capsaicin) the presence of TRPV1 could be 
masking any effect on heat sensitivity due to the loss of TRPM3.   
However, these findings indicate that TRPM3 plays a small role in the heat-sensing 
mechanisms of sensory neurons and are in contrast to the findings by Vriens and 
colleagues (2011) which demonstrated a much larger loss of heat sensitivity in Trpm3-/- 
mice (23% reduction in heat-sensitive neurons). However, due to the large number of heat-
sensitive WT neurons reported in Vriens et al, the larger loss of heat sensitivity still results 
in 59% of DRG neurons which are responsive to heat in Trpm3-/- mice (Vriens et al., 2011). 
The large number of heat-sensitive neurons remaining in Trpm3-/- animals highlights that 
TRPM3 is not required for the heat sensitivity of all neurons.  
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In the current study, the temperature thresholds of wildtype and Trpm3-/- neurons were 
identical. Again, this finding is consistent with TRPM3 and TRPV1 having similar 
temperature activation thresholds.  
4.5.2.3 TRPM3 is partly-responsible for noxious heat responses in vivo  
Notably, Trpm3-/- mice displayed significantly longer latencies to withdrawal from a noxious 
heat stimulus (53°C) than their wildtype counterparts. This finding is consistent with a 
previous study examining heat pain thresholds in mice who lack functional TRPM3 channels 
and suggests that TRPM3 does contribute to noxious heat sensing in vivo (Vriens et al., 
2011). Although the loss in heat sensitivity was modest in sensory neurons isolated from 
Trpm3-/- mice, this small reduction in the number of heat sensitive neurons could be 
significant for the sensation of noxious heat. Alternatively, expression of TRPM3 at other 
sites could contribute this behavioural effect. The results presented in this chapter have 
demonstrated expression of TRPM3 in the spinal cord as well as in multiple areas of the 
central nervous system.  
4.5.2.4 Which proteins are responsible for transduction of heat stimuli in sensory 
neurons? 
The current study suggests that deletion of TRPM3 channels has a small impact on the heat 
sensitivity of sensory neurons. TRPV1 is largely thought to be the molecular transducer for 
noxious heat however there is a discrepancy over the effects of TRPV1 deletion on sensory 
neuron heat sensitivity; some studies have argued that neurons lacking TRPV1 exhibit 
deficits in heat sensitivity (Caterina et al., 2000; Davis et al., 2000) whilst other studies have 
shown that Trpv1-/- neurons possess a residual heat-sensing ability around the temperature 
range which activates TRPV1 (Lawson et al., 2008; Vriens et al., 2011; Woodbury et al., 
2004).  
Moreover, one study has shown that whilst application of a TRPV1 antagonist was able to 
inhibit some of the remaining heat-evoked responses in Trpm3-/- mice, the heat-evoked 
responses of a large population of neurons (~50%) were unaffected by the antagonist 
(Vriens et al., 2011). Which raises the question, what is responsible for the TRPM3/TRPV1-
independent component of heat sensation?  
Anoctamin 1 (ANO1), a Ca2+ activated chloride channel (CaCC), expressed within the 
nociceptive subpopulation of sensory neurons has been implicated in sensory heat 
transduction mechanisms (Cho et al., 2012). The study reported that heating activates Cl- 
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conductances in DRG neurons and that ANO1 is activated by heat with a threshold 
temperature of 44°C. Furthermore, it was noted that co-treatment of neurons with the 
TRPV1 antagonist, capsazepine and the CaCC blocker, mefloquine, results in complete 
inhibition of heat-evoked currents of WT DRG neurons whilst mefloquine blocks heat 
responses in Trpv1-/- neurons (Cho et al., 2012). It is possible that activation of ANO1 by 
heat leads to depolarisation of sensory neurons and opening of voltage gated calcium 
channels.    
Heating results in clustering of STIM1 at ER-plasma membrane junctions leading to Orai1-
mediated Ca2+ influx (Xiao et al., 2011). However, this temperature-dependent activation of 
Orai1 results in responses which function as ‘heat-off’ signals, as they occur during the 
cooling phase after heating (Xiao et al., 2011).  
A rhodopsin encoded by the ninaE gene has also been implicated in temperature 
discrimination mechanisms in Drosophila (Shen et al., 2011). Temperature discrimination 
was impaired in Drosophila larvae when the ninaE gene was mutated. Mutant larvae did 
not show a preference for their ideal temperature (18°C) over other ambient temperatures 
(19-24°C) in a thermotaxis assay. This mechanism of temperature discrimination also 
requires the activity of PLC and TRPA1. Interestingly, thermotactic discrimination abilities 
were rescued by the introduction of the mammalian melanopsin receptor (Shen et al., 
2011). This study highlights an alternative pathway by which an ion channel can be 
activated by heat which could also function in mammals. It is also possible that other 
thermo-sensitive ion channels still remain to be found.  
4.5.3 Modulation of TRPM3 channel activation 
4.5.3.1 TRPM3 is potentiated by cAMP- dependent mechanisms 
Activation of heterologously-expressed TRPM3 channels by PS resulted in robust [Ca2+]i 
responses which were potentiated by combined activation of adenylyl cyclase and 
inhibition of phosphodiesterase enzymes, and by application of a membrane permeable 
cAMP analogue. These findings demonstrate the existence of a cAMP-dependent 
mechanism for potentiation of TRPM3 channels.  
Interestingly, the effects of the membrane-permeable cAMP analogue on PS-induced 
TRPM3 activation could not be reversed by a non-selective protein kinase inhibitor or a 
PKA-selective inhibitor suggesting that the sensitisation evoked by increases in cAMP levels 
is independent of PKA activation. This finding is surprising considering that the majority of 
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cAMP mediated-actions are executed by PKA and also considering the well-established role 
of PKA as a regulator of ion channels (Berridge, 2012).   
4.5.3.2 How do increases in cAMP modulate TRPM3 channel activity?  
It is important to note that whilst PKA is the main effector of cAMP-dependent mechanisms 
it is not the only one; exchange proteins activated by cAMP (Epac) are also targeted by 
cAMP (Berridge, 2012; Kawasaki et al., 1998; de Rooij et al., 1998). Epac are proteins 
encoded by the Epac1 and Epac2 genes, which function as guanine nucleotide exchange 
factors for two members of the ras-related protein (Rap) family, Rap1 and Rap2b  
(Kawasaki et al., 1998; de Rooij et al., 1998; Schmidt et al., 2001). Epac 1 is widely 
expressed in adult human tissues and has strong expression in the kidney, ovary, thyroid 
and spinal cord and lower expression levels in the brain (Kawasaki et al., 1998). Epac 2 is 
not as widely expressed as Epac 1 but has high expression levels in the brain (Kawasaki et 
al., 1998). Epac have been associated with cAMP signalling pathways which function 
independently from PKA. Activation of a Gs-linked GPCR has previously been shown to 
cause cAMP dependent activation of PLCε, mediated by Epac activation of Rap2b (Schmidt 
et al., 2001). Furthermore, Epac has also been implicated in the cAMP-induced, PLC/PLD-
dependent translocation of PKCε to the plasma membrane of DRG neurons (Hucho et al., 
2005). It is possible that the cAMP-dependent, PKA-independent, potentiation of TRPM3 
activity is the result of Epac mediated actions.   
4.5.3.3 PLC activation positively modulates TRPM3 activation  
The majority of TRP channels are regulated in some way by actions downstream of PLC 
activation (Rohacs, 2013). The findings of the current study have demonstrated that TRPM3 
channel activity is positively modulated by activation of PLC. The PS-induced [Ca2+]i 
responses of heterologously-expressed TRPM3 channels were potentiated by the PLC-
activating compound, m-3M3FBS, which stimulates the β2, β3, γ1, γ2, and δ1 isoforms of 
PLC (Bae et al., 2003). This effect was reversed by the presence of the PLC inhibitor 
U73122. Interestingly, U73122 (in the presence of m-3M3FBS) not only reversed the 
potentiating effects of m-3M3FBS but reduced PS-induced responses to lower amplitude 
levels than the responses of untreated cells. This finding suggests that in this experimental 




4.5.3.4 How does PLC activation modulate TRPM3?  
As discussed earlier activation of PLC leads to the hydrolysis of the membrane phospholipid 
PIP2, resulting in the release of the second messengers; DAG and IP3 as hydrolysis products 
(Rohacs, 2013). IP3 acts on receptors present on the membranes of intracellular calcium 
stores stimulating the liberation of Ca2+ and DAG activates PKC. The sensory neuron TRP 
channel, TRPV1, is sensitised by activation of PLCβ which occurs downstream of Gαq-linked 
GPCR activation (Rohacs, 2013). There are two possible pathways which are thought to be 
responsible for this PLC-mediated sensitisation; the first involves phosphorylation of the 
channel by the PKCε isoform and the second involves relief from tonic inhibition of the 
channel by PIP2. The latter pathway is controversial due to conflicting experimental findings 
on the actions of PIP2 on TRPV1 channel activity. PIP2 has been shown to both activate and 
inhibit TRPV1 activity (Chuang et al., 2001; Klein et al., 2008; Lukacs et al., 2007; Prescott 
and Julius, 2003; Ufret-Vincenty et al., 2011; Yao and Qin, 2009) 
2.2.3.1 PKC activation  
The role played by DAG production and any consequent PKC activation in the observed 
potentiation of TRPM3 by PLC activation was investigated. Interestingly, direct activation of 
PKC by PMA or PDBu did not cause a potentiation of channel activity but resulted in an 
inhibition. Similarly, the broad-spectrum protein kinase inhibitor, staurosporine also 
inhibited PS-induced [Ca2+]i responses. The effects of PMA and PDBu could be due to a 
direct effect of these compounds on the channel rather than an effect of PKC inhibition. 
Experiments investigating the effects of the inactive analogues of these compounds, 4α-
PMA and 4α-PDBu, would be useful in determining whether these compounds directly 
interfere with TRPM3 channel activity independently of PKC activation. Staurosporine also 
inhibits PKA, p60v-Src tyrosine kinase and CaM kinase II in addition to PKC, within the same 
concentration range therefore its effects on TRPM3 cannot be interpreted entirely through 
its actions on PKC (Rüegg and Burgess, 1989).  
2.2.3.2 PIP2 hydrolysis 
It is possible that PIP2 exerts an inhibitory effect on the TRPM3 channel, which is relieved 
when it is hydrolysed by PLC thus causing a potentiation of channel activity. PIP2 has been 
shown to inhibit the activity of TRPV3 and TRPA1 in addition to TRPV1, although the effects 




4.5.3.5 Sensitisation of TRPM3 by inflammatory mediators which signal through a PLCβ-
pathway 
Regardless of how PLC-activation leads to an increased sensitivity of TRPM3 to ligand 
activation, these findings suggest that TRPM3 can be sensitised by mediators released 
during inflammation, such as bradykinin and prostaglandins, which activate sensory neuron 
Gq-coupled receptors leading to PLCβ activation. During inflammation, these mediators 
increase the sensitivity of peripheral sensory neurons by modulating the activity of ion 
channels resulting in pain hypersensitivity. Previous studies have already indicated a role 
for TRPM3 channels in the development of heat hyperalgesia, mice lacking functional 
TRPM3 channels do not develop the increased sensitivity to heat which is characteristic of 
inflammatory pain (Vriens et al., 2011).  
Interestingly, the activity of the human TRPM31325 variant was not modulated by activation 
of the histamine H1 receptor or endogenously-expressed muscarinic receptors which can 
couple to Gαq proteins causing activation of PLCβ (Grimm et al., 2003). This finding is 
surprising due to the modulatory effects observed on mouse TRPM3 activation by PLC 
activation in the current study.  
4.5.4 Activation of the CB1 receptor inhibits TRPM3 channel activity  
Stimulation of the CB1-receptor co-expressed with TRPM3 in a CHO cell line resulted in 
decreased PS-induced responses in some cells. Moreover, inhibition of the CB1 receptor 
unmasked PS responses in a subpopulation of cells, suggesting a level of constitutive 
activity of the CB1 receptor. The main effectors of CB1 receptors are the Gαi/o proteins 
which inhibit adenylyl cyclase activity and consequently lead to decreased levels of cAMP 
(Turu and Hunyady, 2010). CB1-induced inhibition of recombinantly expressed TRPM3 
responses are consistent with previous findings (discussed in section 4.5.3.1) showing the 
positive modulatory effect of elevating cAMP levels on TRPM3 channel activity.  
The findings presented in this chapter, have also shown that activation of endogenously 
expressed, sensory neuron CB1 receptors can modulate the activity of native TRPM3 
channels. A small subpopulation of PS-sensitive DRG neurons appeared to be inhibited by 
CB1 receptor stimulation, an effect which in some neurons (5%) was prevented in the 
presence of a CB1 receptor antagonist. Although these findings demonstrate that 
modulation of endogenously expressed TRPM3 channels by CB1 receptors can occur, the 
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modulatory effects were only evident in a very small number of PS-sensitive neurons; this 
could reflect a low co-expression level of CB1 with TRPM3.  
4.5.5 Activation of the μ-opioid receptor inhibits TRPM3 channel activity  
The opioid receptor agonist morphine caused a striking inhibition of PS-induced [Ca2+]i 
responses of sensory neurons, the PS-evoked responses of ~57% of PS-sensitive neurons 
were completely inhibited by morphine. The effects observed with morphine were opioid 
receptor sub-type specific and were reliant on G proteins belonging to the Gαi family; this 
was demonstrated by the lack of effect displayed by morphine in the presence of an opioid-
receptor antagonist and on cells pre-treated with PTX. These findings are consistent with 
the positive modulatory effects of cAMP on TRPM3 activity discussed previously and the 
inhibitory effects of CB1 receptor stimulation on TRPM3 activation (section 4.5.3.1, 4.5.4 
and Figure 4-23).  
The effects of morphine were mimicked by the μ-opioid receptor agonist, DAMGO which 
caused complete inhibition of PS-evoked responses in ~41% of PS-sensitive neurons. 
Activation of the δ-opioid receptor also had a small inhibitory effect on PS-evoked 
responses comparable to activation of the CB1 receptor; however stimulation of the κ-
opioid receptor exerted no inhibitory effects on PS-evoked responses. These findings 
strongly suggest a high level of co-expression of µ-opioid receptors with TRPM3 channels in 
primary afferent sensory neurons. A study by Khasabova and colleagues (2004) 
investigating inhibition of depolarisation-induced [Ca2+]i responses of DRG neurons by 
morphine, also noted an involvement of µ and δ but not κ receptors (Khasabova et al., 
2004).   
Notably, the effects of stimulating µ-opioid receptors on TRPM3 channel activation are 
similar to the effects reported for TRPV1 channels (Endres-Becker et al., 2007). Morphine 
inhibited capsaicin-induced currents in 79% of DRG neurons, effects which were mimicked 
by the µ-opioid receptor agonist DAMGO. This effect was also dependent on Gi proteins 
and could be reversed by application of a cAMP analogue or stimulation of adenylyl cyclase 
(Endres-Becker et al., 2007). Interestingly, the study by Endres-Becker et al reported that 
heat-evoked responses in 86% of DRG neurons were also inhibited by morphine. The 
findings presented here suggest that inhibition of heat-evoked responses by morphine 




4.5.6 CB1 and µ-opioid receptor-mediated modulation of TRPM3 during inflammation  
Opioids are commonly used analgesics for the treatment of pain. Opioids inhibit pain 
transmission, in part, by reducing the excitability of primary afferent neurons (Stein and 
Machelska, 2011). Moreover, cannabinoids which are active at CB1 receptors have been 
shown to be analgesic in various models of pain hypersensitivity (Agarwal et al., 2007; 
McDougall, 2011). 
A study examining mice with a specific deletion of the µ-opioid receptor in Nav1.8 positive 
neurons has shown that in an inflammatory pain model, opiate-induced analgesia is partly 
mediated by µ-opioid receptors expressed on sensory nerve endings (Weibel et al., 2013). 
Similar findings were reported in a study examining specific deletion of the CB1-receptor in 
Nav1.8 positive sensory neurons, which determined that CB1 receptors expressed on 
peripheral nerves are critical for a large part of cannabinoid agonist-induced analgesia 
(produced by systemic administration) in a model of  inflammatory pain (Agarwal et al., 
2007).  
The findings presented in this chapter have already shown that the activity of TRPM3 can 
be sensitised by intracellular pathways downstream of Gs and Gq linked GPCR activation. 
Signalling through these pathways is increased during periods of inflammation leading to 
sensitisation of nociceptive afferents. If sensitisation of TRPM3 channels, expressed on 
sensory neurons, is involved in the generation of pain hypersensitivity, inhibition of TRPM3 
channels by opiates which are active at µ-opioid receptors or cannabinoids which act on 
CB1 receptors could contribute to anti-hyperalgesia. However, modulation of TRPM3 
channels via CB1 receptors in the periphery is probably less prevalent considering the small 
effect of CB1-receptor activation on the PS-induced responses of cultured sensory neurons.  
4.5.7 TRPM3 contributes to the sensation of pain 
As previously discussed (see section 4.5.2.3), the findings presented in this chapter have 
shown that Trpm3-/- mice exhibit a reduced sensitivity to noxious heat in comparison to 
their wildtype counterparts.  In addition, other studies (performed by Clive Gentry, King’s 
College London) have demonstrated that Trpm3-/- mice have normal behavioural responses 
to mechanical and cold (10°C) stimuli. These experimental findings demonstrate that 
TRPM3 channels are not essential for behavioural responses to stimulation with noxious 
cold or mechanical stimuli.  
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Interestingly, further studies (performed by Clive Gentry, King’s College London) have 
shown that Trpm3-/- mice do not develop the cold or heat hypersensitivity normally 
associated with inflammatory (induced by complete Freund’s adjuvant) or neuropathic 
(induced by partial sciatic nerve ligation) pain conditions (unpublished data, Clive Gentry). 
This is an intriguing finding as it suggests that TRPM3 is responsible for regulating 
sensitivity to both heat and cold in these pain states.  
 
 
Figure 4-23 Schematic illustrating inhibition of TRPM3 channels by Gαi linked GPCR receptors  
Activation of sensory neuron expressed CB1 receptors, δ-opioid receptors (δ-OR) and µ-opioid receptors (μ-OR) 
can lead to inhibition of adenylyl cyclase activity via activation of heterotrimeric G protein and release of a Gαi-
GTP monomer (Stein et al., 2003; Turu and Hunyady, 2010). This inhibition of adenylyl cyclase activity results in 
decreased cAMP production and therefore lowers the cellular levels of cAMP; therefore preventing the cAMP-
mediated activity which aids TRPM3 channel function. Effectors of cAMP mediated actions include PKA and 
Epac; Epac can couple to members of the Rap family leading to activation of PLC and PLD enzymes which can 
lead to increases in the activity of the PKCε isoform (Hucho et al., 2005; Schmidt et al., 2001).  
The results of the current study have also implicated TRPM3 channels in behavioural 
sensitivity in a model of persistent pain. The formalin test of nociception induces two 
phases of behaviour, an immediate initial phase and a later second phase. The first phase 
of pain was unchanged in Trpm3-/- mice whereas nociceptive behaviour was reduced in the 
second phase. The first phase of formalin-induced pain is thought to be due to the direct 
activation of nociceptive neurons whereas the second phase is suggested to be driven by 
sensitisation mechanisms (Le Bars et al., 2001). There is debate over whether the 
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sensitisation represented by the second phase is peripherally or centrally located. One 
study argued that the second phase of the formalin test is due to redistribution of 
formaldehyde which results in a second phase of excitation (Fischer et al., 2014). This study 
also suggests that the ‘interphase’ of the formalin test is the result of neuronal 
hyperpolarisation driven by inhibition of sodium currents.  
Interestingly many drugs including; NSAID drugs, NMDA antagonists, morphine and 
gabapentin are only analgesic in the second phase of pain (Le Bars et al., 2001; McNamara 
et al., 2007). The finding that animals lacking functional TRPM3 channels display less 
spontaneous pain behaviour in the second phase of formalin-induced pain could reflect an 
involvement of TRPM3 in peripheral or central sensitisation mechanisms, consistent with 
findings showing that Trpm3-/- mice fail to exhibit heat or cold hypersensitivity in CFA-
induced inflammation and nerve ligation.  
In contrast to the pro-nociceptive roles of TRPM3 indicated by the hot-plate test and the 
formalin test, the results of this chapter suggest an anti-nociceptive role for TRPM3 in 
abdominal pain-sensing mechanisms. Trpm3-/- mice appeared to display a greater number 
of ‘writhing’ movements compared to their wildtype counterparts after administration of 
an intraperitoneal injection of acetic acid however this finding was not statistically 
significant. These results could suggest that mice lacking functional TRPM3 channels are 
more sensitive to acetic-acid induced pain than mice with functional TRPM3 channels. The 
outer lining of the abdomen receives innervation from the somatosensory nervous system 
and therefore the pain could be either visceral or somatic in origin (Le Bars et al., 2001). 
TRPM3 channels expressed in visceral sensory neurons or even non-neuronal tissues could 
play roles which contribute to anti-nociception. However, further investigations will be 
required to determine whether TRPM3 channels do have an anti-nociceptive role in the 




4.5.8 The role played by TRPM3 in the spinal cord and brain  
The findings presented in this chapter have examined modulation and activation of TRPM3 
channels at the level of the DRG neurons. Trpm3-/- animals experience deficits in acute and 
tonic noxious pain sensing and also impaired development of some pain hypersensitivities. 
TRPM3 has been labelled as a noxious heat sensor however deletion of TRPM3 from the 
sensory neuron ganglia only causes a small effect on the heat sensing capabilities of 
sensory neurons and they retain significant heat sensitivity. It is possible that expression of 
TRPM3 channels in other areas of the nervous system is responsible for the nociceptive 
impairments observed in Trpm3-/- mice. TRPM3 was found at relatively high levels in the 
mouse dorsal spinal cord. Furthermore, TRPM3 was found to be expressed at levels 
comparable to the DRG, in the midbrain, cerebellum and olfactory bulb. These findings 
suggest the likelihood of varied and distinct physiological roles for TRPM3 channels which 




TRPM3 is a sensory neuron expressed, Ca2+ permeable channel which can be activated by 
the neurosteroid pregnenolone sulphate and by heat. Functional TRPM3 channels are 
required for sensitivity to noxious heat in vivo and are involved in nociceptive responses to 
tonic pain. Their activity is sensitised by intracellular signalling pathways which are 
downstream of increased cAMP levels and PLC activation. Interestingly, within a sensory 





Chapter 5. A spinal cord synaptosome CGRP release assay for the 




5.1 Introduction  
The peripheral terminals of primary afferent neurons innervate peripheral tissues and 
function as transducers of local stimuli. Depolarisation of the peripheral sensory terminals 
generates action potentials, which are conducted along the peripheral axons to the central 
terminals, where they synapse with second-order neurons in the dorsal horn of the spinal 
cord (primary afferents of the DRG) or spinal trigeminal nucleus (primary afferents of the 
TG).  
Sensory neuron TRP channels are expressed on the membranes of both peripheral and 
central terminals of primary afferent neurons and activation of TRP channels at both sites 
can lead to the release of the neuropeptides CGRP and SP (Eberhardt et al., 2014, 2012; 
Kessler et al., 1999; Kilo et al., 1997; Mogg et al., 2013; Pozsgai et al., 2012; Saria et al., 
1986; Trevisani et al., 2007; Yan et al., 2006). Additionally, stimulation of TRP channels has 
been shown to evoke neuropeptide release from the axons of primary afferent nerves and 
from sensory ganglia (Boillat et al., 2014; Eberhardt et al., 2008; Kunkler et al., 2011; 
Nakamura et al., 2012; Spitzer et al., 2008; Weller et al., 2011). The release of CGRP and SP 
into the periphery by antidromic stimulation causes neurogenic inflammation (Brain and 
Cox, 2006). CGRP has potent vasodilator effects and SP increases vascular permeability 
(Brain et al., 1985; Yano et al., 1989). Moreover, the release of CGRP and SP from central 
terminals is implicated in pain (Brain and Cox, 2006). 
5.1.1 Sensory neurotransmitters 
Synaptic transmission of information relies upon transmitter release. Primary afferent 
neurons conveying information about innocuous stimuli release the excitatory 
neurotransmitter glutamate from their presynaptic terminals eliciting excitatory 
postsynaptic potentials (EPSPs) in second-order sensory neurons (Jahr and Jessell, 1985; 
Woolf and Ma, 2007). However, nociceptive nerve fibres, which are either unmyelinated 
(C) or thinly myelinated (Aδ) fibres, release CGRP and SP in addition to glutamate from their 
presynaptic terminals (Woolf and Ma, 2007). The current study focuses on the release of 
CGRP from central terminals.  
5.1.2 CGRP 
Two isoforms of CGRP exist, CGRPα and CGRPβ, which are formed from two different genes 
(Brain and Cox, 2006). The CGRPα isoform is widely expressed and is localised to C and Aδ 
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fibres of the DRG whereas the CGRPβ isoform is predominantly expressed in neurons of the 
enteric nervous system. Receptors for CGRP are expressed within the dorsal horn of the 
spinal cord and it is thought that release of CGRP at the first central synapse could 
contribute to pain hypersensitivity (Bennett et al., 2000; Chen et al., 2010; Cottrell et al., 
2005; Kawamura et al., 1989; Yu et al., 1994; Zhang et al., 2001). CGRPα-expressing sensory 
nerves have been shown to be sensitive to agonists of TRPV1 and TRPA1, in addition to 
acidic pH, ATP and some pruritic substances (McCoy et al., 2012).  Moreover, CGRPα 
neurons have been shown to be important for behavioural responses to heat and itch, and 
have been reported to suppress cold sensitivity (McCoy et al., 2013).  
5.1.3 TRP Channels at Central Synapses 
The role TRP channels play in sensing chemical, thermal and mechanical stimuli in the 
periphery is well characterised (Caterina et al., 1999; Damann et al., 2008; Peier et al., 
2002b; Story et al., 2003b), yet the role TRP channels play when expressed at central 
terminals remains ambiguous. Sensory neuron TRP channels, notably TRPV1, TRPA1 and 
TRPM8, are expressed on the presynaptic, central terminals of primary afferent neurons, in 
addition to nerve terminals in the periphery, but are not expressed by spinal neurons 
(Andersson et al., 2011; Baccei et al., 2003; Dhaka et al., 2008; Kim et al., 2010; Mogg et al., 
2013; Sikand and Premkumar, 2007; Takashima et al., 2007).   
Activation of TRPV1 and TRPA1 channels expressed on central terminals has been shown to 
increase neurotransmitter release within the spinal cord  (Li and Eisenach, 2001, 2005; 
Mogg et al., 2013; Puttfarcken et al., 2010; Saria et al., 1986; Trevisani et al., 2007) and 
activation of TRPV1, TRPA1 and TRPM8 channels has been shown to increase the frequency 
of spontaneous mEPSCs recorded in the dorsal horn of the spinal cord (Jeffry et al., 2009; 
Wrigley et al., 2009). Conversely, activation of these sensory neuron TRP channels at 
presynaptic central terminals has been shown to inhibit evoked EPSCs (Jeffry et al., 2009; 
Wrigley et al., 2009). This latter finding suggests that activation of TRP channels at central 
terminals can interrupt nociceptive transmission through a process of depolarisation block. 
Consistent with these findings, one study concluded that the intrathecal administration of 
compounds which activate TRPA1, such as cinnamaldehyde and the acetaminophen-
metabolite, N-acetyl-p-benzoquinoneimine, can interrupt spinal nociceptive transmission 
by activation of TRPA1 and a consequent reduction in voltage-gated calcium and sodium 
currents (Andersson et al., 2011). 
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The function of TRP channels at the central synapse appears two-fold, when activated in 
the absence of depolarising stimuli they can increase the frequency of spontaneous 
mEPSCs. However, in the presence of a depolarising stimulus, TRP channels located on the 
presynaptic-membrane can diminish this incoming stimulus inhibiting eEPSCs; positioning 
these channels as novel therapeutic targets in nociceptive conditions.  
5.1.4 Neurotransmitter Release ‘in-vitro’ 
Neurotransmitter release can be used to profile functional TRP channels which are 
expressed at the central terminals of primary afferents. In vivo, microdialysis has commonly 
been used to measure transmitter release however it is impractical for investigating 
detailed concentration-response relationships of different compounds. Furthermore, 
accurate estimations of drug concentrations reaching receptors cannot be made. The aim 
of the current study was to develop and characterise a different approach, measuring CGRP 
release from tissue preparations in vitro using a medium-throughput (96-well format) 




5.2 Aim of the present study  
The aim of the present study was to investigate whether activation of TRPA1 channels 
natively expressed on the central terminals of primary afferent neurons present in the 
dorsal horn of the spinal cord could evoke CGRP release. In addition it was to test whether 
depolarisation-induced CGRP release could be modulated by inhibition of VGCCs, or by 
opioid receptor activation. These experimental aims were investigated by measuring CGRP 
release from samples of homogenised rat spinal cord with an ELISA.  
The initial studies in this chapter were carried out at the laboratories of Eli Lilly and 




5.3 Materials and Methods 
5.3.1 Solutions and Reagents 
Some experiments were completed with Tyrode’s salts with HEPES buffer (Invitrogen; 041-
95897M) + 10µM thiorphan (to prevent CGRP breakdown by endogenous proteases) but 
the majority of the experiments were conducted in HBTS (136mM NaCl, 2.7mM KCl, 1.8mM 
CaCl2, 1.05mM MgCl2, 5mM glucose, 10mM HEPES and 335µM NaH
2PO4) + 10µM thiorphan 
buffered to pH 7.4 (NaOH). HBTS containing high extracellular potassium was made by iso-
osmotic addition of 40mM KCl. For Ca2+-free experiments CaCl2 was omitted from the 
solution and 1mM EGTA was added. 
Master stock solutions of AITC, cinnamaldehyde (Sigma-Aldrich; St Louis, MO), AP18 
(Maybridge; Tintagel, Cornwall, UK) were made in DMSO (Calbiochem; Darmstadt, 
Germany). Master stock solutions of 4-HNE and 4-ONE (Cayman Chemical; Ann Arbour, MI) 
were made in EtOH. Stock solutions of nifedipine, mibefradil dihydrochloride, ω-conotoxin 
MVIIC (Tocris Bioscience; Bristol, UK) were made in HBTS. Master stock solutions of 
morphine and naloxone (Sigma-Aldrich; St Louis, MO) were made in H2O. All master stock 
solutions were aliquotted and stored at -20°C. Dilutions from these aliquots into HBTS were 




5.3.2 Methodology for 96 well CGRP release assay 
Adult, male, Sprague Dawley rats (~250-500g) were killed by exposure to a rising 
concentration of CO2 or by cervical dislocation. The lumbar portion of the spinal cord was 
then dissected, weighed and placed in a Sterilin tube containing ice-cold HBTS buffer 
without thiorphan. The cord was homogenised using approximately 12-15 strokes of a 
glass-Teflon hand homogeniser. The homogenate was then centrifuged for 1 minute at 
1000rpm in a bench-top centrifuge and the supernatant carefully removed and 
reconstituted at a final concentration of 4mg/ml in HBTS. 100μl of the homogenate 
solution was placed in each well of a 96-well filter plate (Millipore, type MSBVN1B50) using 
a multi-channel pipette. The use of filter plates in these experiments allowed the solutions 
bathing the synaptosomes to be easily removed. The filter plate containing the 
homogenate was incubated at 37°C in a humidified incubator gassed with 5% CO2 in air for 
20 minutes prior to compound addition.  
Following the 20 minute incubation period, the filter plate containing the homogenate was 
removed from the incubator and the buffer in the wells filtered to waste using a vacuum 
manifold. Extracellular solutions either in the presence or absence of antagonists or 
modulators were added to the wells of the filter plate (100µl per well) and the filter plate 
was incubated for 10 minutes at 37°C. The contents of the filter plate were then filtered to 
waste using a vacuum manifold. Extracellular solutions containing agonists or KCl (either in 
the presence or absence of antagonists or modulators) were then added to the wells of the 
filter plate (100 µl per well) and incubated for a further 10 minutes at 37°C.  
Following the stimulation period, solutions contained within the wells of the filter plate 
were rapidly transferred to the wells of an ELISA CGRP immunoplate (SPlbio, France) 
containing anti-CGRP-AChE tracer (100µl per well) by centrifugal force (200x g). The 
immunoplate was then covered with plastic film and incubated at 4°C for 16–20 hours. The 
following day, the immunoplate was washed four times and Ellman’s reagent was added to 
the wells of the plate (200µl). The plate was left at room temperature to develop in the 
dark for 45 minutes. The absorbance of each well was then measured at 405 nm using a 96-




5.3.3 Data analysis 
Raw absorbance values were imported into Excel (Microsoft) for further analysis and then 
into Origin (Origin Pro, version 9.1) for graphical representation of the results. The amount 
of CGRP released was reported as a percentage over basal release (the amount of CGRP 
released upon addition of HBTS) or 40mM KCl-induced release. Release stimulated in the 
presence of an antagonist or modulator is normalised to an appropriate 
antagonist/modulator basal release where possible. Where stated, n refers to the number 
of independent experiments performed using spinal cord tissue from different animals. In 
each individual experiment a minimum of 4 replicate samples per treatment were used.  
5.3.4 Statistics 
Normality of data was tested using the Shapiro-Wilk Test and homogeneity of variances 
tested using Levene’s test. Differences in means between two groups were analysed using 
an independent samples t-test. Differences in means between three groups or more were 
analysed using a one-way ANOVA, followed by a Tukey’s HSD post-hoc test (for datasets 
with equal variances) or a Dunnett’s T3 post-hoc test (for datasets with unequal variances). 





5.4.1 Activation of TRPA1 evokes CGRP Release from spinal cord homogenate 
In order to examine whether activation of TRPA1 evokes CGRP release from rat spinal cord 
synaptosomes, spinal cord homogenate was stimulated with TRPA1 agonists and the 
resulting CGRP release examined by ELISA. Stimulation of rat spinal cord homogenate by 
the pungent TRPA1 agonist, cinnamaldehyde, evoked a concentration-dependent increase 
in CGRP release with a mean EC50 value of 54.79 ± 5.84µM (mean ± SEM; n= 10 
experiments; Figure 5-1a). Activation by allyl-isothiocyanate (AITC) also evoked CGRP 
release with an EC50 value of 17.08 ± 0.77µM (mean ± SEM; n= 3 experiments; Figure 5-1b). 
CGRP release was also evoked by electrophilic, endogenous agonists of TRPA1.  4-HNE and 
4-ONE evoked CGRP release from spinal cord homogenate with EC50 values of 17.39 ± 
0.68µM and 63.80 ± 4.26µM, respectively (mean ± SEM; n= 3 experiments; Figure 5-1).   
In order to examine whether the CGRP release induced by the TRPA1 agonists is dependent 
on the influx of Ca2+ ions, the effect of removing external Ca2+ was examined using 
cinnamaldehyde-induced CGRP release. In the presence of extracellular Ca2+, 
cinnamaldehyde induced robust increases in CGRP release and in the absence of 
extracellular Ca2+, cinnamaldehyde-induced CGRP release was attenuated. The average 
response to 1000µM cinnamaldehyde in Ca2+ free solutions was decreased to 18 ± 6% of 
the response in Ca2+ containing solutions (mean ± SEM; n = 3 experiments; Figure 5-2). This 
finding suggests that influx of extracellular Ca2+ ions is required for TRPA1 agonist-induced 
CGRP release.  
5.4.2 TRPA1-induced CGRP release requires synaptosomes which originate from the 
dorsal spinal cord 
TRPA1 is thought to be expressed on the primary afferent nerve terminals of the dorsal 
root ganglia which enter the spinal cord via the dorsal roots and typically terminate within 
layers I-V of the dorsal horn (Story et al., 2003b). In order to investigate whether the CGRP 
release evoked by TRPA1 agonists occurs due to stimulation of dorsal spinal cord 
synaptosomes, separate homogenates were prepared from the dorsal and ventral spinal 
cord and stimulation by cinnamaldehyde (100µM) and KCl (40mM) was examined. 
Stimulation of dorsal spinal cord homogenate by cinnamaldehyde evoked CGRP release 
which was on average 14 ± 5% above the basal levels of release (mean ± SEM; n= 3 
experiments). However, stimulation of ventral spinal cord homogenate by cinnamaldehyde 
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(100µM) failed to evoke CGRP release above basal levels (0 ± 1% over basal release; mean ± 
SEM; n= 3 experiments; Figure 5-3).  
Stimulation of dorsal spinal cord homogenate by KCl (40mM) evoked large increases in 
CGRP release which were on average 67 ± 9% over the basal level of release (mean ± SEM; 
n= 3 experiments). However, stimulation of ventral spinal cord homogenate by KCl (40mM) 
only evoked a small increase in CGRP release which was significantly lower than the release 
evoked by dorsal spinal cord homogenate (6 ± 4% over basal release; p<0.01; t-test; n= 3 
experiments; Figure 5-3).  
These findings suggest that cinnamaldehyde-evoked CGRP release is dependent on 
synaptosomes which originate from the dorsal spinal cord. Furthermore, these findings 
suggest that depolarisation-induced CGRP release relies primarily on the release of CGRP 
from dorsal spinal cord synaptosomes but also indicate that a small amount of CGRP can be 





Figure 5-1 Activation of TRPA1 evokes CGRP release 
The release of CGRP from rat spinal cord homogenate was measured by ELISA. Application of TRPA1 agonists 
evoked concentration-dependent increases in CGRP release from spinal cord homogenate.  (a) Cinnamaldehyde 
induced CGRP release with an EC50 value of 54.78 ± 5.84µM (mean ± SEM; n= 10). (b) AITC evoked CGRP release 
with an EC50 value of 17.08 ± 0.77µM (mean ± SEM; n= 3). (c) The endogenous TRPA1 agonist 4-HNE stimulated 
CGRP release with an EC50 value of 17.39 ± 0.68µM (mean ± SEM; n= 3). (d) Another endogenous TRPA1 agonist, 
4-ONE, also induced CGRP release with an EC50 value of 63.80 ± 4.26µM (mean ± SEM; n= 3). Representative 
plots shown, data points are the mean normalised release (% of 40mM KCl-induced release) of quadruplicate 




Figure 5-2 Cinnamaldehyde-induced CGRP release is dependent on extracellular Ca
2+
 
Cinnamaldehyde-induced CGRP release from rat spinal cord homogenate was measured by ELISA in the 
presence and absence of external Ca
2+
. In the absence of external Ca
2+
 ions cinnamaldehyde-induced CGRP 
release was attenuated. Representative plot shown, data points are the mean normalised (% of 40mM KCl-





Figure 5-3 Cinnamaldehyde induces CGRP release from dorsal but not ventral spinal cord synaptosomes  
CGRP release from dorsal and ventral spinal cord homogenate was measured by ELISA.  Cinnamaldehyde 
(100µM) induced CGRP release from dorsal spinal cord homogenate (14 ± 5% over basal release; mean ± SEM; n 
= 3 experiments) but did not evoke release from synaptosomal preparations from the ventral spinal cord (0 ± 
1% over basal release; mean ± SEM; n = 3 experiments). KCl (40mM) evoked a large increase in CGRP release 
from dorsal spinal cord homogenate (67 ± 9% over basal release; mean ± SEM; n = 3 experiments). The CGRP 
release evoked by KCl in ventral spinal cord homogenate was significantly lower (6 ± 4% over basal release; 





5.4.3 Cinnamaldehyde- and AITC-evoked CGRP release is mediated through activation 
of TRPA1  
In order to test whether the CGRP release evoked by TRPA1 agonists is mediated through 
activation of TRPA1, the effect of a TRPA1 antagonist (AP18) on cinnamaldehyde- and AITC-
induced CGRP release was examined. Dorsal spinal cord homogenate was stimulated with 
100µM cinnamaldehyde and 100µM AITC in the presence and the absence of 50µM AP18. 
In the absence of AP18, both cinnamaldehyde and AITC evoked notable increases in CGRP 
release. Cinnamaldehyde evoked CGRP release (39 ± 8% of 40mM KCl-evoked release, 
mean ± SEM; n= 3 experiments) was completely inhibited in the presence of AP18 (average 
release reduced to -1 ± 3% of 40mM KCl-evoked release, mean ± SEM; p< 0.05; t-test; n= 3 
experiments; Figure 5-4). Similar to cinnamaldehyde-evoked release, AITC-induced CGRP 
release was also significantly inhibited in the presence of AP18, where the average release 
was reduced from 42 ± 11% to 8 ± 5% of the amount released by 40mM KCl (mean ± SEM; 
p< 0.05; t-test; n= 3 experiments; Figure 5-4). These findings demonstrate that both 
cinnamaldehyde and AITC evoke CGRP release in this preparation by activating TRPA1.  
5.4.4 VGCC blockade does not affect TRPA1-induced CGRP release  
TRPA1 channel opening leads to an influx of Na+ and Ca2+ ions, an event which causes 
membrane depolarisation. The depolarisation may, in turn, result in the opening of voltage-
gated ion channels. To investigate whether Ca2+ influx through voltage-gated calcium 
channels (VGCCs) contributes to the CGRP release evoked by TRPA1 activation, the effect of 
VGCC inhibitors on cinnamaldehyde-induced CGRP release from dorsal spinal cord 
homogenate was investigated.  
Dorsal spinal cord homogenate was stimulated with 100µM cinnamaldehyde in the 
presence and absence of the L-type VGCC inhibitor nifedipine (5µM), the T-type VGCC 
inhibitor mibefradil dihydrochloride (10µM), a low concentration of ω-conotoxin MVIIC 
(200nM) to inhibit P/Q-type VGCCs or a high concentration of ω-conotoxin MVIIC to inhibit 
N and P/Q-type VGCCs (1µM). The CGRP release evoked by 100µM cinnamaldehyde was 
not significantly altered in the presence of the VGCC inhibitors (NS; ANOVA; n= 3-4 
experiments; Figure 5-5). However, a trend for increased CGRP release was evident when 
homogenate was stimulated by cinnamaldehyde in the presence of nifedipine (5µM) where 
release was increased from 32 ± 6% to 50 ± 9% of 40mM KCl-evoked release (mean ± SEM; 






Figure 5-4 AITC and cinnamaldehyde-induced CGRP release is inhibited by a TRPA1 antagonist  
The effect of a TRPA1 antagonist, AP18 (50µM), on cinnamaldehyde (100µM) and AITC (100µM) evoked CGRP 
release (measured by ELISA) from rat dorsal spinal cord homogenate was examined. (a) Graph displaying CGRP 
release (as measured by absorbance at 405 nM) evoked by 100µM AITC and 100µM cinnamaldehyde in the 
presence and absence of 50µM AP18 in a representative experiment. Also shown are the levels of CGRP release 
evoked by negative (basal) and positive (40mM KCl) controls. Columns represent mean ± SEM of quadruplicate 
wells. (b) Cinnamaldehyde-induced CGRP release was significantly inhibited by AP18, release was reduced from 
39 ± 8% of 40mM KCl-evoked release in the absence of AP18, to -1 ± 3% of 40mM-KCl evoked release in the 
presence of AP18. Columns represent mean ± SEM (* P < 0.05; t-test; n= 4 experiments). (c) AITC-induced CGRP 
release was also significantly inhibited by AP18, AITC-induced release was reduced from 42 ± 11% of 40mM KCl-
evoked release to 8 ± 5% of 40mM KCl-evoked release in the presence of AP18. Columns represent mean ± SEM 
(* P < 0.05; t-test; n= 4 experiments).  
 
 
Figure 5-5 Blocking VGCCs does not affect cinnamaldehyde-induced CGRP release 
The effect of VGCC-blockade on 100µM cinnamaldehyde-induced CGRP release (measured by ELISA) from rat 
dorsal spinal cord homogenate was examined. (a) 100µM cinnamaldehyde-induced CGRP release (control) was 
not significantly affected in the presence of 5µM nifedipine, 200nM ω-conotoxin MVIIC (CTX) or 10µM 
mibefradil dihydrochloride. Columns represent mean ± SEM (ANOVA; n= 4 experiments). (b) 100µM 
cinnamaldehyde-induced CGRP release (control) was not significantly altered in the presence of 1µM ω-
conotoxin MVIIC (CTX) or a cocktail of VGCC blockers (containing 5µM nifidepine, 1µM ω-conotoxin MVIIC and 
10µM mibefradil dihydrochloride). Data is normalised to 40mM KCl-induced release. Columns represent mean ± 




5.4.5 T-type VGCCs are required for CGRP release induced by depolarisation  
CGRP release is evoked by high concentrations of KCl which lead to depolarisation and 
opening of VGCCs. In order to study the differential contribution of VGCC subtypes to 
depolarisation-induced CGRP release, the effect of VGCC inhibitors on KCl-induced CGRP 
release from dorsal spinal cord homogenate was investigated.  
Dorsal spinal cord homogenate was stimulated with 40mM KCl in the presence and 
absence of individual VGCC inhibitors; nifedipine (5µM), mibefradil dihydrochloride 
(10µM), ω-conotoxin MVIIC (200nM), ω-conotoxin MVIIC (1µM).  
Depolarisation-induced CGRP release was not affected by the presence of 5µM nifedipine 
or 200nM ω-conotoxin MVIIC. Block of N and P/Q type VGCCs by 1µM ω-conotoxin MVIIC 
lead to a small reduction in depolarisation-induced CGRP release, however this effect was 
not significant (73 ± 8% of 40mM KCl-evoked release; mean ± SEM; NS; ANOVA followed by 
Tukey’s HSD test; n= 4 experiments; Figure 5-6). Interestingly, depolarisation evoked CGRP 
release was significantly inhibited in the presence of the T-type VGCC inhibitor, mibefradil 
dihydrochloride (10µM) (48 ± 6% of 40mM KCl-evoked release, mean ± SEM; p<0.001; 
ANOVA followed by Tukey’s HSD test; n= 5 experiments; Figure 5-6). Furthermore, 
depolarisation-induced CGRP release was profoundly inhibited in the presence a VGCC 
inhibitor cocktail (containing 5µM nifidepine, 1µM ω-conotoxin MVIIC and 10µM mibefradil 
dihydrochloride), where CGRP release was reduced to 28 ± 9% of 40mM KCl-evoked release 
(mean ± SEM; p<0.001; ANOVA followed by Tukey’s HSD test; n= 4 experiments; Figure 5-
6). These findings suggest an importance of T- and to a lesser extent N-type VGCCs for 






Figure 5-6 Depolarisation-evoked CGRP release is inhibited by VGCC blockade  
The effect of VGCC-blockade on depolarisation-induced (40mM KCl) CGRP release (measured by ELISA) from rat 
dorsal spinal cord homogenate was examined. 40mM KCl evoked CGRP release which was significantly 
decreased in the presence of the t-type VGCC blocker, mibefradil dihydrochloride (10µM) and a cocktail of 
VGCC inhibitors (containing 5µM nifidepine, 1µM ω-conotoxin MVIIC and 10µM mibefradil dihydrochloride). 
There was a trend for homogenate treated with 1µM ω-conotoxin MVIIC (CTX) to exhibit a reduced release to 
40mM KCl although this was not significant. Treatment with 5µM nifedipine and 200nM ω-conotoxin MVIIC had 
no effect on KCl-induced release. Data is normalised to 40mM KCl-induced release (control). Columns represent 
mean ± SEM (*** P <0.001; ANOVA followed by Tukey’s HSD test; nifedipine, 200nM CTX, 10µM Mib, n= 5 




5.4.6 Modulation of depolarisation-induced CGRP release by morphine  
Activation of opioid receptors expressed on sensory neurons causes inhibition of voltage-
gated calcium channels. In order to examine whether depolarisation-induced CGRP release 
could be inhibited by opioid receptor activation, the effects of the prototypical opioid 
receptor agonist, morphine, on KCl-induced CGRP release was investigated.  
Dorsal spinal cord homogenate was stimulated with KCl (5-60mM) in the presence and 
absence of 10µM morphine. The concentration dependent KCl-evoked CGRP release was 
suppressed in the presence of 10µM morphine; the largest effects were on CGRP release 
evoked by 40 and 60mM KCl (Figure 5-7a).  
An inhibitory trend of morphine (10µM) on CGRP release was observed, CGRP release 
evoked by 40mM KCl was reduced from 77 ± 7% to 62 ± 5% over basal release in the 
presence of morphine (mean ± SEM; NS; ANOVA; n= 4 experiments). Furthermore, CGRP 
release evoked by 60mM KCl was reduced from 131 ± 17% to 103 ± 6% over basal release 
(mean ± SEM; NS; ANOVA; n= 4 experiments). In order to examine whether the inhibitory 
effects of morphine on CGRP release were mediated by opioid receptors, dorsal spinal cord 
homogenate was stimulated with KCl (40 and 60mM) in the presence of  morphine (10µM) 
and the opioid receptor antagonist naloxone (1µM). The inhibitory effects of morphine 
were reduced by naloxone indicating that the release of CGRP can be modulated by opioid 




Figure 5-7 The effect of morphine on depolarisation-induced CGRP release  
(a) The effect of morphine on depolarisation-induced CGRP release (measured by ELISA) from rat dorsal spinal 
cord homogenate was examined. KCl evoked CGRP release in a concentration dependent manner which was 
inhibited by morphine (10µM). Representative plot shown, data points are the mean normalised (% over basal) 
release of quadruplicate wells ± SEM. (b) There was a trend for homogenate treated with morphine to exhibit a 
reduced CGRP release in response to 40mM and 60mM KCl. This effect was reversed in the presence of 
naloxone. Data is normalised to basal release. Columns represent mean ± SEM (NS; ANOVA followed by Tukey’s 





The results presented in this chapter describe a medium-throughput methodology for 
examining stimulation of spinal cord synaptosomes and have shown that activation of 
TRPA1 by pungent food compounds and products of lipid peroxidation evokes CGRP release 
from this preparation. The results of this study suggest that TRPA1 mediated CGRP release 
does not require opening of VGCCs. Additionally, the results have demonstrated an 
involvement of low-threshold T-type VGCCs and to a lesser extent, N-type VGCCs, in the 
depolarisation-evoked release of CGRP within the spinal cord.   
5.5.1 CGRP release is evoked by TRPA1 agonists 
The CGRP release assay allowed full concentration response curves to be constructed for 
cinnamaldehyde, AITC, 4-HNE and 4-ONE. Concentrations of cinnamaldehyde, AITC and 4-
HNE required to evoke CGRP release from synaptosomes were within the same range as 
those needed to activate TRPA1 channels expressed in recombinant cell systems 
(Macpherson et al. 2007; Taylor-Clark et al. 2008; Bandell et al. 2004). However the 
concentration of 4-ONE required for half-maximal release of CGRP reported in the current 
study (~64µM) is higher than the EC50 value (~2µM) reported for recombinant TRPA1 
channels in other studies  (Taylor-Clark et al., 2008b). Cinnamaldehyde-induced CGRP 
release was dependent on extracellular calcium. Moreover, cinnamaldehyde- and AITC-
evoked CGRP release was inhibited by the TRPA1-selective inhibitor, AP18, confirming that 
the release is mediated by the TRPA1 channel.  
5.5.2 CGRP release occurs predominantly from the dorsal spinal cord  
CGRP release induced by activation of TRPA1 was restricted to dorsal spinal cord 
homogenate. Stimulation of ventral spinal cord homogenate with the TRPA1 agonist, 
cinnamaldehyde, failed to release CGRP above basal levels. In light of the findings that 
TRPA1 expression in the dorsal spinal cord is abolished with dorsal rhizotomy (Kim et al., 
2010), these findings are consistent with TRPA1-induced CGRP release from the central 
terminals of TRPA1-expressing primary afferent neurons which terminate in the superficial 
layers of the dorsal horn (Kim et al., 2010).  
CGRP release evoked by high potassium was significantly higher in homogenate samples 
from the dorsal spinal cord in comparison to samples from the ventral spinal cord. 
However, a small release of CGRP in response to high potassium was evident in ventral 
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spinal cord homogenate; this suggests that depolarisation of some motor neuron terminals 
could lead to the release of CGRP. This finding is consistent with reports of CGRP 
expression within motor neuron cell bodies of the ventral spinal cord where it is suggested 
to be involved in repair mechanisms following nerve injury (Chen et al., 2010; McCoy et al., 
2012).  
5.5.3 TRPA1-induced CGRP release is largely independent of VGCCs 
Interestingly, inhibition of L-type, T-type, P/Q-type and N-type VGCCs did not significantly 
alter the levels of CGRP released by a sub-maximal concentration of cinnamaldehyde. This 
finding suggests that Ca2+ influx through the TRPA1 channel itself is sufficient to evoke 
release and is consistent with reports of a high Ca2+ permeability of TRPA1 (see Zygmunt 
and Högestätt, 2014 for review). Similar findings were reported for TRPV1 in a study 
examining CGRP release from rat sciatic nerve axons which found that capsaicin-induced 
CGRP release was unaffected by blockade of L-type and T-type VGCCs both of which were 
important for high potassium-induced CGRP release (Spitzer et al., 2008).  
A trend was observed for potentiation of cinnamaldehyde-induced release by nifedipine; 
release was increased from 32 ± 6% to 50 ± 9% (of KCl-evoked release) in the presence of 
5µM nifedipine. The 1,4-dihydropyridines have been demonstrated to be TRPA1 agonists 
and nifedipine has been shown to activate recombinantly-expressed TRPA1 channels with 
an EC50 value of ~0.4μM (Fajardo et al., 2008b). An increased release of CGRP could 
therefore be due to the synergistic activation of TRPA1 by cinnamaldehyde and nifedipine, 
resulting in increased Ca2+ influx and CGRP release (Fajardo et al., 2008b). Moreover, 
nifedipine has also been identified as an activator of the sensory neuron-expressed 
channel, TRPM3, with an EC50 value of ~30µM (Wagner et al., 2008). Activation of TRPM3 
channels could also contribute to the release of CGRP, although it has not yet been 
identified whether these channels are expressed on peptidergic nerve terminals. 
Confounding activation of TRPA1 or TRPM3 by the L-type VGCC inhibitor and consequent 
CGRP release could mask any inhibition and makes assessing the role of L-type VGCCs in 
cinnamaldehyde-induced release difficult. However inhibition of other VGCCs present on 
sensory nerves had no effect on TRPA1-induced release, suggesting that TRPA1-induced 




5.5.4 Depolarisation-induced CGRP release requires low-threshold T-type VGCCs 
In the current study, the contribution of VGCC subtypes to depolarisation-induced CGRP 
release was also examined. Studies examining CGRP release evoked by high extracellular 
potassium from isolated lung and skin have identified a reliance upon N and L-type high 
VGCC subtypes (Kress et al., 2001; Lou et al., 1992). However, the importance of T-type low 
VGCCs was not investigated in these studies. In the current study, high potassium (40mM) 
induced CGRP release which was significantly decreased by inhibition of T-type VGCCs. 
Mibefradil dihydrochloride, decreased high potassium induced-CGRP release by ~50%. 
Consistent with this finding, a dependence on T-type VGCCs has also been demonstrated 
for nitric oxide-induced CGRP release from cultured trigeminal ganglion neurons and high 
potassium-induced CGRP release from sciatic nerve axons (Bellamy et al., 2006; Spitzer et 
al., 2008).  Moreover, inhibition of T-type VGCCs has been shown to decrease mEPSC 
frequency in the dorsal horn of the spinal cord (Bao et al., 1998). It is important to note 
that mibefradil dihydrochloride also has a small effect on high threshold L-type VGCC, 
however it has a 12-13 fold greater affinity for T-type VGCCs and the concentration used in 
this study (10µM) should act predominantly to inhibit T-type VGCCs (Martin et al., 2000). 
Interestingly, T-type calcium channels are implicated in nociception. Thermal and 
mechanical hypersensitivity induced by peripheral nerve injury and diabetic neuropathy 
has been shown to be alleviated by T-type channel blockers  (Dogrul et al., 2003; Latham et 
al., 2009; Lee et al., 2010b; Pathirathna et al., 2005) and oligodeoxynucleotide antisense 
knockdown of Cav3.2 (Bourinet et al., 2005).  
In contrast to other studies investigating CGRP release (Kress et al., 2001; Lou et al., 1992; 
Spitzer et al., 2008), pharmacological blockade of L-type VGCCs had no effect on high 
potassium-induced CGRP release. However, as discussed in section 5.5.3, the 1,4-
dihydropyridine drug, nifedipine (5µM) used to investigate L-type VGCC involvement can 
activate TRPA1 within this concentration range and could also activate TRPM3. Such an 
effect could be masking any potential inhibition of release achieved by block of L-type 
VGCCs (Fajardo et al., 2008b; Wagner et al., 2008). Interestingly, some studies have used 
another 1,4-dihydropyridine compound, nimodipine, which is also an agonist of TRPA1, to 
test the involvement of L-type VGCC but reported inhibition of high potassium-induced 
CGRP release (Kress et al., 2001; Spitzer et al., 2008).  
In the current study, pharmacological blockade of P/Q-type VGCCs alone by a low 
concentration of ω-conotoxin MVIIC (200nM) did not significantly alter CGRP release 
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evoked by high potassium. However, block of both N and P/Q type VGCCs by a higher 
concentration of ω-conotoxin MVIIC (1µM) lead to a reduction in high potassium-evoked 
CGRP release, although this was not a significant effect. This result suggests that N-type 
VGCCs could contribute to depolarisation-induced CGRP release. Consistent with this 
possibility, application of a VGCC inhibitor cocktail reduced high-potassium evoked release 
by ~72%, which is a greater inhibition than achieved by mibefradil dihydrochloride alone 
indicating that other VGCC subtypes are also required for CGRP release.  
5.5.5 Modulation of depolarisation-evoked release 
Opioid receptors are expressed on the peripheral and central terminals of sensory neurons. 
Activation of opioid receptors causes a decrease in cAMP levels and inhibition of VGCCs 
(Stein et al., 2003). Consistent with this, morphine inhibited high potassium-induced CGRP 
release and this effect could be reversed using the opioid antagonist naloxone. These data 
are consistent with an anti-nociceptive effect of morphine in the dorsal horn by presynaptic 
inhibition of CGRP expressing primary afferent nerve fibres. Similar findings have been 
demonstrated by a study examining CGRP release from the rat brainstem, which reported 
that morphine inhibited high-potassium evoked CGRP release which could be reversed by 
naloxone (Greco et al., 2014).   
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5.6 Conclusion  
Activation of TRPA1 channels natively expressed in the rat dorsal spinal cord induces 
release of the neuropeptide transmitter, CGRP. TRPA1-dependent CGRP release does not 
require activation of T-type, N-type or P/Q-type VGCCs. However, CGRP release evoked by 
depolarisation is predominantly dependent on activation of low-threshold T-type VGCCs 
and can be inhibited by activation of natively-expressed opioid receptors.    
In summary, the findings of this results chapter have demonstrated the use of a dorsal 
spinal cord homogenate assay for investigation of natively-expressed TRPA1 channels and 
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